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This study examined Ecstasy use in 322 young adults between the ages of 18 and 25 
years who participated in an Internet study regarding their history of substance use. The 
primary goal of this study was to increase our understanding of what factors differentiate 
between different ‘types’ of Ecstasy users. Specifically, this study examined potential 
factors that distinguish between young adults who experiment with the use of Ecstasy and 
then quit (“Experimenters”); become active users of Ecstasy and continue use (“Users”); 
and become active users of Ecstasy and then quit (“Quitters”). In addition, a non-ecstasy 
using polydrug using group served as a “Control” group. The following primary outcome 
variables were examined: age of first use of Ecstasy; patterns of Ecstasy consumption; 
Ecstasy use by peers; levels of social conformity, sensation seeking, risk appraisal, and 
risky behaviors; motivations for initial use of Ecstasy; motivations for continued use of 
  
Ecstasy; psychological addiction to Ecstasy; testing of Ecstasy pills; use of 5-HTP and 
vitamins; reasons reported by non-Ecstasy users for lack of experimentation with 
Ecstasy; and, general knowledge and beliefs about Ecstasy. Results indicated that Ecstasy 
Users (Experimenters, Users, and Quitters) were similar in the following characteristics: 
history of polydrug use; social conformity; sensation-seeking; appraisal of risky 
activities; history of engaging in risky activities; and self-report of reasons for first using 
Ecstasy. In addition, findings revealed the following characteristics to be distinguishing 
factors among the three groups (Users, Experimenters, and Quitters): extent of polydrug 
use; age of first use of ecstasy; patterns of ecstasy use; number of peers who currently use 
Ecstasy; and reasons for continued use of ecstasy. Notably, all of the participants in this 
study self-reported polydrug use, and Users were found to be significantly more likely to 
report having used a greater number of substances during the past 90 days than 
Experimenters, Quitters, and Controls. Furthermore, results suggest that young adults 
who have peers who use Ecstasy are at great risk for either the initiation of or 
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 The terms, MDMA and Ecstasy, are often used interchangeably in the substance 
use literature. However, in the following literature review, MDMA will be used to refer 
to the chemical substance (3,4-Methylenedioxymethamphetamine) and research 
conducted using MDMA within the context of laboratory or human clinical trials. The 
term “Ecstasy” will be used to refer to the street drug sold as MDMA, which may or may 
not actually contain MDMA. 
   Substance abuse among young adults has created a national crisis and continues to 
be an area of heightened concern and active research among medical and mental health 
professionals. Over the past ten years, the use of club drugs, a class of synthetic 
compounds that have various stimulant and hallucinogenic properties, has become more 
prominent among the spectrum of drugs used by young adults in the United States 
(Rivas-Vazquez, & Delgado, 2002). Club drugs such as ketamine hydrochloride (a 
derivative of phencyclidine hydrochloride or PCP), lysergic acid diethylamide (LSD), 
Gamma-hydroxybutyrate (GHB), and Ecstasy are often used recreationally to enhance 
social, physiological, and psychological experiences. 
One of the significant trends in the use of illicit club drugs in the US has been the 
abuse of Ecstasy among young adults. The use of Ecstasy in the United States has been 
particularly followed by researchers throughout the past decade. A nationally 
representative survey of more than 14,000 college students from 119 4-year colleges in 
the United States (1997 and 1999 Harvard School of Public Health College Alcohol 
Study) found that the prevalence of past year Ecstasy use had risen from 2.8% in 1997 to 
4.7% in 1999, an increase of 69%. Results of a follow-up study of the same sample 
       
2 
showed that the trend of increased ecstasy use continued through 2000 (Strote, Lee, & 
Wechsler, 2002). The Monitoring the Future Study found that the lifetime and annual 
prevalence of Ecstasy use among college students in 2001 was 14.7% and 9.2%, 
respectively (Johnston, O'Malley, & Bachman, 2003). According to the 2001 National 
Household Survey on Drug Abuse, young adults between the ages of 18 and 25 
represented the majority (2-3 million) of the past year Ecstasy users (Substance Abuse 
and Mental Health Services Administration, 2002). More recently, past year use of 
Ecstasy among young adults declined from 5.8% in 2002 to 3.7% in 2003, and to 3.1% in 
2004 (National Survey on Drug Use and Health, 2004). Although the number of Ecstasy 
users remained relatively constant between 2003 and 2004, study findings indicated that 
approximately 450,000 individuals had used Ecstasy during 2004, which is still of 
significant concern, and documents the continued use of Ecstasy among young adults 
(Substance Abuse and Mental Health Services Administration, 2005).  
With the widespread use of Ecstasy has come an increase in research on both its 
physiological and psychological characteristics. However, studies of Ecstasy use have 
tended to focus on examining the pharmacology and toxicology of Ecstasy; the 
demographics/characteristics of Ecstasy users; and the psychological and physiological 
effects of Ecstasy use. To date, researchers have not looked at what factors distinguish 
groups of young adult Ecstasy users. For example, why does one individual experiment 
with Ecstasy and then quit, while another tries Ecstasy and continues using Ecstasy?   
Notably, past research has found that there is predictive utility in differentiating 
types of drug users. Specifically, McCusker, Roberts, Douthwaite, and Williams (1995) 
examined illicit drug use among teenagers, and two of the groups they investigated 
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included two groups of users (experimental and repeated). Findings indicated that the two 
user groups differed on key variables identified by the authors as potential risk factors for 
escalation of drug use, including using a greater number of drugs and having a greater 
percentage of friends who used drugs.    
With regard to Ecstasy, McCusker et al. (1995) suggest that there may be 
different factors that are associated with continued use of Ecstasy in comparison to 
experimental (transient) use. Consistent with McCusker et al. (1995), prior research 
suggests that polydrug use and peer drug use are associated with intensity of Ecstasy use 
among young adults (Boys & Marsden, 2003). The McCusker et al. (1995) study 
demonstrates the utility of examining different types of Ecstasy users rather than viewing 
them as a homogenous group. Therefore, a significant contribution could be made to the 
Ecstasy literature by examining the following: (1) why and under what circumstances 
young adults use Ecstasy; (2) what factors contribute to young adults beginning use of 
Ecstasy; and (3) what factors contribute to young adults quitting use of Ecstasy.   
The goal of the current study was to increase our understanding of what factors 
differentiate between different ‘types’ of Ecstasy users. Specifically, what factors 
distinguish individuals who simply experiment with Ecstasy and cease use from 
individuals who initially experiment with Ecstasy and become regular users?  Secondly, 
what factors distinguish individuals who become regular users of Ecstasy and eventually 
quit from individuals who continue to use? 
In the literature review which follows, I will discuss relevant literature pertaining 
to: (1) history of MDMA; (2) pharmacology of MDMA; (3) neurotoxicity of MDMA; (3) 
descriptions of the Ecstasy experience/"trip;" (4) polydrug use among Ecstasy users;     
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(5) risk factors for substance use among adolescents and young adults, with a focus on 
Ecstasy; and, (6) motivations for substance use among adolescents and young adults, with 
a focus on Ecstasy. Following the literature review, I will state the problem of interest for 
this study and provide an explanation of hypotheses. Next, the Methods section will 
provide a detailed description of the design, recruitment of participants, methodology for 
collecting data, survey measures, and specific procedures. The Methods section will 
conclude with a description of how the data were analyzed, and the Results section will 
explain the findings of the study. Finally, the Discussion section will examine the 
implications of this research, study limitations, and directions for future research.   
       
5 
Introduction 
History of MDMA 
Although MDMA (3,4-Methylenedioxymethamphetamine) has only received 
mass media attention in the last two decades, its history dates back to the early 1900s 
when it was first synthesized as an intermediate chemical in the development of a styptic 
medication by Merck. In 1976, Dr. Alexander Shulgin, a chemist who synthesized 
MDMA, thought this rediscovered drug could be a legal adjunct to the psychotherapeutic 
process. In 1978, Drs. Shulgin and Nichols published the first human pharmacological 
study of MDMA in which they described its ability to produce a heightened sense of 
emotional awareness and sensual overtones without interfering with normal thought 
processes (Shulgin & Nichols, 1978). 
Sales of MDMA as "Ecstasy" to recreational users appears to have begun in 1981 
(Cohen, 1998). The expansion of the market for Ecstasy took off in 1983 when a 
distribution group in Texas (Texas Group) began large-scale marketing to the public.  
Because the drug was then legal, it was even available at bars and nightclubs. In 1984, 
with rampant production, marketing, and recreational use of Ecstasy, the Drug 
Enforcement Agency (DEA) recommended adding Ecstasy to the list of Schedule 1 
substances based on the Controlled Substances Act. With this foreknowledge, the Texas 
Group allegedly mass-produced and sold over two million Ecstasy pills just prior to the 
emergency scheduling (Beck & Rosenbaum, 1994).   
The ban of Ecstasy took effect in 1985 but was later challenged and temporarily 
overturned by the federal courts. Meanwhile, the excitement in the courtroom led to 
extensive media coverage and recreational use of Ecstasy continued to rise in the mid-
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1980s. Finally, after multiple court appeals, Ecstasy was permanently listed as a Schedule 
1 drug in 1988. The penalty for possession, delivery, and manufacturing Ecstasy can 
include a fine as high as $100,000 and up to a 99 year or life in prison sentence, 
depending on the amount seized (Holland, 2001). 
Pharmacology of MDMA 
 MDMA (3,4-Methylenedioxymethamphetamine) is a synthetic drug that has both 
stimulant (amphetamine-like) and hallucinogenic properties and is structurally similar to 
methamphetamine (stimulant) and mescaline (hallucinogen) (Holland 2001; Leshner, 
2002; O'Leary, Nargiso, & Weiss, 2001). MDMA causes neurotransmitters (serotonin, 
dopamine, and norepinephrine) to be released from presynaptic neurons and prevents 
their metabolism by inhibiting monoamine oxidase. The net result is a surplus of these 
neurotransmitters available at the synapse, disruption of their synthesis, and depletion. 
Compared to the very potent stimulant, methamphetamine, MDMA causes greater 
serotonin release than dopamine release. Notably, the use of MDMA results in the 
disruption of the serotonin system which plays a significant role in regulating mood, 
sleep, sensitivity to pain, aggression, emotion, appetite, and sexual behavior (Kalant, 
2001; Leshner, 2002). Consequently, the examination of the use of Ecstasy by young 
adults has become an important part of biomedical and psychological research.  
Neurotoxicity of MDMA 
 The heated debate regarding the classification of MDMA as a neurotoxin continues 
as a result of limitations in research methodology (Cole, Bailey, Sumnall, Wagstaff, & 
King, 2002; Green, Mechan, Elliott, O'Shea, & Colado, 2003; Murray, 2001). 
Alarmingly, MDMA has been found to produce dose-dependent hyperthermia in rodents, 
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primates, and humans that is potentially fatal (Kalant, 2001; Mechan, O'Seah, Colado, & 
Green, 2001). Studies of MDMA have also detailed serotonin neurodegeneration that 
lasts for months in rats and years in primates (Malberg, & Seiden, 1998; Ricaurte, Irwin, 
Forno, DeLanney, & Langston, 1987). Furthermore, research of MDMA administration 
in mice has found evidence of a selective long-term loss of dopamine in nerve endings 
(Stone, Merchant, Hanson, & Gibb, 1987). However, caution must be taken in 
generalizing findings from neurotoxicity studies in animals to humans. Some argue that 
these animal studies are not representative of human consumption, particularly of 
recreational users of MDMA (e.g., Cole et al., 2002). Experts in the field of human 
MDMA pharmacology and pharmacokinetics have concluded that non-linear 
pharmacokinetics make it very difficult to rely on interspecies scaling to determine 
human-equivalent doses on the basis of studies in animals (de la Torre & Farre, 2004).   
Furthermore, human studies of Ecstasy use have often been problematic. Potential 
confounds may result from using subjective reports of drug use, variability in the 
composition, and simultaneous use of other drugs (Cole et al., 2002; McCann, Ricaurte, 
& Molliver, 2001; Rivas-Vazquez & Delgado, 2002). For example, several studies have 
examined memory deficits in recreational users of Ecstasy (Morgan, 1999; Parrott, 2000; 
Parrott, Buchanan, Schooley, Heffernan, Ling, & Rodgers, 2002; Taffe, Davis, Yuan, 
Schroeder, Hatzidimitrious, Parsons, et al., 2002; Thomasisus, Petersen, Buchert, 
Andresen, Zapletalova, Wartberg et al., 2003; Verkes, Gijsman, Pieters, Schoemaker, de 
Visser, & Kuijpers, 2001; Zakzanis, & Young, (2001), and recent studies suggest that 
diminished serotonergic neurotransmission may interfere with memory and learning 
processes (Buhot, Martin, & Segu, 2000); however, the findings from this line of research 
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have been contradictory. Dafters, Hoshi, and Talbot (2004) examined memory 
performance in participants who were users of both Ecstasy and cannabis. Findings 
revealed an association between low memory performance and extent of concomitant use 
of cannabis rather than use of Ecstasy. Furthermore, Gouzoulis-Mayfrank et al. (2005) 
examined memory performance in Ecstasy users over the course of 18 months. Results 
showed that participants who discontinued the use of Ecstasy after the baseline 
assessment did not improve in memory performance. However, memory performance of 
participants who continued the use of Ecstasy did not deteriorate. These findings do not 
support, but they also do not rule out, memory decline following the use of Ecstasy. 
Further research is clearly needed to clarify the impact of Ecstasy use on cognitive 
functioning.  
Recently, researchers have been using various brain imaging techniques to 
examine the effects of MDMA on brain functioning. Studies comparing current Ecstasy 
users with former users and polydrug users have found a slight but significant decrease in 
numbers of serotonin transporter sites in current, but not former, Ecstasy users (Buchert 
et al., 2003; Buchert et al., 2004), suggesting that a risk of reduced serotonin system 
function following repeated Ecstasy use appears to resolve after prolonged abstinence. 
Notably, two studies have found that current female Ecstasy users evidenced a greater 
reduction in serotonin transporter sites than males (Buchert et al., 2004; Reneman et al., 
2001), suggesting that female users of Ecstasy may be at greater risk of incurring changes 
in serotonin system function than males. 
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The Ecstasy Experience 
Beck and Rosenbaum (1994) conducted a remarkable study in which they 
interviewed 100 users of Ecstasy and detailed the common stages of the Ecstasy high.  
When an average dose of Ecstasy (100-125mg) was ingested orally on an empty stomach, 
its effects were usually experienced after 20 to 60 minutes, and were often described as a 
sudden and intense high, a perfect euphoria. However, for some users, this "rush" was far 
from perfect, as trepidation, tension, stomach tightness, and/or nausea ensued. Following 
this initial period, users generally reported a relatively stable and enjoyable period that 
tended to last between 2 and 3 hours. Finally, the "coming down" phase hit 
approximately 3 to 4 hours after ingestion. Users reported using other substances such as 
alcohol, tranquilizers, or marijuana to ease the comedown. 
Not surprisingly, the Ecstasy experience is often associated with varying 
undesirable side-effects (Hammersley, Khan, & Ditton, 2002; Maxwell, 2003). Physical 
effects can include the following symptoms: loss of appetite, nausea, vomiting, blurred 
vision, increased heart rate and blood pressure, muscle tension, faintness, chills, 
sweating, tremor, insomnia, convulsions, and a loss of control over voluntary body 
movements (Beck & Rosenbaum, 1994; Kalant, 2001). Some psychological difficulties 
may include agitation, confusion, depression, insomnia, drug craving, and paranoia 
during and sometimes weeks after use (Kalant, 2001). Because Ecstasy is typically 
produced in clandestine laboratories, pills often contain various adulterants 
(methamphetamine, caffeine, cough suppressants with PCP-like effects, and cocaine) that 
increase the risks associated with use (Hansen, Riddle, & Sandoval, 2002; Drug 
Enforcement Administration, 2001). For example, Kalasinsky, Hugel, and Kish (2004) 
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examined hair samples of individuals who believed they had only taken Ecstasy. 
Although MDMA was detected in most of the hair samples, MDA (90%) and either 
amphetamine or methamphetamine (57%) were also detected in the hair samples. 
Polydrug Use and Ecstasy 
 Polydrug use has become very common among young adult drug users, and 
numerous research studies have found that Ecstasy users tend to be polydrug users (Boys, 
Lenton, & Norcross, 1997; Morgan, 1998; Morgan, 1999; Parrott, Sisk, & Turner, 2000; 
Shifano, 2000; Boys, Marsden, & Strang, 2001). Yacoubian (2003) conducted an analysis 
of data collected in 1999 through the Monitoring the Future survey and found that high 
school seniors who had used Ecstasy in the past year were significantly more likely to 
have engaged in polydrug use within that past year. According to a report by the Drug 
Enforcement Administration (2001), Ecstasy is often used in combination with alcohol, 
other club drugs (GHB and ketamine), marijuana, methamphetamine, psilocybin 
mushrooms, and LSD. Consistent with the report by the DEA (2001), Strote et al. (2002) 
recently analyzed the data on Ecstasy use of college students from the 1997 and 1999 
Harvard School of Public Health College Alcohol Study and found that the variable with 
the strongest correlation with Ecstasy use was marijuana use in the past year (91.2% of 
students who used Ecstasy in the past year also used marijuana).   
Prior research also suggests that the concurrent use of drugs is commonplace 
among young adults as a means to improve the effects of other drugs and/or to help 
manage negative effects (Boys et al., 2001; Boys & Marsden, 2003). A recent study by 
Scholey et al. (2004) examined polydrug usage patterns reported by non-Ecstasy users, 
novice Ecstasy users (1-9 occasions), moderate Ecstasy users (10-99 occasions), and 
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heavy Ecstasy users (100+ occasions). Findings revealed that Ecstasy users reported 
significantly greater psychoactive drug usage than non-Ecstasy users. In addition, 
increased use of Ecstasy was associated with more intensive patterns of Ecstasy intake as 
well as a greater use of illicit CNS stimulants and hallucinogens.  
Consistent with the findings of Scholey et al. (2004), Arria, Yacoubian, Fost, and 
Wish (2002) found that Ecstasy users recruited from rave settings were more likely to 
report past experiences with marijuana, cocaine, and other drugs than their non-Ecstasy 
using counterparts. More recently, Ter Bogt and Engels (2005) conducted a study of 
Ecstasy use at rave settings in the Netherlands. As in the United States, Ecstasy users 
were found to be polydrug users. Of the rave attendees who reported Ecstasy use, 74% 
reported (at least) monthly use of cannabis, 15% of psilocybin mushrooms, 27% of speed 
and 36% of cocaine. Consistent with the above findings, Yacoubian, Arria, Fost, and 
Wish (2002) and Wish, Fitzelle, O’Grady, Hsu, and Arria (in press) reported similar 
findings in a sample of juvenile offenders and college students, respectively. 
Furthermore, in a recent study of Ecstasy use in college students, Levy, O’Grady, Wish, 
and Arria (2005) found that all of the Ecstasy using participants reported a history of 
polydrug use. Finally, Butler and Montgomery (2004) conducted a study of 
undergraduate Ecstasy users in London. Results revealed that Ecstasy users were more 
likely to have used amphetamines, cocaine, LSD, and magic mushrooms than participants 
who were non-Ecstasy using polydrug users. In summary, the literature clearly indicates 
that one of the key characteristics of Ecstasy users is that they tend to be polydrug users. 
Therefore, the current study will examine the relationship between Ecstasy use and 
polydrug use among the sample population. 
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Risk Factors for Ecstasy Use among Young Adults  
Overview 
 The literature pertaining to risk factors for substance use, in general, among young 
adults will be examined, and parallels will be drawn to explore risk factors for Ecstasy 
use. Specifically, five factors will be examined: prior drug experience; substance use by 
peers; social conformity; sensation seeking; and risk taking. 
Prior Drug Experience 
One factor that has been consistently cited in the literature as a predictor of future 
substance abuse among young adults is prior substance use. Individuals who experiment 
with illicit drugs at an early age are at greater risk for later drug abuse (Hawkins, 
Catalano, & Miller, 1992). For example, Petraitis, Flay, Miller, Torpy, and Greiner 
(1998) examined results of prospective studies of illicit substance use among adolescent 
and young adults and found that those with a history of using a variety of substances, 
particularly cigarettes, alcohol or marijuana, were at risk for future use of illicit 
substances, particularly marijuana. Notably, results of the 2004 National Survey on Drug 
Use and Health indicate that the mean age of first use of marijuana for individuals aged 
12 or older was 18. In contrast, the mean age of first use of Ecstasy was 19.5 (20.5 for 
males and 18.3 for females). These findings are consistent with the above mentioned 
findings that the majority of Ecstasy users tend to have a history of marijuana use.  
Recently, Boys and Marsden (2003) examined the use of alcohol, cannabis, 
Ecstasy, amphetamine and cocaine hydrochloride in a non-treatment sample of young 
polysubstance users (age 16-22).  Results indicated that age of first use was negatively 
associated with current intensity of use for all five substances.  However, initiating use at 
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a younger age was only significantly associated with more intensive use for Ecstasy, 
cannabis, and cocaine. With regard to Ecstasy, age of first use of Ecstasy accounted for 
22% of the variance in predicting intensity of current use.  These results suggest that 
individuals who begin using Ecstasy at a young age are at greater risk for more intense 
use in the future. Although this relationship is not of primary interest in the current study, 
the correlation between age of first use of Ecstasy and current intensity of Ecstasy use 
was examined in the sample population.  
Substance Use by Peers 
 Extensive research has been conducted examining the influence of peers as a risk 
factor for substance use among adolescents and young adults. Prior research has 
consistently found that involvement in a substance-using peer group tends to be 
associated with various forms of both licit and illicit substance use (Chassin, Presson, 
Sherman, Montello, & McGrew, 1986; Hawkins et al., 1992). Dating back to 1978, 
Kandel found that associating with drug-using peers was a significant risk factor for 
initiating illicit drug use. In line with the above findings, Petraitis et al. (1998) conducted 
a meta-analysis of 58 prospective studies of illicit substance use among adolescents and 
young adults (younger than 27 years old) and found that peer role models were 
particularly influential. They drew three important conclusions regarding illicit substance 
use: (1) illicit substance use tends to occur after exposure to other substance users; (2) 
illicit substance users tend to have friends who approve of and have used illicit 
substances; and, (3) bonding with deviant peers typically precedes illicit substance use. 
Consistent with this prior research, according to Hussong (2002) and supported by 
numerous studies (e.g., Copeland & Martin, 2004; Hawkins et al., 1992; Oetting & 
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Beauvais, 1986), the peer context is possibly the most salient, robust predictor of an 
adolescent’s substance use.  
 Furthermore, researchers not only postulate that friends can influence drug use but 
also that drug use itself can influence the selection of friends (Bauman & Ennett, 1996; 
Dishion & Owen, 2002; Kandel, 1978). The former, the peer selection hypothesis, 
suggests that individuals select their friends based on their substance use, implying that 
individual use precedes use within the peer context. The latter, the peer socialization 
process, indicates that having friends who use substances influences use, suggesting that 
individual use follows that within the peer context.   
Recent research by Dishion and Owen (2002) lends support to both of the above 
interpretations. They found that substance use in young adulthood was determined by 
both friendship selection processes and friendship influence. In line with prior research 
(Dishion, 2000; Dishion, Capaldi, & Yoerger, 1999), results indicated that the strongest 
proximal correlate of adolescent substance use was the tendency to cluster into peer 
groups that used substances.  Furthermore, relationships within these peer groups 
appeared to shape attitudes and behavior, indicating a bi-directional relationship.  In their 
longitudinal analysis of young adult drug use, Dishion and Owen found that overall levels 
of substance use predicted marijuana abuse, dangerous drug use, and drug injection. 
 Consistent with the above findings, Boys and Marsden (2003) found that 
participants' perception of substance use by their peers was a significant predictor of their 
own intensity of use for all 5 substances (alcohol, cannabis, Ecstasy, amphetamine, and 
cocaine hydrochloride).  Similarly, Ter bogt and Engels (2005) found that among rave 
attendees, Ecstasy use by friends was associated with quantity of own Ecstasy use, 
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suggesting that peer pressure to use or to abstain from Ecstasy use does exist; however, 
participants tended to deny that conformism played a role in their drug use. Notably, 
individuals who were not using Ecstasy tended to use fewer drugs than those with peers 
using Ecstasy; they also tended to have a circle of friends who predominantly were not 
using Ecstasy. Ter bogt and Engels (2005) made an important point regarding conformity 
and drug use among young adults when they stated, “In a multivariate set-up, 
conformism was not related to quantity of Ecstasy use, while Ecstasy use by friends was, 
suggesting that Ecstasy use by friends is a better indicator of conformism than 
conformism itself. Young people deny they are motivated to do what their friends do; in 
fact they seem to conform to rules on drug use in their circle of friends” (p. 1495). In 
summary, the literature highlights the significant influence of peer substance use on own 
use. Accordingly, the current study will examine the association between participants’ 
current use of Ecstasy and the use of Ecstasy by their peers.  
Social Conformity 
 As noted by Petraitis et al. (1998), results of their meta-analysis strongly support 
one particular theory of illicit substance use, Jessor and Jessor's (1977) theory of problem 
behavior.  This theory purports that adolescents who hold certain personal values, 
particularly unconventional social norms, are at risk for illicit substance use. In line with 
this theory, Petraitis et al. found that illicit substance use was more common among 
individuals who had the following characteristics: (1) were nonconforming and sought 
independence from their parents; (2) held untraditional or unconventional values; (3) 
were critical of and tolerated deviance from mainstream society; (4) were detached from 
       
16 
politics or lacked conservative ideals; (5) were detached from religion; (6) lacked 
commitment to school; and (7) were rebellious.  
 Furthermore, Stein, Newcomb, and Bentler (1987) analyzed data obtained from a 
study of young adults junior high school students) who participated in an 8-year 
longitudinal study of adolescent development and drug use (Huba & Bentler, 1982; 
Newcomb & Bentler, 1986). In this study, social conformity was measured using a 
modified form of the Bentler Psychological Inventory (Bentler & Newcomb, 1978; Huba 
& Benter, 1982). Three traits were used as indicators of a Social Conformity latent 
construct: law abidance, (lack of) liberalism, and religious commitment (Huba & Bentler, 
1982, 1984). Stein et al. found that Social Conformity at Year 1 was predictive of both 
drug use (b = -.31, p ≤ .001) and peer drug use (b = -.22, p ≤ .001) at Year 5; the less 
conforming students were at Year 1, the more likely they were to use drugs and to have 
peers who used drugs at Year 5. The strong influence of the Social Conformity latent 
construct on other latent variables illustrates the need to consider intrapersonal factors 
when examining drug use among young adults (Stein et al., 1987).      
 In another study of adolescents and young adults, Newcomb and Bentler (1989) 
also found an association between social conformity and risk-taking behaviors.  They 
examined social conformity in terms of degree of religiosity, law abidance, and 
conservatism. Results indicated that individuals who received low scores on measures of 
social conformity were more likely to engage in socially proscribed activities such as 
drug use.  These results suggest that social conformity may be an important variable in 
examining Ecstasy use among young adults and is a primary focus in the current study. 
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Sensation Seeking, Risk Appraisal, and Risky Behavior 
 Definition of sensation seeking. One personality variable that has been found to be 
associated with substance use is sensation seeking (Zuckerman, & Bone, 1972). Taking a 
biosocial approach, Zuckerman initially defined the sensation seeking trait as "the need 
for varied, novel, and complex sensations and experiences and the willingness to take 
physical and social risks for the sake of such experience” (Zuckerman, 1979, p. 10).  He 
later modified his definition of sensation seeking to be "a trait defined by the seeking of 
varied, novel, complex, and intense sensations and experiences, and the willingness to 
take physical, social, legal, and financial risks for the sake of such experience” 
(Zuckerman, 1994, p. 27). One who is a sensation seeker has a preference for engaging in 
activities that provide greater, rather than less, stimulation or arousal (Zuckerman, 1971). 
Development of the Sensation Seeking Scale (SSS). In the early 1960s, the first 
form of the Sensation Seeking Scale (SSS) was developed as a measure of individual 
differences in optimal levels of stimulation and arousal as a peripheral line of research in 
sensory deprivation (Zuckerman, Kolin, Price, & Zoob, 1964). Data obtained through the 
SSS has been associated with various traits, cognitive and perceptual styles, and types of 
experience. For example, Zuckerman and Link (1968) found that high sensation seekers 
were more oriented to body sensation, extraverted, impulsive, antisocial, non-conformist, 
and less anxious than low sensation-seekers. A high sensation seeker tends to be very 
aware of internal sensations and selects external stimuli that maximize them (Zuckerman, 
1979). The expression of sensation seeking has been associated with participation in a 
variety of risky activities including: potentially risky experiments, sports, vocations, 
criminal activities, sexual behavior, smoking, heavy drinking, drug use and abuse, 
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reckless driving and driving under the influence of alcohol, and gambling (Arnett, 1996; 
Zuckerman, 1979, 1994).   
Sensation seeking and drug use. Zuckerman (1979) identified three aspects of 
drug use that attracted sensation-seekers in the 1960s. First, because using drugs was 
socially unconventional, it was likely that other people who were also using drugs would 
be unconventional in other ways and appealing to the sensation-seeker. Second, there 
were bodily risks from using drugs as well as legal risks of being caught which may have 
added to the excitement. Third, using drugs allowed for new types of sensations and 
experiences and enhanced more mundane activities. Therefore, it is easy to see how high 
sensation-seekers would be attracted to a drug such as Ecstasy, which is a social drug that 
enhances bodily sensations. 
Since the 1970s, many studies have been conducted examining the relationship 
between sensation seeking and drug use, particularly among young adults (Galizio, 
Rosenthal, & Stein, 1983). Zuckerman, Neary, and Brustman (1970) administered a drug 
questionnaire to undergraduate students who were selected from the extreme ranges on 
the SSS (high and low) and found that 74% of the high verses 23% of the low sensation 
seekers had used at least one illegal drug. Results suggest that high sensation-seekers are 
more likely than low sensation-seekers to try any drug (Zuckerman, 1979). Zuckerman 
and colleagues (Zuckerman, Bone, Neary, Mangelsdorff, & Brustman, 1972) later 
conducted a second study using the same drug questionnaire but examined three groups 
of sensation-seekers (high, middle. and low). Again, drug experimentation (used one or 
more of the drugs on the list) was the highest in the high sensation group (67%), in 
comparison to only 36% of the middle group, and 31% of the low group. Approximately 
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two decades later, Kumar, Pekala and Cummings (1993) conducted a similar study 
among university students in the same geographic region and found that 69% of high and 
23% of low sensation seekers had used an illegal drug. Furthermore, in a longitudinal 
study of individuals from adolescence to young adulthood, Newcomb and McGee (1991) 
examined the effects of sensation seeking on later deviant behavior and attitudes. They 
found robust associations between sensation seeking and both licit and illicit drug use.  
The results of these studies clearly indicate that high sensation seekers are at significant 
risk for drug experimentation. 
Sensation seeking and polydrug use. Studies indicate that high sensation-seekers 
who abuse drugs tend to be polydrug users (Zuckerman, 1999). In examining scores on 
the SSS, particularly on the Experience Seeking (ES) and Disinhibition (Dis) subscales, 
polydrug users tended to score in the high range of sensation seeking (Galizio et al., 
1983).  Ball, Carroll, and Rounsaville (1994) found a similar relationship between 
sensation seeking and polydrug use in their study of cocaine abusers. Specifically, in 
contrast to low sensation seeking cocaine abusers, high sensation seekers were more 
likely to be polysubstance abusers and had an earlier age of onset for substance use and 
abuse. In addition, the high sensation-seekers exhibited more severe symptoms of 
substance abuse and psychosocial impairment. Furthermore, a recent study was 
conducted by Gerra et al. (2004) which examined substance use among Italian high 
school students (ages 14-19). Consistent with prior studies, findings revealed that alcohol 
abusers, cannabis users, and particularly polydrug users, had significantly higher total 
scores on the SSS compared to abstinent participants (M = 19.17, S.D. = .45; M = 19.38, 
S.D. = .49; M = 24.47, S.D. = .98; and M = 15.96, S.D. = .29, respectively). Based upon 
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these findings, and the previously mentioned literature which suggests that Ecstasy users 
tend to be polydrug users, it is likely that Ecstasy users are also high sensation-seekers. 
Sensation seeking and Ecstasy use. Unfortunately, there has been very little 
research examining the relationship between the use of Ecstasy and sensation seeking, 
especially in the United States. Four studies of non-US samples are of particular interest, 
all indicating that users of Ecstasy tend to score in the high range on measures of 
sensation seeking. First, a study of secondary students aged 13-30 years old was 
conducted in Oviedo, Spain during the 1998-1999 school year (Martinez et al., 2001). 
The SSS was administered and Ecstasy users were found to have a psychological profile 
characterized by high levels of sensation seeking and psychoticism. Second, another 
study conducted in Spain examined drug use in young males (mean age of 20.19 years) 
entering compulsory military service in Asturias, Spain between 1995 and 1999 (Bobes et 
al., 2002). Results indicated that users of Ecstasy had more extensive drug abuse histories 
than those who had never used Ecstasy as well as higher levels of sensation seeking. In 
addition, they also had higher scores on the Neuroticism and Psychoticism Subscales of 
the Eysenck Personality Questionnaire-A.  Third, Daumann, Pelz, Becker, Tuchtenhagen, 
and Gouzoulis-Mayfrank (2001) examined the relationship between the psychological 
profiles of abstinent recreational Ecstasy users (aged 18-29 years old with concomitant 
use of cannabis only) in Germany and the patterns of their drug use. Findings indicated 
that former users of Ecstasy had elevated scores on sensation seeking, impulsiveness, 
anxiety, somatic complaints, obsessive-compulsive behavior and psychoticism. These 
elevated scores were also associated with heavier use of Ecstasy and cannabis. Finally, 
Butler and Montgomery (2004) found that Ecstasy users and polydrug (non-Ecstasy) 
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users had higher levels of impulsivity, venturesomeness (individual is aware of the risk, 
but engages in the behavior for the thrill of it), and novelty seeking behavior compared to 
non-drug users. Furthermore, they found that high Ecstasy users (>20 occasions) scored 
higher on a measure of novel risk-taking than low Ecstasy users (<20 occasions) and non-
drug users. Although one cannot determine the direct effect of each drug consumed, the 
above literature appears to support an association between heavier use of Ecstasy and 
higher levels of sensation seeking. Therefore, this line of research suggests that users of 
Ecstasy not only tend to be high sensation-seekers but that there is also an association 
between degree of sensation seeking and intensity of use. Consequently, the relationship 
between Ecstasy use and sensation seeking will be examined in the current study. 
Disinhibition. As mentioned above, individuals who tend to engage in risk-taking 
behaviors, such as using drugs, often score highly on measures of sensation seeking.  One 
aspect of sensation seeking that has been highly correlated with both licit and illicit 
substance use is disinhibition (seeking release in uninhibited social activities) (Newcomb 
& McGee, 1991). In addition, disinhibition has been found to be negatively associated 
with law abidance as well as religiosity. Newcomb and McGee (1991) hypothesize, 
"drugs may serve as a ‘releaser’ for normally restrained social behaviors by providing 
access to the desired disinhibited states." Based upon these findings, it is not surprising 
that users of Ecstasy tend to receive high scores on measures of sensation seeking and 
low scores on indices of law abidance and religiosity, suggesting a lack of social 
conformity (Strote et al., 2002). Accordingly, the current study will also explore the 
relationship between social conformity and sensation seeking within the study sample. 
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Risk Appraisal and Risky Behaviors.  Zuckerman (1979) defined risk as "the 
appraised likelihood of a negative outcome" (p. 11). For example, drug abusers may think 
about the possibility of their drug use leading to negative outcomes such as addiction, 
overdose, and financial or legal problems versus their expected pleasurable experience of 
getting "high" (Zuckerman & Kuhlman, 2000). A characteristic of high sensation seekers 
is to evaluate risk as lower and to anticipate experiencing less anxiety than low sensation 
seekers. This differential in appraisal of risk increases the likelihood that high sensation 
seekers will engage in behaviors that low sensation seekers would view as too risky 
(Horvath & Zuckerman, 1993; Zuckerman, 1979).  
Horvath and Zuckerman (1993) investigated correlations between risk appraisal 
and risky behaviors for self and for peers across four areas of risk (criminal, minor rule-
violations, financial, and sports) in a sample of college students. In this study, risk 
appraisal was defined as "a cognitive trait specific to particular areas of risky behavior" 
(p. 50). Findings suggest that there are individual differences in how people perceive the 
likelihood of negative consequences for various behaviors that they may or may not 
choose to engage in. Not surprisingly, participants who tended to evaluate risk for 
themselves as low were more likely to report having engaged in those risky behaviors.  In 
this study, sensation seeking was found to be strongly correlated with participants' 
appraisal of risk for themselves and their actual engagement in risky behaviors. 
Specifically, there was a significant negative correlation between sensation seeking and 
participants' appraisal of risk for themselves for all areas of risk except financial; high 
sensation seekers typically appraised risk for activities as lower than low sensation 
seekers. In addition, a positive correlation was found between sensation seeking and 
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experience in risky behaviors in all four areas of risk. Possibly, it is the greater 
willingness of sensation-seekers to accept risks that puts them at greater risk through their 
behavior (1993). Expanding upon Horvath and Zuckerman’s study (1993), the current 
study will examine risk appraisal and risky behaviors among young adult Ecstasy users.   
Perceived Motivations for Substance Use 
Perceived Motivations for Initial Use 
 Johnston and O'Malley (1986) examined data pertaining to reasons given by high 
school seniors for the use of licit and illicit substances.  This data was part of a larger 
project, the Monitoring the Future survey (1978, 1984), which surveyed American high 
school students. The most commonly reported reasons for drug use were 
experimentation, social/recreational, and relaxation. With respect to Ecstasy, results of a 
study of Ecstasy use at rave parties in the Netherlands, conducted by Van de Wijngaart, 
et al. (1999), indicated that Ecstasy was typically taken for the first time because of 
curiosity and a desire to “try out” the drug. More recently, Levy et al. (2005) questioned 
college students about the reason(s) they took Ecstasy the first time, and a variety of 
responses were given: 1) positive effects on mood; 2) “social pressure” rather than peer 
pressure (“You see friends having a great time and you want to join in”); 3) curiosity 
(“You hear friends talking about it and see them on it so you’re curious what it’s like”); 
4) availability (“Was there so I tried it”); 5) boredom (“Something to do”); 6) desire for 
an altered state of mind (“Desire to get screwed up”); 7) desire to escape (“It’s like a 
vacation. Nothing bothers you. Take it and chill”); 8) self- medication – some 
participants reported that Ecstasy enabled socially anxious individuals and/or those with 
low self-esteem and confidence to fit in with others and to have a good time, while others 
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reported it provided temporary relief from depressive symptoms; 9) desire to have fun; 
and, 10) ease of use of Ecstasy in comparison to other drugs. The above studies suggest 
that curiosity and a desire for experimentation play an important role in the initiation of 
Ecstasy use. The current study examined how reasons for first use of Ecstasy vary among 
young adults with a history of Ecstasy use.  
Perceived Motivations for Continued Use  
 Newcomb, Chou, and Bentler (1988) examined the motivations for alcohol and 
cannabis use among high school students in the 10th, 11th and 12th grades. In analyzing 
the 15 reasons that were assessed, results reflected four generalU motivations for drug use 
(Enhance Positive Affects and Creativity; Reduce Negative Affect; Social Cohesion; and 
Addiction). In trying to understand adolescents and young adults' motivations for using 
drugs, it is important to examine how motivations may differ depending on the type of 
substance (Newcomb et al., 1988). For example, if the desired effect is increased nervous 
system arousal, stimulants such as amphetamines, Ecstasy or cocaine may be used. In 
contrast, if the desired effect is nervous system depression, depressants such as alcohol or 
cannabis may be used (Boys, Marsden, & Strang, 2001).   
With regard to Ecstasy, Van de Wijngaart, et al. (1999) found that, following 
initial use which was typically driven by curiosity, Ecstasy users reported different 
motivations for subsequent use of Ecstasy, including the following: (1) “the pleasant 
feeling XTC evokes;” (2) “being able to dance all night;” (3) get into the music;” (4) 
“easier contact with others;” (5) “euphoria;” (6) “self-insight;” and (7) “forgetting 
problems.” In examining the responses from the above study, one way to evaluate 
motivations for substance use is to think of what functions use of a particular substance 
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serve. Boys et al. (2001) defined function as "the primary or multiple reasons for, or 
purpose served by, the user of a particular substance in terms of the actual gains that the 
user perceives that they will attain" (p. 458). In interviewing adolescents and young 
adults (ages 16-21) in the United Kingdom, Boys et al. (1999) examined perceived 
functions (mood and social/contextual) and actual use of four target substances (alcohol, 
cannabis, amphetamines, and Ecstasy). For Ecstasy users, higher scores on the Mood 
Function scale were associated with more frequent use of Ecstasy in the 3 months prior to 
the assessment. This scale consisted of 3 items: (1) “make yourself feel better when you 
were low or depressed;” (2) “to help you to relax;” and (3) “to help make an everyday 
activity less boring.” Therefore, it appears that participants who used Ecstasy as a mood 
altering drug tended to use it more frequently. 
In a more recent study of substance use by polydrug users (ages 16 to 22) in the 
United Kingdom, Boys et al. (2001) found that the most popular functions for substance 
use among six substances (cannabis, amphetamine, Ecstasy, LSD, cocaine hydrochloride, 
and alcohol) included the following functions: to relax (96.7%), to become intoxicated 
(96.4%), to keep awake at night while socializing (95.9%), to enhance an activity 
(88.5%), and to alleviate depressed mood (86.8%). Seven of the 17 function items were 
endorsed by over half of those who had used Ecstasy in the past year. The most common 
functions for using Ecstasy were to keep going (91.1%); to enhance activity (79.6%); to 
feel elated/euphoric (77.7%); to stay awake (72%); to get intoxicated (68.2%); to enjoy 
the company of friends (63.1%); and to enhance feeling when having sex (63.1%).   
Most recently, Ter Bogt and Engels (2005) examined motives for the use of 
Ecstasy at different types of dance parties in the Netherlands. They developed a scale for 
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motivations for the use of Ecstasy at rave parties by incorporating the findings reported 
by Van de Wijngaart et al. (1999) as well as a model of motivations for alcohol use 
developed by Cox and Klinger (1988). Cox and Klinger had characterized motives for 
alcohol use into four areas: (1) drinking to get into a positive mood (enhancement); (2) 
drinking to obtain social rewards (need for sociability); (3) drinking to deal with negative 
emotions (coping); and (4) drinking to avoid social rejection (conformism).  Drawing 
upon the works of Van de Wijngaart et al. (1999), Cox and Klinger (1988) Ter bogt and 
Engels (2005) measured motives for the use of Ecstasy at a rave using 28 items relating 
to enhancement, sociability, coping, and conformity. A seven-factor scale was developed, 
which was supported by factor analysis. Results were indicative of a hierarchy of 
motivations for the use of Ecstasy by rave attendees: (1) energy (82%); (2) euphoria 
(62%); (3) sociability/flirtatiousness (27%); (4) sexiness (21%); (5) self-insight (17%); 
(6) coping (14%); and (7) conformism (4%). Notably, the only significant gender 
differences on these seven scales were that males were more highly motivated by 
“sexiness” and reported being more susceptible to peer pressure than females. The results 
of the study by Ter bogt and Engels (2005) suggest that the motivations for the use of 
Ecstasy can be categorized in a similar manner to the motivations for the use of alcohol: 
enhancing, social, coping, and conformism.  
The above research studies have helped to increase researchers’ understanding of 
the reasons why young adults use Ecstasy. The current study will expand this knowledge 
base to examine how the reasons for Ecstasy use may differ among different types of 
Ecstasy users. 
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Gender Differences in Consumption Patterns of Ecstasy 
 There have only been a few published studies examining gender differences among 
Ecstasy users and findings have been inconsistent. Results of the 2001 National 
Household Survey on Drug Abuse indicated that among young adults (ages 18-25), males 
were more likely to have used Ecstasy than females. In contrast, a study of young adults 
(ages 18-29) recruited in London, Manchester, Padua, and Rome (Milani, Parrott, Turner, 
& Fox, 2004) failed to find significant gender differences in lifetime consumption of 
Ecstasy; however, the “usual amount” of Ecstasy tablets taken in one occasion tended to 
be greater for males than females. Verheyden, Hadfield, Calin, and Curan (2002) 
conducted a study of recreational Ecstasy users recruited from a nightclub and also found 
significant gender differences. Males reported taking an average of one more Ecstasy 
tablet per occasion than females, had used Ecstasy for an average of 2 years longer than 
females, and therefore, generally had higher cumulative lifetime use rates than females. 
However no gender differences were found for frequency of Ecstasy use.  
Consistent with Verheyden et al. (2002), Fingeret, Moeller, and Stotts (2005) 
conducted a study in the US of Ecstasy users (ages 16 to 52) and found that males were 
more likely than females to be heavier users of Ecstasy. However, in contrast to 
Verheyden et al. (2002), males were also more likely than females to use Ecstasy with 
greater frequency. Ter Bogt and Engels (2005) also found significant gender differences; 
males were more likely than females to report a history of Ecstasy use. In addition, males 
reported using Ecstasy more frequently, taking more pills per occasion, and having used 
for a longer period of time.  
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Notably, Liechti, Gamma and Vollenweider (2001) found that equal doses of 
Ecstasy per kilogram body weight produced stronger responses in females than males, 
suggesting that females are more susceptible to the 5-HT-releasing effects of MDMA. 
Possibly, these differential gender effects of MDMA help to explain the above gender 
differences in consumption patterns of Ecstasy. The lack of consistency in the findings 
from the literature examining gender differences among Ecstasy users is indicative of the 
great need for further research and will be thoroughly examined in the current study.  
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Statement of the Problem and Hypotheses 
Statement of the Problem 
 One of the significant emerging trends in the use of illicit substances among young 
adults has been the increased use of Ecstasy. Use of this drug appears to be associated 
with psychological and psychiatric problems, and its long-term negative effects are still 
being studied. For example, some researchers have classified MDMA as a neurotoxin 
based upon serotonin neurodegeneration in animals. Young adults who use Ecstasy 
regularly tend to be polydrug users, and often engage in concurrent drug use to improve 
the effects of other drugs or to help mange negative effects. Thus, it is difficult to isolate 
the effects of MDMA separate from the use of other illicit substances in this population. 
Unfortunately, although research on the use of Ecstasy has increased over the 
years, there are still significant gaps in the literature. First, in exploring predictors of 
Ecstasy use, only one study has expanded the traditional Ecstasy user versus non-user 
dichotomy to include non-users; users (light, moderate, and heavy); and ex-users 
(McMillan et al., 2003). Consistent with the literature regarding the association between 
normative influence and substance use (e.g., Hussong, 2002; Kandel, 1978), McMillan et 
al. (2003) found that normative influence differentiated the following: (1) heavy users 
from both moderate and light users and (2) light users from moderate users. However, it 
is important to note a second limitation of the literature; it lacks a standard classification 
system for types of users. For example, McMillan et al. defined light users as individuals 
who had used Ecstasy once or twice; moderate users as Ecstasy users who had used 
Ecstasy three or more but less than 20 times; and heavy users as Ecstasy users who had 
used Ecstasy 21 or more times.  In contrast, Parrott et al. (2002) made the following 
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distinctions among Ecstasy users: novice users (1-9 occasions); moderate users (10-99 
occasions); and heavy users (+100 occasions). Problematically, no two studies in the 
literature have divided Ecstasy users into groups by the same criteria.   
Another limitation regarding the Ecstasy literature is that research has tended to 
focus on the following topics: (1) pharmacology and toxicology of Ecstasy (Parrot et al., 
2002; Thomasius et al., 2003); (2) demographics/characteristics of Ecstasy users (Strote 
et al., 2002); and (3) psychological and physiological effects of Ecstasy use (Kalant, 
2001).  Although the aforementioned literature has been useful in broadening general 
knowledge regarding Ecstasy, researchers have yet to gain a clear understanding of the 
following important areas: (1) why and under what circumstances young adults use 
Ecstasy; (2) what factors contribute to young adults beginning the use of Ecstasy; and (3) 
what factors contribute to young adults quitting the use of Ecstasy.   
Although scarce, some studies have examined specific risk factors for the active 
use of Ecstasy among young adults. First, individuals who begin using Ecstasy and other 
illicit substances at a young age are at greater risk for more intensive use in the future 
(Boys & Marsden, 2003; Hawkins et al., 1992; Petraitis et al., 1998). Therefore, it is 
likely that those who become active users of Ecstasy have a history of early 
experimentation with Ecstasy and other illicit substances. Second, the literature indicates 
that young adults' perceptions of Ecstasy use by their peers is a significant predictor of 
their own intensity of use of Ecstasy (Boys & Marsden, 2003; McMillan et al., 2003).  
Based upon this line of research, active users of Ecstasy are likely to perceive that the use 
of Ecstasy among their peers is normative which increases their likelihood of use. Third, 
researchers have found that young adults who score in the low range on measures of 
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social conformity (religiosity, law abidance, and conservatism) are more likely to engage 
in socially proscribed activities such as drug use (Petraitis et al., 1998). With regard to 
Ecstasy specifically, research suggests that young adults with a history of Ecstasy use 
value the arts and parties more than religion (Strote et al., 2002). Although very little 
research has explored the association between Ecstasy and social conformity, it is likely 
that active users of Ecstasy would score in the low range.   
In addition to prior substance use, perceived substance use by peers, and social 
conformity, researchers have also examined the associations between sensation seeking, 
risk taking, and substance use among young adults; results support strong positive 
correlations between sensation seeking and risk taking and substance use (Zuckerman, 
1979, 1994). Specifically, young adults who are high-sensation seekers tend to appraise 
risk in three areas (criminal behavior, minor rule-violations, and engaging in sports) as 
lower than low-sensation seekers and are more likely to participate in these risky 
activities (Horvath & Zuckerman, 1993). Furthermore, young adults who abuse drugs 
tend to score in the high range on measures of sensation seeking (Zuckerman, 1979, 
1994, 1999). In examining the literature regarding Ecstasy and sensation seeking, among 
those who use Ecstasy, higher scores on sensation seeking appear to be related to heavier 
use of Ecstasy (Bobes et al., 2002; Daumann et al., 2001). Notably, one aspect of 
sensation seeking that has been highly correlated with illicit drug use is disinhibition 
(Newcomb & McGee, 1991). Disinhibition has been found to be negatively associated 
with law abidance and religiosity, two aspects of social conformity. Therefore, it appears 
that active users of Ecstasy are likely to be very high-sensation seekers who score in the 
low range on measures of social conformity. 
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Finally, another important variable to examine in studying young adults' use of 
Ecstasy is motivation for use. What functions does the use of Ecstasy serve? Prior 
research (Boys & Marsden, 2003; Boys et al., 1999) indicates that the most common 
reasons young adults give for using Ecstasy are to keep going, enhance activity, feel 
elated/euphoric, stay awake, get intoxicated, enjoy the company of friends, and enhance 
feeling when having sex. The question of interest in the current study is how does the 
primary motivation for using Ecstasy differ between the three groups (Experimenters; 
Users; and Quitters). It is logical that all three groups would share many of the above 
motivations for use of Ecstasy that are social in nature. Accordingly, Boys and Marsden 
(2003) did not find support for a relationship between social functions for Ecstasy use 
and intensity of use.   
In contrast to the expected similarities among the three groups in the endorsement 
of social functions for the use of Ecstasy, the literature suggests an association between 
intensity of Ecstasy use and the endorsement of mood functions (Boys & Marsden, 
2003). Because the use of Ecstasy is associated with depressive symptomatology, it is 
likely that more frequent users of Ecstasy would experience more frequent negative mood 
symptoms and may continue to use to alter their mood. Therefore, it is likely that young 
adults who are active users are likely to endorse mood functions when questioned about 
their motivation(s) in using Ecstasy. 
The aforementioned research examines specific variables that are likely to be 
associated with young adult users of Ecstasy. In integrating all of the above research, it is 
likely that, in general, active users of Ecstasy have the following characteristics: (1) 
began using Ecstasy and other illicit substances at a young age; (2) perceive that the use 
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of Ecstasy is normative among their peers; (3) score in the low range on measures of 
social conformity (religiosity, law abidance, and conservatism); (4) score in the high 
range on measures of sensation seeking; (5) appraise little risk with regard to potentially 
risky activities; (6) engage in a variety of potentially risky activities; (6) endorse 
functions for Ecstasy use relating to mood; and (7) have a history of polydrug use.   
Although the McMillan et al. study is a good start, research has yet to examine 
factors predictive of quitting the use of Ecstasy after active use.  Therefore, based largely 
upon conjecture, it is likely that, in general, quitters will have the following 
characteristics which are also, in general, similar to those of active users: (1) began using 
Ecstasy and other illicit substances at a young age; (2) perceive that the use of Ecstasy is 
Usomewhat U normative among their peers (quitters are likely to still have some peers who 
use Ecstasy but are less likely to have as many peers who use Ecstasy as active users); (3) 
score in the low range on measures of social conformity (religiosity, law abidance, and 
conservatism); (4) score in the high range on measures of sensation seeking; (5) appraise 
little risk with regard to potentially risky activities; (6) engage in a variety of potentially 
risky activities; (6) endorse functions for Ecstasy use relating to mood; and (7) have a 
history of polydrug use (although they have quit using Ecstasy, because they are likely to 
be high sensation seekers based upon their history of Ecstasy use, they are also likely to 
engage in polydrug use).   
Although literature exists examining the differences between users and non-users 
of Ecstasy (Strote et al., 2002), researchers have not explored what characteristics 
distinguish young adults who experiment with Ecstasy and then quit from those who 
experiment and continue to use. Again, based largely upon conjecture, it is likely that, in 
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general, experimenters will have the following characteristics: (1) began using illicit 
substances at a young age; (2) perceive that the use of Ecstasy is UsomewhatU normative 
among their peers (the normative influence is what likely impacts their decision to 
experiment); (3) score in the low range on measures of social conformity (religiosity, law 
abidance, and conservatism); (4) score in the high range on measures of sensation 
seeking; (5) appraise little risk with regard to potentially risky activities; (6) engage in a 
variety of potentially risky activities; (6) primarily endorse social functions for Ecstasy 
use; and, (7) have a history of polydrug use (because they are experimenting with an 
illicit substance, they are likely to be high sensation seekers; therefore, they are also 
likely to engage in polydrug use).   
In summary, researchers to date have not examined what factors distinguish 
between young adults who: (1) experiment with the use of Ecstasy and then quit 
(Experimenters); (2) become active users of Ecstasy and continue use (Users); and (3) 
become active users of Ecstasy and then quit (Quitters). The goal of this study is to 
examine how these three groups differ on key variables established through prior studies.  
Results of this study will aid in the development of appropriate intervention programs 
targeting young adults who actively use Ecstasy. 
Hypotheses 
All the hypotheses below are based on comparisons of means among three groups 
of users of Ecstasy (“Experimenters,” “Users,” and “Quitters”). Specifically, hypotheses 
are based on relative comparisons between Users and Experimenters and Users and 
Quitters.  (Although I am quite interested in the comparisons of how Experimenters and 
Quitters might differ from each other, I don’t believe there is sufficient literature or 
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research on which I can base hypotheses.) For example, because participants in all three 
groups would likely receive relatively high scores on a measure of sensation seeking 
simply based upon their prior experiences with Ecstasy, it is, nevertheless, the case that 
the three groups of Experimenters, Users, and Quitters would differ on their mean scores.  
Therefore, because sensation seeking is positively associated with level of drug use, it is 
hypothesized that Users and Quitters will display higher sensation seeking scores than 
will Experimenters.   
Table 1 provides a summary of the expected relative comparisons among the three 
groups. Signs represent relative mean comparisons among the three groups to a 
normative sample of young adults. The type of sign (plus or minus) indicates whether the 
group mean is thought to be larger (plus) or smaller (minus) than that of a normative 
sample. (Scores of the three groups will not be compared to any normative sample(s) on 
any of the dependent measures. The use of + and – is simply to indicate that the three 
groups under study are unlikely to be similar to a normative group, and to indicate how I 
think they might differ from the ‘average’ young adult.) Groups with the same quantity of 
signs are hypothesized to have similar means (+/+ or !/!), while groups with a greater 
number of signs are hypothesized to have larger (++) or smaller (! !) means than those 
groups with the corresponding single sign (+/!). 
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Table 1 
Relative Comparisons among Three Groups of Young Adult Users of Ecstasy 
________________________________________________________________________ 
 
Criterion Variables   Experimenters Users  Quitters 
________________________________________________________________________ 
 
Polydrug Use (past 90 days)  +   ++   + 
 
Normative Influence   +   + +   + 
 
Social Conformity   !   ! !   ! ! 
 
Sensation Seeking   +   + +   + + 
 
Risk Appraisal  (self)  !   ! !   ! ! 
 
Risk Taking Behaviors (self)  +   + +   + + 
 
Functional Use of Ecstasy  +     + +     + +   
to Alter Mood (past 90 days)   
________________________________________________________________________ 
Note. Signs represent relative mean comparisons among the three groups to a normative 
sample of young adults. The type of sign (plus or minus) indicates whether the group 
mean is expected to be larger (plus) or smaller (minus) than that of a normative sample. 
Groups with the same quantity of signs are hypothesized to have means that are similar in 
magnitude (+/+ or !/!), while groups with a greater number of signs are hypothesized to 
have larger (++) or smaller ( ! !) means than those groups with the corresponding single 
sign (+/!). 
+ (large) 
+ + (larger) 
! (small) 
! ! (smaller) 
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Hypothesis 1: Polydrug Use (Number of Substances Used in Past 90 Days) 
 There will be significant group differences in the number of substances used in the 
past 90 days. Specifically, Hypothesis 1 predicts the following: 
 (a) Users will, on average, have used a greater number of substances in the past 90 
days than Experimenters. 
 (b) Users will, on average, have used a greater number of substances in the past 90 
days than Quitters. 
Hypothesis 2: Normative Influence 
 There will be significant group differences in level of normative influence.  
Specifically, Hypothesis 2 predicts the following: 
 (a) Users will, on average, have higher scores on normative influence than 
Experimenters.  
(b) Users will, on average, have higher scores on normative influence than 
Quitters. 
Hypothesis 3: Social Conformity 
 There will be significant group differences in level of social conformity.  
Specifically, Hypothesis 3 predicts the following: 
 (a) Users will, on average, have lower scores on social conformity than 
Experimenters. 
 (b) Users will, on average, have similar scores on social conformity to Quitters. 
Hypothesis 4: Sensation Seeking 
 There will be significant group differences in level of sensation seeking.  
Specifically, Hypothesis 4 predicts the following: 
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 (a) Users will, on average, have higher scores on sensation seeking than 
Experimenters. 
 (b) Users will, on average, have similar scores on sensation seeking to Quitters. 
Hypothesis 5: Risk Appraisal 
 There will be significant group differences in level of risk appraisal (for self).  
Specifically, Hypothesis 5 predicts the following: 
 (a) Users will, on average, have lower scores on risk appraisal than Experimenters. 
 (b) Users will, on average, have similar scores on risk appraisal to Quitters. 
Hypothesis 6: Risk Taking Behaviors 
 There will be significant group differences in level of risk taking behaviors (for 
self).  Specifically, Hypothesis 6 predicts the following: 
 (a) Users will, on average, have higher scores on risk taking behaviors than 
Experimenters. 
 (b) Users will, on average, have similar scores on risk taking behaviors to Quitters. 
Hypothesis 7: Functional Use of Ecstasy to Alter Mood 
 There will be significant group differences in the functional use of Ecstasy to alter 
mood.  Specifically, Hypothesis 7 predicts the following: 
 (a) Users will, on average, endorse having used Ecstasy to alter mood more 
frequently than Experimenters. 
 (b) Users will, on average, endorse a similar frequency of having used Ecstasy to 
alter mood as Quitters. 
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 Expected Patterns among Group Means 
 The hypotheses stated above indicate two expected patterns among the group 
means on the following dependent variables:  
(1) Users, on average, will have higher/lower (depending on the dependent 
variable) scores than Experimenters and similar scores to Quitters for sensation seeking, 
social conformity, risk appraisal, risk taking behaviors, and functional use of Ecstasy to 
alter mood.   
 (2) Users, on average, will have higher scores than Experimenters and Quitters 
for normative influence and number of substances used in the past three months.   
Alternative Hypotheses 
 Prior research has not examined differences between the specific types of Ecstasy 
users defined in this study (Users, Experimenters, and Quitters). Although the stated 
hypotheses are based upon the available literature, there are alternative hypotheses, 
particularly regarding the comparisons between Users and Quitters. For example, 
possibly those individuals who are Quitters have not only quit using Ecstasy but also 
drugs in general and have become more socially conforming than Users. In contrast, it is 
also possible that Quitters are no longer using Ecstasy but are using other substances. In 
this case, Quitters, on average, would be expected to have used a similar number of 
substances in the past three months in comparison to Users. Unfortunately, due to the 
limitations of the current literature, the hypotheses in this study are partially based on 
conjecture. 




 The basic design of this study can best be characterized as a five-group one-way 
design with concomitant variables. The primary focus of the analyses was on 
comparisons among five groups of young adults with a history of polysubstance use 
(“Experimenters,” “Users,” “Quitters,” “Infrequent Users,” and “Controls”) as described 
below. Because this study used convenience sampling, it should be considered a quasi-
experimental design. 
Participants   
Recruitment of participants. Numerous studies of Ecstasy users have been 
conducted using the Internet (e.g., Gamma et al., 2005; Parrott et al., 2001; Scholey et al., 
2004). As noted by Fernández et al. (2004, p.954), “The Internet’s intermediary position 
between a mass medium and an interpersonal source of communication makes it an ideal 
venue for explaining a study, creating interest and even screening a large number of 
potential participants efficiently.” Fernández et al. (2004) also highlighted the utility of 
the Internet in recruiting “at-risk” groups of participants who may be less willing to 
respond to more conventional approaches such as person-to-person interviews. Notably, 
prior Internet studies of Ecstasy users have employed “purposive sampling,” recruiting 
participants from sources where a large number of Ecstasy users are likely to be drawn 
(Degenhardt, Copeland, & Dillon, 2004). Recent research has found that the 
characteristics and drug use patterns of Ecstasy users recruited through purposive 
sampling were similar to those of participants recruited in a general population household 
survey (Topp, Barker, & Degenhardt, 2004).   
       
41 
Based upon the above success of prior recruitment of Ecstasy users via the 
Internet, participants for this study were also recruited through the Internet. Recruitment 
notices providing a link to the study website were posted on Internet sites including drug 
and non-drug related forums, message boards, and chat rooms. (A copy of the recruitment 
posting can be found in Appendix A). The recruitment procedure involved the following 
tasks. First, a link to the study survey and key words (Ecstasy, MDMA, drug, research, 
survey, marijuana, amphetamines, LSD, cocaine powder, psilocybin mushrooms, heroin, 
prescription drugs, etc.) were submitted to a popular Internet search engine, Google. 
Consequently, when Internet users conducted a search using any of the above key words, 
the survey webpage appeared on a list of relevant websites, which was generated by 
Google. This strategy enabled a wide range of participants to be recruited; recruitment 
targeted anyone searching the Internet rather than individuals from a particular website. 
Next, the experimenter employed a second strategy for recruitment. She 
conducted searches for drug and non-drug related Internet community forums. First, the 
search for drug-related community forums was conducted by using the key words 
mentioned above. Second, the experimenter conducted a general search for “community 
forums” and advertised on these sites as well. This strategy was used to target two types 
of participants: (1) participants who engaged in drug-related Internet communication 
within an Internet community forum of substance users; and, (2) participants with a 
history of substance use who engaged in Internet communication within an Internet 
community forum which was not drug-oriented. Finally, postings were made within drug 
and non-drug related chat rooms and message boards of large internet service providers 
such as American Online and Yahoo. Overall, this methodology allowed for the possible 
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recruitment of a large, broad sample of individuals with a history of substance use, which 
would not have been plausible without the use of the Internet. (See Drug History 
Questionnaire for a review of the validity of Internet surveys). 
Inclusion criteria for five participant groups. Participants included young adults 
in the United States between the ages of 18-25 who had taken Ecstasy at least once in 
their lifetime or had not used Ecstasy but were using at least two of the following 
substances: marijuana, amphetamines, LSD, cocaine powder, psilocybin mushrooms, 
heroin, or prescription drugs in a non-prescribed manner.  Participants were recruited to 
fill one of four groups. The first group was composed of individuals who had used 
Ecstasy 12 or more times in the past year and intended to continue using Ecstasy in the 
future (Users). The second group consisted of individuals who had used Ecstasy three or 
fewer times, had not used Ecstasy in the past six months, and did not intend to use 
Ecstasy in the future (Experimenters). The third group was composed of individuals who 
had used Ecstasy 12 or more times, had not used Ecstasy in the past six months, and did 
not intend to use Ecstasy in the future (Quitters). Finally, the fourth group consisted of 
polysubstance users who had never used Ecstasy but were using at least two of the 
following substances: amphetamines, LSD, cocaine powder, psilocybin mushrooms, 
heroin, or prescription drugs in a non-prescribed manner. They also indicated that they 
intended to continue using these two substances or others on the list in the future 
(Controls).   
 In examining the data following collection and prior to any analyses, it became 
apparent that there were 19 participants who had used Ecstasy 8-11 times in the past year, 
but who did not meet the criteria for the User group (12 or more times in the past year). 
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Therefore, the cutoff for the User group was lowered to 8 times in the past year.  This 
cutoff estimates the use of Ecstasy approximately once every six weeks. In addition, there 
was a large number of Ecstasy users (32) who had an extensive history of use, but who 
did not meet the criteria for a User as they has not used 12 or more times in the past year. 
This group appeared to be distinct from the User group in that they had a history of 
extensive use, but were currently using less frequently. This decrease in use may be 
accounted for by the development of a tolerance and/or the experience of negative side 
effects, thus necessitating longer periods of time between usages. Therefore, a fifth group 
was created (Infrequent Users). The cutoff for this group of Infrequent Users was set to 
the use of Ecstasy 4 or fewer times in the past year, with a lifetime history of use greater 
than or equal to 20 times. This cutoff provides for a clear differentiation between the two 
groups of Users, with Infrequent Users using half as often as Users in the past year. A 
summary of the criteria for each of the five groups can be found in Table 2.   
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Table 2 
Inclusion Selection Criteria for the Five Ecstasy Use Groups  
 
Group     n Inclusion Selection Criteria 
 
 
User     56 •  Have used ecstasy 8 or more times in the past year   
•  Intend to continue using ecstasy in the future  
Experimenter  55 •  Have used ecstasy 3 or fewer times  
•  Have not used ecstasy in the past 6 months 
•  Do Unot U intend to use ecstasy in the future 
Quitter   64 •  Have used ecstasy 12 or more times in lifetime  
•  Have not used ecstasy in the past 6 months; and  
•  Do Unot U intend to use ecstasy in the future 
Infrequent User  46 •  Have used ecstasy 4 or fewer times in the past year  
•  Have used ecstasy 20 or more times in lifetime   
•  Intend to continue using ecstasy in the future 
Control    101 •  Have Unever U used ecstasy   
•  Are using at least 2 of the following substances 
amphetamines, LSD, cocaine powder, psilocybin 
mushrooms, heroin, or prescription drugs in a non-
prescribed manner   
•  Intend to continue using the 2 substances or others 
 
on the list in the future  
Total Sample  322 
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 Participant screening. Initially, prospective participants were screened based on 
five criteria: (1) country of origin (United States); (2) age (18-25); (3) history of Ecstasy 
use including the number of separate occasions during which they had consumed 
Ecstasy); (4) intent to use Ecstasy in the future; and (5) use of at least two substances not 
including Ecstasy (amphetamines, LSD, cocaine powder, psilocybin mushrooms, heroin, 
and prescription drugs in a non-prescribed manner) and intent to use in the future. First, 
participants were asked to review two statements about their country of residence (“I 
currently live in the United States of America”) and age (“My age falls into the category 
of 18-25 years old including 18 and 25”) and to consider whether or not both of these 
statements were true. If their response was “Yes,” they were asked to click “Next” to 
continue with the survey. If their response was “No,” they were asked to click on a link 
which forwarded them to a web page explaining that they did not meet the criteria for this 
study and thanking them for their time. This web page for non-participants contained 
educational information about Ecstasy and a list of educational Internet sites about 
Ecstasy. Next, participants were asked to read and respond “Yes” or “No” to four 
additional questions intended to assess if they met the criteria for one of the four groups 
(Users, Experimenters, Quitters, or Controls). Participants were then instructed to review 
their responses. If they had answered “Yes” to any of the questions (the four screening 
items), they were to click “Next” which connected them to the Informed Consent Page. If 
they had responded “No” to all of the screening questions, they were instructed to click 
on a link which forwarded them to the non-participant debriefing web page.   
As data were collected during the first four days, it became apparent that 3 of the 
11 participants had endorsed items indicating that they met the criteria for two or more 
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mutually exclusive groups or did not meet the criteria for any of the four groups, but had 
failed to click on the link which would exit them from the survey because they did not 
meet the study criteria. Since it was plausible that at least some of the remaining 8 
participants had also responded in a manner to gain entry into the study, the data from 
these 11 participants were excluded from all analyses. In order to decrease the likelihood 
of participants deliberately responding in a manner so that they would meet the study 
criteria, the screening methodology for inclusion in the study was modified. Prospective 
participants were only screened for country of origin (United States) and age (18-25). 
Prospective participants who did not meet these two criteria were forwarded to the web 
page explaining that they did not meet the criteria for this study and thanking them for 
their time. All other participants were directed to continue with the survey by clicking 
“NEXT” at the bottom of the page. The resulting information regarding participants' 
history of Ecstasy or non-Ecstasy polysubstance use as well as intent to use in the future 
was used to determine eligibility for one of the five groups.   
 Exclusion criteria. After completion of data collection, the data were reviewed and 
inclusion/exclusion criteria (see Table 3) were applied to select the final sample of 322 
participants. First, the data was reviewed for multiple submissions. After completing the 
survey, participants were asked to click “Done” to submit their data. Some participants 
clicked on the done button several times, resulting in multiple submissions of their data. 
Multiple submissions were identified by sequential identical responses to free- response 
questions. There were 35 second (or, third etc.) submissions which were excluded from 
the data set. Second, participants’ responses for their state of residence were reviewed, 
and data from 3 participants were excluded because they lived outside of the United 
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States. Third, responses to the screening questions were reviewed, and data from 36 
participants were excluded because they had endorsed items indicating that they met the 
criteria for two or more mutually exclusive groups. Fourth, responses to the five items of 
the infrequency scale (described below) were examined, and 17 participants who had 
endorsed two or more items with an infrequent response were excluded. Fifth, 51 
participants were excluded due to inconsistent data. For example, participants who (a) 
had endorsed being a Quitter for the screening but later responded that they had not quit 
using Ecstasy, and (b) had endorsed being a User for the screening but later responded 
that they had quit using Ecstasy were all excluded. Sixth, incomplete data from 5 
participants were excluded (3 participants had provided incomplete data for concomitant 
variables and 2 participants had failed to respond to an entire scale). Seventh, 107 
participants endorsed being high while taking the survey and 47 of these high participants 
had provided invalid data; therefore, data from all of the high participants were excluded. 
Eighth, 195 participants who produced valid profiles but who did not meet the specific 
criteria for any of the five groups were excluded. Ninth, 11 participants who produced 
valid data but had taken the survey prior to revisions of the screening measure were 
excluded. Tenth, 17 participants who produced valid data but had taken the survey prior 
to revisions of the Reasons for Use of Ecstasy Scale: AMPS were excluded (see 
Measures for details). Finally, participants’ drug histories were reviewed for endorsement 
of polythenzine, a fictitious substance included to detect socially desirable responding 
such as the tendency to over-report drug use (McMillan, Sherlock, & Connor, 2003) as 
well as random responses; no subjects had endorsed using polythenzine. The application 
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of these exclusion criteria reduced the screening sample from 799 respondents to the final 
sample of 322 participants. 
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Table 3 
Exclusion Criteria for Sample Selection  
 




Failed to meet inclusion criteria     195 
for a specific Ecstasy Use group 
 
Collected prior to revision of screening   11 
 
Collected prior to revision of  
Reasons for Use of Ecstasy Scale: AMPS  17 
 
Invalid Data 
 Multiple submissions      35 
 Non-U.S.        3 
 Screening (endorsed criteria for     36 
 2 or more mutually exclusive groups) 
 
 Infrequency Scale      17 
 Inconsistent data       51 
 Incomplete data for concomitant variables  5 
 “High” while taking survey     107 
Initial Sample Recruited      799 
Total Excluded        477  
Final Sample        322 
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 Participant compensation. As an incentive to participate in the study, individuals 
were offered the opportunity to be part of a lottery for monetary compensation ($50) for 
their participation. Following completion of the survey, at the bottom of the debriefing 
page, participants were offered the opportunity to click on a link which connected them 
to a webpage of the experimenter (hosted by the University of Maryland, College Park 
Internet server). Participants were asked to enter an email address with which they 
wanted to be contacted by PayPal (see below) if they were a winner in the lottery. These 
email addresses were sent to the experimenter’s university email account, which was 
password protected, and downloaded into a Microsoft Excel file. The random number 
function was used to assign each email address a random number. The data was then 
sorted by random number, and the first five email addresses were selected as winners.   
Pay-Pal payment. PayPal, an Internet payment service, was used to award the five 
payments. The only participant information needed to use PayPal was an email address. 
Participants were provided the opportunity to click on a link to Yahoo (www.yahoo.com) 
to create a free email account. The method of payment through PayPal (see Appendix B) 
was explained on the informed consent page as well as on the lottery page (see Appendix 
C). In addition, a link to the PayPal website was provided on the lottery page for 
participants to obtain further information.   
The experimenter used her PayPal account to send an email to each lottery 
winner. The email explained to the recipient that he/she had received a payment from the 
experimenter through PayPal. If the recipient was not an existing PayPal member, he/she 
received instructions explaining how to open a free account in order to receive the 
payment. Existing PayPal members were instructed to log into their account. The 
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payment was sent to the recipient’s PayPal account, and he/she could then choose to 
transfer the funds to a checking account, request a check, or send the funds to someone 
else. 
Internet Data Collection Using the University of Maryland Questionnaire Tool 
Survey Website (http://cgi.umd.edu/survey/display?UMD/SURVEY) 
   
The Office of Information Technology (OIT) at the University of Maryland, 
College Park maintains a secure website which enables faculty and staff with a valid 
University ID number and PIN to construct an internet survey which is accessible via a 
web browser. The experimenter created the survey using the OIT software. Access to the 
survey data required the experimenter’s university ID and PIN. Response data were 
stored as a file, and only the experimenter and employees of OIT who maintain the 
website had access to this data file, thus ensuring data integrity.   
Participant anonymity. Participants were never asked to provide any identifying 
information. After completing the survey, they were instructed to click on the button, 
“Done,” which automatically submitted the data to the secure OIT database. Participants 
were then connected to another web site (the experimenter’s secure University of 
Maryland home page) to provide an email address for the lottery. Two separate databases 
were generated on two separate secure web sites, one database consisting of the email 
addresses for the lottery and another consisting of the survey data. Therefore, survey data 
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Measures 
Participant Screening Questionnaire 
Participants were asked to provide information regarding the following: (1) 
country of origin; (2) age; (3) history of Ecstasy use (number of separate occasions 
during which they consumed Ecstasy); (4) intent to use Ecstasy in the future; and (5) 
polysubstance use not including Ecstasy and intent to use in the future. A copy of this 
questionnaire can be found in Appendix D. 
Demographics Questionnaire 
 Participants were asked to provide the following demographic information: (1) age; 
(2) sex; (3) sexual orientation; (4) level of completed education; (5) household income; 
(6) ethnicity; (7) history of attending substance use related counseling or support group 
(treatment); (8) and referral source for the survey (how did they hear about the study). A 
copy of this questionnaire can be found in Appendix E. 
Drug History Questionnaire 
Based upon interview items assessing past consumption patterns (Maudsley 
Addiction Profile [MAP]; Marsden, Gossop, Stewart, Best, Farrell, Lehmann, et al., 
1998) and lifetime use (Boys & Marsden, 2003; Boys, Marsden, & Strong, 2001), the 
Drug History Questionnaire was constructed for the proposed study to assess participants' 
history of drug use for the following substances: alcohol; marijuana; amphetamine; 
Ecstasy; LSD; cocaine powder; psilocybin mushrooms; prescription drugs in a non-
prescribed manner; and polythenzine. For each substance, participants were asked 
questions pertaining to the following information: (1) age of first use; (2) number of 
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times used in the past 30 days; (3) number of times used in the past 90 days; (4) number 
of times used in the past year; and (5) number of times used in lifetime.   
Boys and Marsden (2003) found that age of first use of Ecstasy was a significant 
negative predictor of consumption intensity of Ecstasy. Specifically, initiating use of 
Ecstasy at a younger age was associated with more intensive use when controlling for the 
following: age; gender; peer use; functions; and negative effects. In addition, results 
demonstrated that the perceived functions that drug use fulfills have a consistent, positive 
association with patterns of consumption. These results are consistent with previous 
research indicating an association between reasons for substance use and more intensive 
consumption (Johnston & O'Malley, 1986; Newcomb et al., 1988; Simons, Correia, & 
Carey, 2000).  
The Drug History Questionnaire (see Appendix F) is partially modeled after the 
substance use section of the MAP, a brief (60-item), interviewer-administered 
questionnaire that measures substance use, health risk, physical/psychological health and 
personal/social functioning (Marsden et al., 1998). In their study of treatment outcomes 
for people with drug and/or alcohol problems, Marsden et al. (1998) defined the recall 
period for the MAP as the 30-day period before intake to substance treatment. The 
assessment of substance use (illicit heroin, methadone, benzodiazepines, cocaine and 
alcohol) was conducted in the following manner: (1) the participant is shown a response 
card with seven frequency patterns (ranging from one day per week to every day and is 
asked to select the response that best summarizes their frequency of use (the 
corresponding number of days is recorded); (2) if a substance is only used periodically or 
when there is no typical pattern of use, the interviewer shows a calendar to prompt recall 
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of the last day the substance was used (this last day and any previous days during the 
recall period is recorded); (3) the participant is asked to report the amount of substance 
consumed on a typical day in the past month (self-reports are recorded verbatim) to 
assess intensity of substance use; (4) if the quantity of the substance consumed has varied 
in the past month, the participant is asked to recall the amount used on the 2-3 most 
recent days of use (self-reports are recorded verbatim and averaged). As reported by 
Marsden et al., participants had few problems in estimating the frequency and intensity of 
their substance use.   
 Overall, internal consistency reliability and concurrent validity assessments of 
these scales have been highly satisfactory (Marsden et al., 1998). Concurrent validity for 
self-reported drug use was assessed by adding items from relevant instruments to the 
researcher-administered interview. In order to assess the accuracy of self-reported drug 
use, 64 drug users were asked if they had used heroin, methadone, benzodiazepines, or 
cocaine during the 48-hour period prior to treatment intake. Urinalyses were conducted 
and concordance rates for heroin (morphine), methadone, cocaine and benzodiazepines 
and their metabolites averaged 90% (average κ = .74). To assess test-retest reliability, 
MAP interviews were re-administered after 3.1 days (SD = 2.7). The intraclass 
correlation coefficient (ICC) was used as an index of test-retest reliability (Bartko, 1966).  
ICCs for the assessed substances were high (averaging .94 overall and .88 for subjects 
reporting use), indicating good test-retest reliability. 
 Although the proposed study did not use an interviewer-administered 
questionnaire, results of the Marsden et al. study (1998) suggest that self-report substance 
use data can be valid and reliable. Notably, Van de Wijngaart et al. (1997) examined the 
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validity of self-reports for Ecstasy use by comparing urine samples taken from 
participants with self-reported drug use. Results indicated that, in 93% of the cases, self-
report matched the outcome of the urine analysis, 3% had overestimated their use of 
Ecstasy, and 4% had underestimated their use of Ecstasy. Furthermore, because 
participants completed the proposed questionnaires on their private computers via the 
Internet (increased privacy and anonymity), the veracity of their self-report data for 
substance use may be greater than if interviewed directly by a researcher. Accordingly, 
past research indicates that disclosure of high-risk sexual behaviors, HIV infection, as 
well as alcohol and tobacco misuse may be enhanced by Web-based assessments (Gerber 
et al., 1999; Turner et al., 1998). 
In addition to reporting general history of drug use, participants who reported a 
history of Ecstasy use were asked questions pertaining to the following areas: (1) whether 
or not they had quit using Ecstasy; (2) largest number of Ecstasy pills taken in one 
occasion; (3) whether they currently were or once were psychologically addicted to 
Ecstasy; (4) testing of Ecstasy pills for content; (5) drugs or substances taken to prevent 
unwanted Ecstasy side-effects from Ecstasy; and (6) estimate of the quantity of Ecstasy 
consumed (number of pills) on a "typical using day" (Boys, & Marsden, 2003). 
 Finally, participants who had UneverU used ecstasy were first asked to respond “True” 
or “False” to a list of possible reasons for why they had UneverU used ecstasy. Second, they 
were asked to list any additional reasons why they had never used ecstasy. Last, they 
were asked to list the main reason why they had UneverU used ecstasy. 
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Normative Influence 
As developed by McMillan et al. (2003) and modified for the current study, 
participants were asked to estimate how many of their friends currently used Ecstasy (the 
original scale targeted six substances) based upon a 6-point scale (coded 0-5). Response 
options ranged from none, a few, some, about half, most to all. Friends were defined as 
people with whom participants regularly (i.e., at least once a month) spent time (Boys & 
Marsden, 2003). As stated previously, McMillan et al. found that normative influence 
was positively associated with level of Ecstasy use and differentiated between three types 
of users as defined in their study: (1) light (used Ecstasy once or twice and intended to do 
so in the future); (2) moderate (used Ecstasy three or more but less than 20 times and 
intended to do so in the future); and (3) heavy (used Ecstasy 21 times or more and 
intended to do so in the future). Specifically, McMillan et al. found that higher levels of 
normative influence were associated with a greater likelihood of (1) being a moderate or 
heavy user rather than a light user or (2) being a heavy user rather than a moderate user.   
Social Conformity Scale (SCS) 
 Stein, Newcomb, and Bentler (1987) analyzed data obtained from a study of young 
adults (junior high school students) who participated in an 8-year longitudinal study of 
adolescent development and drug use (Huba & Bentler, 1982; Newcomb & Bentler, 
1986). In this study, social conformity was measured using a modified form of the 
Bentler Psychological Inventory (Bentler & Newcomb, 1978; Huba & Benter, 1982). The 
Social Conformity Scale is a 12-item measure of social conformity which contains three 
subscales: law abidance, liberalism, and religiosity. Each of the subscales is composed of 
four self-description items. A Total score for social conformity was obtained by summing 
       
57 
the 12 items (scored 0-4). Items were displayed in a five-choice semantic differential 
format with opposite adjective phrases at each end (Huba & Bentler, 1982).  
 For the Social Conformity Scale, participants were asked to select one choice for 
each subscale-item which best described them most of the time. The first subscale, the 
Law Abidance scale, consists of the following four items: (1) return incorrect 
change─willing to keep extra change (coded 4-0); (2) might use a false ID─afraid of 
getting caught (coded 0-4); (3) might shoplift─wouldn't know how or want to (coded 0-
4); and (4) goodie-goodie honest type─not quite so honest (coded 4-0).  As indicated, 
items 1 and 4 were reverse scored where 4 indicates the highest score for law abidance. 
The second subscale, the Liberalism scale, consists of the following four items: (1) 
support women's liberation─don't feel women need or want it (coded 4-0); (2) see cops as 
law enforcers─see cops as "pigs" (coded 0-4); (3) think police should carry guns─think 
cops shouldn't carry guns (coded 0-4); and (4) approve of many protests─approve of few 
protests (coded 4-0). As indicated, items 1 and 4 were reverse scored where 4 indicates 
the highest score for liberalism. Finally, the third subscale, the Religiosity scale, consists 
of the following four items: (1) Am not religious─am a religious person (coded 0-4); (2) 
believe in religion or the Bible─believe in science (coded 4-0); (3) feel that prayers are 
answered─feel that praying is a waste (coded 4-0); and (4) think religion is 
outdated─think religion is not outdated (coded 0-4). As indicated, items 2 and 3 were 
reverse-scored where 4 indicates the highest score for religiosity. Cronbach’s internal 
consistency reliability (α) was reported to equal .72 for each of the subscales of the Social 
Conformity Scale (Huba & Bentler, 1982).  
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Sensation Seeking Scale Form V (SSS-V)       
 This 40-item scale was used to assess participants' levels of sensation seeking.  
Research conducted by Jaffe and Archer (1987) found that out of five self-report 
assessment measures, the SSS was typically the most powerful predictor of substance use 
and abuse. Form V of the SSS uses a Total Score based on the sum of four factor scores 
(Zuckerman, Eysenck, & Eysenck, 1976). Each of the four factors is composed of 10 
items: (1) Thrill and Adventure Seeking (TAS) is composed of items reflecting desires to 
engage in sports or activities involving some degree of physical danger or risk; (2) 
Experience Seeking (ES) consists of items expressing the desire to seek new experiences 
through the mind and senses by living in a nonconforming lifestyle with unconventional 
friends and through travel; (3) Disinhibition (Dis) contains items that describe the need to 
disinhibit behavior in the social environment by drinking, partying and seeking variety in 
sexual partners; and (4) Boredom Susceptibility (BS) consists of items that suggest an 
aversion for repetitive experience of any kind, routine work, or dull/predictable people.  
In addition, it includes items indicating a restless reaction when things are unchanging 
(Zuckerman, 1994). Form V is the most widely used version of the SSS and has been 
found to have high criterion-related validity and adequate internal reliability (Gilchrest et 
al., 1996).  
Table 4 shows the scale reliabilities for the SSS-V based on American 
participants, as reported in Zuckerman (1979). Each subscale will be summed to obtain a 
factor score. In addition, a Total score will be obtained by summing the four subscale 
scores.  
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Table 4  
Internal Consistency " for the Sensation Seeking Scale (SSS-V) 
 
Reported by Zuckerman (1979) 
________________________________________________________________________ 
 
Internal Consistency Coefficients  Re-test Reliabilities 
           (3-week interval) 
________________________________________________________________________ 
 
      Male (N = 97)    Female (N = 122) 
     ____________       ____________ 
  
TAS .77 .77 .94 
 
ES .61 .61 .89 
 
Dis .74 .76 .91 
 
BS .57 .56 .70 
 
Total .84 .85 .94 
________________________________________________________________________ 
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General Risk Appraisal Scale (GRAS)  
This 120-item measure was used to assess participants' appraisal of risk for self 
and their peers across various situations as well as reports of self and peers' past 
participation in various risky behaviors. Factor analyses have identified four domains of 
risk including crime, financial, minor violations, and sports (Horvath & Zuckerman, 
1993). Participants responded to four questions for 30 risky activities, using 5-point 
Likert-type scales: (1) personal risk appraisal (Own Risk), the chance of the negative 
outcome if the participants themselves engaged in the activity; (2) Own Behavior, the 
number of times participants engaged in the risky behavior; (3) peer risk appraisal (Peer 
Risk), participants' estimates of the chance that a peer of their own sex and approximate 
age would experience the negative outcome if he/she engaged in the activity; and (4) 
Peer Behavior, an estimate of the percentage of participants' peers who engage in the 
activity.  
Table 5 shows the Cronbach’s internal consistency " for the four risk factors 
(Crime, Financial, Minor Violations, and Sports) for the GRAS (Horvath & Zuckerman, 
1993). The GRAS collected data included participants’ responses to both self (risk 
appraisal and risky behavior) and peer (risk appraisal and risky behavior) items; however, 
the specific hypotheses for this study only pertained to items related to self (risk appraisal 
and risky behavior). Responses to each item were weighted (1-5), and factor scores were 
calculated by summing the designated items for each factor. A Total score was calculated 
by summing the item weights.  
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Table 5 
Cronbach’s Internal Consistency " Reported in the Scoring Manual of the General Risk 

























Own Behavior .69 .72 .55 .43 
 
Peer Risk .78 .70 .73 .71 
 
Peer Behavior .79 .75 .74 .62 
 
Note. N = 447.  
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Horvath and Zuckerman (1993) conducted exploratory multiple regressions using 
one's own risky behavior as the dependent variable and four other factors (peer behavior, 
sensation seeking, impulsivity [measured by the Narrow Impulsivity scale of Eysenck 
and Eysenck (1978)], and risk appraisal) as the predictor variables. The results of these 
analyses are provided below in Table 6. The following variables showed significant 
prediction in all four areas of risk and are listed in order by relative strength of prediction: 
(1) peer behavior; (2) sensation seeking; and (3) risk appraisal. Impulsivity was the 
poorest predictor of risky behavior. For this reason, a measure of impulsivity was not 




Predictors of Own Risky Behavior: Multiple Regression Beta Weights Reported by 
 
Horvath and Zuckerman (1993) 
 
 
   Crime  Violations  Financial  Sports 
 
 
Peer Behavior  .43  .54   .49   .39 
 
Sensation seeking .27  .23   .15   .15 
 
Impulsivity   .13  .11    ─ PaP    ─ P a 
 
Risk appraisal           -.15           -.14            -.18             -.14 
 
Multiple r   .71  .72   .59   .47 
 
RP2 P    .50  .51   .34   .21 
________________________________________________________________________
Note. PaPDid not enter multiple regression equation. N = 447. 
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Functions for Substance Use Scale 
 Initially, when the study survey was first posted on the Internet for data collection, 
the Functions for Substance Use Scale was used (Boys, Marsden, & Strang, 2001). This 
questionnaire consists of a 17-item scale designed to measure perceived functions for 
substance use spanning five domains including the following: 1) using to change mood; 
2) using for specific physical effects; 3) using for social purposes; 4) using to facilitate 
activity; and 5) using to help manage the effects from other substances (Boys, et al., 
2001). This scale consists of items first developed by Boys Marsden, Fountain, Griffiths, 
Stillwell, and Strang (1999) in addition to items generated from the research literature, 
informal discussions with young drug users, and qualitative interviews (Boys et al., 
1999).   
In the Boys et al. study (2001), Ecstasy was used to fulfill all of the functions that 
were measured. Cronbach's α for the Ecstasy scale items was .76. Seven of the 17 
function items were endorsed by over half of the participants. The average total number 
of different functions endorsed for Ecstasy was eight. The above data suggest that 
Ecstasy users differ in their motivations for use and have different functional profiles. In 
their recent study (Boys & Marden, 2003), functions for substance use strongly predicted 
intensity of use of Ecstasy (explained an additional 11% of the variance) when 
controlling for peer use, age of first use, and demographics.   
Development of the Reasons for Use of Ecstasy Scale: AMPS. As noted 
previously, after the necessary changes were made to the screening section, the survey 
was re-posted to the Internet for data collection. For the following three days, data 
continued to be examined. It was noted that many participants had provided feedback 
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indicating that there were many reasons why they had used Ecstasy which were not listed 
in the questionnaire. Again, the survey was revised and feedback was utilized to 
incorporate 11 additional items for possible reasons why participants may have used 
Ecstasy, totaling 30 items. Participants were asked to report how frequently they had used 
Ecstasy for each of the listed reasons, using a five-point Likert-type scale (never to 
always; coded 0-4, respectively). Participants were then asked to list any additional 
reasons why they had used Ecstasy as well as their primary reason for using Ecstasy. A 
copy of this questionnaire can be found in Appendix G. 
 Following completion of data collection, the frequency distributions of the 30 items 
(reasons for the use of Ecstasy) were examined (see Appendix H) and rational scale 
construction was used to identify four main categories of reasons for use of Ecstasy. 
These four categories were used to create the Reasons for Ecstasy Use Scale: AMPS 
(Alter Perception, enhance Mood, facilitate Personal Growth, and enhance 
Social/Interpersonal Relationships). The first category of use was to alter perception and 
was composed of two items: (1) “Just get really stoned or intoxicated” and (2) “Enhance 
sensations (touch, taste, sight and smell).” The second category of use was to enhance 
mood and was composed of five items: (1) “Make yourself feel better when down or 
depressed;” (2) “Help you to feel elated or euphoric;” (3) “Help you to relax;” (4) “Help 
you to stop worrying about a problem;” and (5) “Help make something you were doing 
less boring.” The third category of use was to facilitate personal growth which also 
consisted of five items: (1) “Develop insight into yourself;” (2) “Have a new experience 
that would help you to see the world differently;” (3) “As part of religious/spiritual 
practices;” (4) “Facilitate a psychotherapeutic process;” and (5) “Facilitate creative 
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processes such as drawing, writing, playing music, singing or other artistic activities.” 
The last category of use was to enhance social/interpersonal relationships which 
consisted of ten items: (1) “Help you to 'keep going' on a night out with friends;” (2) 
“Help you to enjoy the company of your friends;” (3) “Help you to feel more confident or 
better able to talk to people in a social situation;” (4) “Help you to lose your inhibitions;” 
(5) “Enhance feelings when having sex;” (6) “Enhance empathy;” (7) “Enhance 
intimacy;” (8) “Develop insight into others;” (9) “Increase your ability to express 
yourself openly and honestly;” and (10) “Fit in with peers (others were using).”  
Further analyses revealed adequate reliability for each of subscales of the Reasons for 
Ecstasy Scale: AMPS, especially given the number of items for each subscale: (1) Alter 
Perception (2 items): α = .338; (2) Mood (5 items): α = .627; (3) Personal Growth (5 
items): α = .793; and (4) Social/Interpersonal (10 items): α = .790. Finally, simple 
Pearson product-moment correlations among the four subscales were examined in order 
to evaluate the degree of overlap (see Table 7); each subscale was judged to uniquely 
contribute to the scale. In addition, a factor analysis was conducted to explore alternative 
groupings of the 30 reasons for use of Ecstasy and 4 factors were found.   
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Table 7 
Means (M), Standard Deviations (SD), and Intercorrelations of the Reasons for Ecstasy 
Use Scale: AMPS with Cronbach’s Internal Consistency Reliability α on the Diagonal 
                                
Mood   Alter Perception    Personal Growth  Social/Interpersonal
  
Mood                   (.627)      .412        .294      .630 
Alter Perception            .466           (.338)       .154      .407 
Personal Growth           .303           .187            (.793)     .600 
Social/Interpersonal     .658            .444             .636           (.790) 
M               11.74       6.41        10.84      24.09 
SD              3.74       2.13        4.54      8.34 
Note. N = 219. Correlations below the diagonal are the simple Pearson product moment 
correlations, while correlations above the diagonal are the Pearson product moment 
correlations from which Age, Gender, Ethnicity, Education, Sexual Orientation, 




Development of the Reasons for First Use of Ecstasy Scale. In addition to thinking 
about their general use of Ecstasy, participants were asked to think about the reasons why 
they had used Ecstasy their Ufirs Ut time and to do the following: (1) select all of the  
applicable reasons from the same list of the thirty items discussed above with the addition 
of one item (“Curious what it would be like to use Ecstasy;”) (2) list any additional 
reasons; and (3) list their primary reason for their first use of Ecstasy. The same four 
subscales discussed above (Alter Perception, Mood, Personal Growth and 
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Social/Interpersonal Relationships) were used for the Reasons for First Use of Ecstasy 
Scale so that a comparison could be made between reasons for UfirstU use of Ecstasy and 
reasons for general use of Ecstasy. A copy of this questionnaire can be found in 
Appendix I. In addition, a factor analysis was conducted to explore alternative groupings 
of the 31 reasons for first use of Ecstasy and 4 factors were found.  
 Measure of Knowledge and Beliefs about Ecstasy 
 In thinking of their knowledge and beliefs about Ecstasy, all participants were 
asked to respond “Yes” or “No” to questions in the following 9 areas: (1) having read 
about Ecstasy on the Internet; (2) having read books about Ecstasy; (3) having read 
scientific research articles about Ecstasy; (4) consider Ecstasy to be a safe drug; (5) 
believe that Ecstasy is an addictive drug; (6) feel they have needed or would need to take 
more Ecstasy each time they used in order to get the same desired effects; (7) feel that the 
benefits of using Ecstasy outweigh the risks; (8) feel they would stop using Ecstasy if 
they learned that it caused permanent brain damage; and (9) believe that they are more 
likely to engage in certain risky behaviors (unsafe sexual activity, driving, etc.) while 
using Ecstasy than when not under the influence of Ecstasy. A copy of this questionnaire 
can be found in Appendix J. 
Infrequency Scale 
 Five items from the Infrequency Scale of the Jackson Personality Inventory were 
included in the survey as a validity scale. These items were interspersed among the 
Knowledge and Beliefs about Ecstasy items reviewed above. Participants were asked to 
respond true or false to each of the following items: (1) “I believe there are some jobs 
that I would not enjoy doing;” (2) “I do some things better than others;” (3) “Some things 
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don't turn out exactly as I plan them;” (4) “I have sometimes hesitated before making a 
decision” and (5) “Of the people I know, I like some better than others.” As explained 
above, data from participants who had endorsed the infrequent response (False) for two 
or more of the five items were excluded.           
Procedure 
Selection of Participants 
 Recruitment postings for this study directed prospective participants to the study 
website address (http://cgi.umd.edu/survey/display?UMD/SURVEY). Prospective 
participants were first connected to the participant screening web page. After completing 
the screening items, individuals who met the study criteria (living in the United States 
and between the ages of 18 and 25) were asked to click on the "NEXT" button at the 
bottom of the page which connected them to the informed consent web page (see 
Informed Consent, below). As explained previously, those who did not meet the criteria 
for the study were connected to a web page stating that they did not meet the criteria for 
the study and providing educational information about Ecstasy as well as addresses of 
educational websites pertaining to Ecstasy. A copy of this educational information 
regarding Ecstasy can be found in Appendix K. 
Informed Consent 
 Individuals who met the study criteria were asked to review the informed consent 
web page which explained their rights and responsibilities as a research participant in this 
study. Participants were informed that they had the right to withdraw their consent and to 
discontinue participation at any time. In addition, participants were invited to take part in 
the lottery for 5 awards of $50 each as a form of compensation for their participation.  
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Participants were informed that in order to participate in the lottery, they needed to 
provide an email address that would not be connected in any way to their survey data.  In 
addition, the payment process through PayPal was explained in detail. Participants were 
provided the option to print a copy of the informed consent by simultaneously pressing 
two keys (Control and P). A copy of the informed consent can be found in Appendix L.  
After reviewing the informed consent page, participants provided their consent 
electronically by clicking the “NEXT” button to continue with the survey.   
Completion of Questionnaires 
 Directions were provided for participants at the top of each questionnaire.  
Participants clicked “NEXT” at the bottom of each web page in order to move from page 
to page. Participants completed the questionnaires in the following order: (1) 
Demographics Questionnaire; (2) Drug History Questionnaire; (3) Reasons for Ecstasy 
Use Scale: AMPS (completed only by Controls); (4) Reasons for Not Using Ecstasy 
Scale: AMPS (completed only by Controls); (5) Sensation Seeking Scale Form V; (6) 
Perceived Peer Substance Use of Ecstasy; (7) Knowledge and Beliefs about Ecstasy 
Measure and Infrequency Scale; (8) Social Conformity Scale; and (9) General Risk 
Appraisal Scale. Questionnaires were ordered such that, in general, less intensive 
measures (e.g., measures that were briefer) were completed first and shorter measures 
were completed in between long measures to break up the monotony of questions.  
Debriefing 
Following completion of the survey, participants clicked the “DONE” button at 
the bottom of the page. They were then were forwarded to the debriefing page, thanking 
them for their participation and providing educational information about Ecstasy as well 
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as addresses of educational websites pertaining to Ecstasy. Participants had the option to 
print the debriefing page by simultaneously pressing two keys ("Control" and "P.") A 
copy of the debriefing page can be found in Appendix M.   
Entrance into the Lottery 
After reviewing the debriefing page, participants were given the opportunity to be 
connected to a web page reviewing the details of the lottery. They were also provided an 
optional link to the PayPal website for further information. Participants who chose to 
enter the lottery were asked to provide an email address through which notification would 
be made if they were selected as a winner in the lottery. Participants were also provided 
the option to click on a link to create a free email account.    
Analysis of Data 
Scoring of Measures 
 For each of the outcome measures, sum scores were calculated for each Ecstasy 
Use Group (Users, Experimenters, Quitters, Infrequent Users, and Controls). First, the 
mean for each measure for each participant was calculated by taking the mean of the 
items in the measure (using all available data) and then multiplying by the number of 
items for that subscale. Thus, scores were calculated for each participant who responded 
to at least one item on a given measure. Finally, for the case in which multiple outcome 
measures were included in a multivariate analysis, linear composite scores, representing a 
weighted combination of scores on the outcome measures, were calculated for each 
significant effect, using the unstandardized canonical variate coefficients (Harris, 2001).  
 Missing data was examined (see Table 8) for the subscales of the dependent 
measures (Sensation Seeking Scale, Social Conformity Scale, and Reasons for Ecstasy 
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Use Scale: AMPS). First, for each of the 4 subscales of the Sensation Seeking Scale 
(Thrill and Adventure Seeking, Experience Seeking, Disinhibition, and Boredom 
Susceptibility), the number of participants who failed who answer at least one item was 
12, 11, 8, and 9, respectively. Second, for each of the 3 subscales of the Social 
Conformity Scale (Law Abidance, Liberalism, and Conformity), the number of 
participants who failed to answer at least one item was 1, 5, and 5, respectively. Third, 
for the 4 subscales of the General Risk Appraisal Scale (Own Risk Appraisal) (Crime 
Risk, Financial Risk, Minor Violations Risk, and Sports Risk), the number of participants 
who failed to answer at least one item was 18, 14, 20, and 19, respectively. Fourth, for 
the 4 subscales of the General Risk Appraisal Scale (Own Risky Behavior) (Crime Risk, 
Financial Risk, Minor Violations Risk, and Sports Risk), the number of participants who 
failed to answer at least one item was 18, 14, 14, and 19, respectively. Finally, for the 4 
subscales of the Reasons for Ecstasy Use Scale: AMPS, the number of participants who 
failed to answer at least one item was 2, 5, 1, and 13, respectively. In examining the 
percent of available data for each of the subscales, the percentages suggest that missing 
data was not problematic.  




Percents of Available Data for the Sensation Seeking Scale, Social Conformity Scale,  
 
and Reasons for Ecstasy Use Scale: AMPS 
 
        
      Missing Missing   Missing  Available  
      1 Item 2 Items 3-6 Items  Data 
Scale      (n)  (n)  (n)   (%) 
 
 
USensation Seeking Scale 
 
     Thrill and Adventure Seeking 11  1  0   99.6  
      n (scale items) = 10 
 
     Experience Seeking   11  0  0   99.7 
 n (scale items) = 10 
 
     Disinhibition    8  0  0   99.8 
 n (scale items) = 10 
 
     Boredom Susceptibility  9  0  0   99.7 
 n (scale items) = 10 
 
USocial Conformity Scale 
 
     Law Abidance    1  0  0   99.2 
 n (scale items) = 4 
 
     Liberalism    3  2  0   99.5 
  n (scale items) = 4 
 
     Religiosity    3  2  0   99.5 
  n (scale items) = 4 
 
Note. N = 322.
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Table 8 (continued) 
 
Percent of Available Data for the Sensation Seeking Scale, Social Conformity Scale,  
 
General Risk Appraisal Scale, and Reasons for Ecstasy Use Scale: AMPS  
 
               
      Missing Missing   Missing  Available  
      1 Item 2 Items 3-6 Items  Data 
Scale      (n)  (n)  (n)   (%) 
 
 
General Risk Appraisal Scale 
 U(Own Risk Appraisal) 
  
 Crime Risk     11  0  7   97.8 
  n (scale items) = 6 
 
 Financial Risk     8  3  3   98.4 
  n (scale items) = 5 
 
 Minor Violations Risk   4  0  16   95.0 
  n (scale items) = 5 
 
 Sports Risk      6  0  13   95.5 
  n (scale items) = 4 
 
 
General Risk Appraisal Scale 
 U(Own Risky Behavior) 
  
 Crime Risk     10  1  7   97.8 
  n (scale items) = 6 
 
 Financial Risk     8  3  3   98.9 
  n (scale items) = 5 
 
 Minor Violations Risk   8  3  3   95.3 
  n (scale items) = 5 
 
 Sports Risk      6  0  13   94.1 
  n (scale items) = 4 
 
Note. N = 322.
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Table 8 (continued) 
 
Percent of Available Data for the Sensation Seeking Scale, Social Conformity Scale,  
 
General Risk Appraisal Scale, and Reasons for Ecstasy Use Scale: AMPS  
 
               
      Missing Missing   Missing  Available  
      1 Item 2 Items 3-6 Items  Data 
Scale      (n)  (n)  (n)   (%) 
 
 
Reasons for Ecstasy Use: AMPS 
 
 Alter Perception   2  0  0   99.7 
  n (scale items) = 2 
 
 Enhance Mood   4  1  0   99.6 
   n (scale items) = 5 
      
     Personal Growth   1  0  0   99.9  
 n (scale items) = 5 
 
     Social/Interpersonal   12  1  0   99.6 
 n (scale items) = 10     
 
Note. N = 322.
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Statistical Model 
  Outcome measures. Dependent variables were determined to be either primary or 
secondary prior to data collection. Primary variables were outcomes of interest that 
specifically relate to the hypotheses. Secondary variables were outcomes of interest that 
do not specifically relate to the hypotheses, but were thought to have the potential to 
make a significant contribution to the existing literature relating to Ecstasy use among 
young adults. All 7 primary dependent variables were continuous random variables while 
secondary variables were either continuous or dichotomous variables (see Table 9 for a 
list of the primary and secondary dependent variables). 
 Explanatory variables. The predictor variables can be categorized as either an 
UEffect of InterestU or a UConcomitant Variable U. (From a statistical viewpoint, this 
categorization is arbitrary and is utilized here simply for ease of presentation.) 
  UEffect of Interest.U The predictor variable of primary interest was Ecstasy Use Group 
(User v. Experimenter v. Quitter v. Infrequent User v. Control). The definition of the 5 
groups used to define the levels of this factor can be found in Table 2. It should be noted 
that the Control group was omitted from the analysis of several secondary outcome 
variables which pertained only to participants with a history of Ecstasy use. 
  UConcomitant Variables.U There were 7 concomitant variables: (1) Age; (2) Gender 
(Male v. Female); (3) Ethnicity (Caucasian v. Non-Caucasian); (4) Education (High 
School v. College v. Post College); (5) Sexual Orientation (Heterosexual v. Homosexual 
v. Bisexual); (6) Treatment (Psychological Counseling/Support Group v. No 
Psychological Counseling/Support Group); and (7) Type of Referral Source (Drug v. 
Non-Drug v. Rave/Music v. Unknown). 




Explanatory, Concomitant, and Criterion Variables   
 
 




Group (Experimenter, User, Quitter, Infrequent User, and Control) 
UConcomitant 
Age      Demographics Questionnaire  
Gender     Demographics Questionnaire 
Ethnicity     Demographics Questionnaire 
Education     Demographics Questionnaire 
Sexual Orientation   Demographics Questionnaire 
Treatment     Demographics Questionnaire 
Referral Type    Demographics Questionnaire 
UCriterion (Primary) 
Polydrug use    Drug History Questionnaire  U, E, Q, I, and C 
Reasons for Ecstasy use  Reasons for Ecstasy    U, E, Q, and I 
      Use Scale: AMPS 
 
Normative influence   Normative Influence Scale  U, E, Q, I, and C 
Social conformity   Social Conformity Scale  U, E, Q, I, and C 
Sensation seeking   Sensation Seeking Scale Form-V U, E, Q, I, and C 
Risk appraisal    General Risk Appraisal Scale  U, E, Q, I, and C 
Risk taking behaviors   General Risk Appraisal Scale  U, E, Q, I, and C 
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Table 9 (continued)   
Explanatory, Control, and Criterion Variables  
 
 




Age of First Use of Ecstasy   Drug History   U, E, Q, and I 
       Questionnaire    
 
Past 90-Day Use     Drug History    U, E, Q, I, and C 
       Questionnaire 
 
Psychological Addiction to Ecstasy  Drug History   U, E, Q, and I 
       Questionnaire 
 
Testing of Ecstasy Pills    Drug History   U, E, Q, and I 
       Questionnaire 
 
Substances Taken to Prevent    Drug History    U, E, Q, and I 
Side-Effects of Ecstasy    Questionnaire 
 
 
Reasons for Having Never   Drug History    C 
Used Ecstasy     Questionnaire 
 
Knowledge and Beliefs    Measure of Knowledge  U, E, Q, I, and C 
about Ecstasy     and Beliefs about Ecstasy   
  
Intensity of Ecstasy Use   Drug History    U 
       Questionnaire 
 
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control.   
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  Planned contrast. Although there were five distinct groups that formed the Ecstasy 
Use Group effect, one of the groups, the Infrequent Users, was determined following 
inspection of the frequencies for Ecstasy use in the sample, while another of the groups, 
the Control group, was included simply as a reference group. No hypotheses involved 
either of these two groups. Therefore, a 2-df planned comparison involving the mean 
differences among the Users, Quitters, and Experimenters was constructed to test for the 
mean differences among these three specific groups. 
  Analytic approach. Analyses were conducted by sets of variables, where each set 
contained one or more outcome variables thought to measure the outcome of interest. 
Because multiple tests of significance were undertaken, some adjustment to α was 
necessary to limit the cumulative error rate. Therefore, it was determined that the α for 
each set of primary outcome variables would be .05, with .04 assigned to the Planned 
Contrast (User v. Experimenter v. Quitter), and .01 divided up equally among the 
Concomitant Variables (that is, .01/7). Finally, because there were 5 groups in the 
Ecstasy Use Group effect, in order to examine for possible differences between these 5 
groups, not all of which were included in the Planned Contrast, the Ecstasy Use Group 
effect was tested against a post hoc critical value with α = .04. In the case of a single 
outcome variable, this meant against a Scheffé critical value for the Ecstasy Use Group 
effect, while for case of multiple outcome variables, Gabriel’s simultaneous test 
procedure, the multivariate ‘extension’ of Scheffé’s adjustment procedure, was utilized 
(Harris, 2001). In contrast, α for secondary outcome variable was set to .01 for the 
Ecstasy Group main effect, and .01/7 for the concomitant variables, in order to partially 
control the error rate associated with ‘data snooping’ of the secondary outcome measures. 
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 Although this approach to setting α limits the error to, at most, α for each set of 
primary outcome measures, it should be understood that the cumulative error rate for the 
study exceeds .05. Moreover, it is also the case that the power associated with the tests of 
the Concomitant Variables is probably generally quite low, and so some unknown 
number of relationships between the Concomitant Variables and the outcome variables 
that were found to be nonsignificant may in fact exist in the population. (This low power 
for the tests of the Concomitant Variables had no bearing on the power of the tests for the 
Planned Contrast or the Ecstasy Use Group effect.)  This fact should be kept in mind in 
any interpretation of failure to find relationships between the Concomitant Variables and 
the outcome measures. 
   Statistical methods. A General Linear Model (GLM) approach was utilized to 
conduct all analyses of continuous outcome variables, while logistic regression analysis 
was employed in the analysis of the binary outcome variables. The General Linear Model 
(GLM) models the relationship between a continuous, normally-distributed response 
variable and one or more explanatory variables. The explanatory variables may be either 
categorical, continuous, or any combination thereof. GLM underlies many of the 
statistical analyses that are used in behavioral science research. It is the foundation for the 
t-test, Analysis of Variance (ANOVA), Analysis of Covariance (ANCOVA), simple and 
multiple regression analysis, and many multivariate methods including discriminant 
function analysis, canonical correlation, and multivariate analysis of variance and 
covariance (MANOVA and MANCOVA).  A more formal statement of the GLM can be 
in the equation: y = bB0 B + b B1 BXB1B + ... + b Bk BXBkB + e, where y = criterion variable (the variable or 
set of variables to be modeled or explained); XB1 B, ... XBkB  = predictor variables which are 
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assumed fixed (measured without error); e = random error which is determined by the 
principle of ordinary least squares to maximize the prediction of y; and b Bi B  = the 
contribution of the independent variable xBi B.  For those analyses in which there was a 
single outcome variable, the resulting analysis can be seen as a oneway ANCOVA with 
seven control variables, one of which is continuous, age, with the remaining six being 
categorical.  Age can be considered to be a covariate, and the remaining six variables can 
be seen as blocking factors.  Similarly, when there was more than one outcome variable 
included in a given analysis, the analysis can be viewed as a MANCOVA.  Roy’s greatest 
characteristic root test was used to test all multivariate effects.  A virtue of this test 
statistic is that it indicates the amount of variance explained in the linear composite of the 
dependent variables by the effect of interest.  In the case of a single outcome measure, the 
F test was utilized.  However, to simplify the presentation of results, RP2 Prather than F is 
reported, to allow direct comparison of the explanatory power of the effect of interest for 
both the univariate and multivariate cases.   
 Finally, a profile analysis, sometimes termed repeated-measures MANOVA, 
(Harris, 2001), was conducted for each of the two measures of motivations for the use of 
ecstasy (Reasons for Use of Ecstasy Scale: AMPS and Reasons for First Use of Ecstasy 
Scale: AMPS), in order to examine for the possibility that the Ecstasy Use Groups might 
differ in the relative importance they would place on the reasons for use of Ecstasy and/or 
the reasons for first use of Ecstasy. In this case, the same effects were included in the 
model as in the other analyses, plus an effect for Measure, which allows for the 
examination of the interaction of each of the between-subjects effects with the within-
subjects effect of Scale. Such an interaction would indicate that the Scale profile differed 
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among the levels of the between-subject effect. (The means rather than the sums of the 
scores on the subscales of the Reasons for Use of Ecstasy Scale as well as the Reasons 
for First Use of Ecstasy Scale were used in the profile analysis, because the subscales had 
differing numbers of items, so use of the sum rather than the mean would introduce a 
scaling artifact into the profile analyses). 
 Logistic regression analysis (Hosmer & Lemeshow, 1989) models the relationship 
between a discrete response variable and one or more explanatory variables. The logistic 
regression model utilizes the explanatory variables to predict the probability that the 
response variable takes on a certain value. The explanatory variables may be either 
categorical, continuous, or any combination thereof. Although similar to linear 
regression, logistic regression is useful for predicting the presence or absence of a 
characteristic or outcome that is binary (e.g., psychologically addicted to Ecstasy v. not 
psychologically addicted to Ecstasy) or ordered polytomous (e.g., high school graduate v. 
college graduate v. post-college graduate). Logistic regression applies maximum 
likelihood estimation after transforming the dependent variable into a logit variable (the 
natural log of the odds of the dependent variable occurring or not). In this way, logistic 
regression estimates the probability of a certain event occurring. 
  In logistic regression, probabilities are constrained to lie between 0 and 1, with ½ 
as a neutral value for which both outcomes are equally likely. The constraints at 0 and 1 
make it impossible to construct a linear equation for predicting probabilities. More 
formally, the linear logistic regression model can be stated as: log[p Bi B / (1 - pBi B)] = βB0 B + x Bi Bβ, 
where p Bi B = P(y Bi B = yB1 B | xBi B), the response probability to be modeled where P is taken to mean 
‘the probability of;’ yBi B is taken to mean the ith ordered level of the response variable; | is 
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taken to mean ‘given;’ β B0B is the intercept parameter; β is the vector of slope parameters; 
and x Bi B is the vector of explanatory variables. Thus, this expression of the logistic 
regression equation models the log transformation of the ratio of the ith individual’s 
response probability to non-response probability as a linear function of the explanatory 
variables, xBi B. Finally, standard errors and tests of significance were adjusted by the 
deviance in the model, in order to control for possible overdispersion. 





The final study sample consisted of 322 participants for whom basic background 
information was obtained through the on-line survey. Tables 10 through 16 provide basic 
demographic information for the total sample and each Ecstasy Use Group. A little more 
than one half (58.4%) of participants were males, and the majority (87%) endorsed being 
heterosexual. The average age of participants was 21.7 years (range = 18-25, inclusive, 
by sampling design) and most (78.6%) were Caucasian. More than half (62.1%) of the 
sample had completed some college study and about one-fifth (20.8%) had earned a 
college or postgraduate degree. About one-half (50.6%) were recruited from non-drug 
related websites such as community forums or though a search engine (e.g., Google). 
Approximately 17% of participants were recruited from drug related websites, and about 
sixteen percent from rave or music related websites. Finally, approximately 16% of the 
sample reported having attended substance-related psychological counseling or a support 
group.  
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Table 10   
Demographics: Gender Distributions in the Total Sample and Each Ecstasy Use Group 
      
Group 
 
Gender         Total Sample  U E Q I C 
 
Male   n (Group) 188   42 24 32 27 63 
  
 Group % 58.4   75.0 43.6 50.0 58.7 62.4 
Female   n (Group) 134   14 31 32 19 38 
   
 Group % 41.6   25.0 56.4 50.0 41.3 37.6 
Total  n (Group) 322      56 55 64 46 101 
 
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control.   
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Table 11 
Demographics: Sexual Orientation Distributions in the  




Sexual Orientation       Total Sample  U E Q I C 
  
Heterosexual n (Group) 280   46 48 58 37 91 
  Group % 87.0    82.1 87.3 90.6 80.4 90.1 
Homosexual n (Group) 11    3 2 1 3 2 
 
  Group % 3.4   5.4  3.6 1.6 6.5 2.0 
  
Bisexual n (Group) 31   7 5 5 6 8 
 Group % 9.6   12.5 9.1 7.8 13.0 7.9 
Total  n (Group) 322      56 55 64 46 101  
 
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control.   
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Table 12 
Demographics: Age Distributions in the Total Sample and Each Ecstasy Use Group  
 
         Group 
 
Age         Total Sample U  E  Q  I  C 
 
18 n (Group)  45  12  5  3  1  24 
 Group %  14.0  21.4  9.1  4.7  2.2  23.8 
19 n (Group)  29  7  2  1  3  16 
 Group %  9.0  12.5  3.6  1.6  6.5  15.8 
20 n (Group)  39  7  5  3  7  17 
Group %  12.1  12.5  9.1  4.7  15.2  16.8 
 
21 n (Group)  37  8  5  6  5  13 
Group %  11.5  14.3  9.1  9.4  10.9  12.9 
 
22 n (Group)   38  3  13  5  6  11 
Group %   11.6  5.4  23.2  7.6  13.0  10.8 
23 n (Group)  37  5  8  11  7  6 
 
 Group %  11.5  8.9  14.5  17.2  15.2  5.9 
24 n (Group)  34  6  7  12  3  6 
Group %  10.6  10.7  12.7  18.8  6.5  5.9 
 
25 n (Group)  63  8  10  23  14  8 
Group %  19.6  14.3  18.2  35.9  30.4  7.9 
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Table 12 (continued) 
Demographics: Age Distributions in the Total Sample and Each Ecstasy Use Group  
      
Group 
 
Age         Total Sample U  E  Q  I  C 
 
Total n (Group)  322  56  55  64  46  101 
M   21.73  21.11  22.20  23.20  22.50  20.52 
SD   2.43  2.51  2.14  1.99  2.16  2.22 
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control.   
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Table 13 




Ethnicity          Total Sample  U E Q I C 
 
Caucasian n (Group) 253   46 44 49 31 83 
  
 Group % 78.6   82.1 80.0 76.6 67.4 82.2 
Non-Caucasian   n (Group) 69   10 11 15 15 18 
  
 Group % 21.4   17.9 20.0 23.4 32.6 17.8 
Total  n (Group) 322      56 55 64 46 101 
 
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control.   
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Table 14 
Demographics: Level of Education Distributions in the  




Level of Education       Total Sample  U E Q I C 
  
Some H.S. or n (Group) 55   19 8 5 5 18 
H.S. Diploma/ 
G.E.D. Group % 17.1    33.9 14.5 7.8 10.9 17.8 
  
Some College  n (Group) 200    30 33 35 32 70 
  
  Group % 62.1   53.6  60.0 54.7 69.6 69.3 
  
B.A. or  n (Group) 67   7 14 24 9 13 
Graduate Work 
 Group % 20.8   12.5 25.5 37.5 19.6 12.9 
Total  n (Group) 322      56 55 64 46 101  
 
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control.   
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Table 15 
Demographics: Type of Recruitment Website Distributions in the  
Total Sample and Each Ecstasy Use Group 
 
        Group 
 




Drug Related  n (Group) 55     10 7 4 8 26 
 
      Group % 17.1   17.9 12.7 6.3 17.4 25.7 
Non-Drug    n (Group) 163   15 37 36 15 60 
Related      
 Group % 50.6   26.8  67.3 56.3 32.6 59.4 
  
Rave or Music  n (Group) 51    22 1 12 15 1 
 Group % 15.8    39.3 1.8 18.8 32.6 1.0 
Unknown   n (Group) 53    9 10 12 8 14 
 
 Group % 16.2    15.8 17.9 18.2 17.4 13.7 
Total    n (Group) 322      56 55 64 46 101  
 
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control.    
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Table 16 
Demographics: Participants Who Attended Substance Related Psychological Counseling 
or a Support Group Distributions in the Total Sample and Each Ecstasy Use Group 
 
       Group 
 
Counseling or Support     Total Sample  U E Q I C 
Group Attendance 
 
Yes n (Group)    52    10 10 16 8 8 
  Group %   16.1    17.9 18.2 25.0 17.4 7.9 
No  n (Group)    270    46 45 48 38 93  
 Group %    83.9   82.1  81.8 75.0 82.6 92.1 
Total n (Group)    322      56 55 64 46 101 
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control.   
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Participants were also asked to indicate whether they were financially 
independent or dependent and to list annual household income [their own income if 
independent or their caregiver(s) income if dependent]. In reviewing the incomes of 
participants who reported being independent and comparing those incomes to those 
reported by participants who were dependent, it was decided that this measure of income 
was not likely to provide an adequate measure of socio-economic status, as young adults 
who were independent were less likely to earn as much as a caregiver. Therefore, socio-
economic status was not used as a control variable.        
Substance Use History for the Entire Sample 
Age of First Use. Participants were asked to report the age that they first used 
each of the eight substances (Ecstasy, marijuana, psilocybin mushrooms, cocaine powder, 
LSD, amphetamines, prescription medications in a non-prescribed manner, and alcohol). 
Table 17 provides the means and standard deviations for first use for the entire sample. 
Of the 221 study participants who had used Ecstasy (68.6%), the average age of first use 
was 18 (SD = 2.15). The 2-df Ecstasy Use Group planned contrast revealed a significant 
difference (see Table 18) among the three groups (Users, M = 18.90, SE = .41; 
Experimenters, M = 19.35, SE = .42; and Quitters, M = 17.58, SE = .41) for age of first 
use of Ecstasy (RP2P = .170, p < .001) as well as a main effect for the four groups (RP2 P = 
.115, p < .001). Pairwise comparisons revealed that Experimenters were significantly 
more likely to be older than both Quitters and Infrequent Users (M = 17.64, SE = .43) 
when they first used Ecstasy (see Table 19). No significant effects were found for 
Gender, Ethnicity, Education, Sexual Orientation, Treatment, or Referral Type (all ps > 
.008). 
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Table 17 
Age of First Use of Ecstasy, Marijuana, Amphetamines, LSD, Powder Cocaine, 
Psilocybin Mushrooms, Prescription Drugs in a Non-Prescribed Manner and Alcohol  in 
the Total Sample and Each Ecstasy Use Group  
 
                  Group 
             Total Sample  U    E    Q    I   C 
Drug     n (group)  322  56    55    64    46   101 
 
Ecstasy     M    18   18.0   18.9   17.6   17.7  ── 
 
      SD  2.15  2.28   2.06   2.25   1.66  ── 
Marijuana    M    15.6   15.3    16.7   18.2   17.2  16.0 
      SD  2.38  2.41   2.50   2.34   2.23  2.35 
Amphetamnes   M    17.3  17.3   15.8   15.0   15.7  16.0 
SD  4.98  4.72   5.65   2.37   5.46  6.35
 
LSD      M    17.4  17.6   17.8   17.2   17.4  17.2
SD  2.41  2.33   2.06   2.34   3.08  1.81 
 
Powder Cocaine  M    18.5  18.0   18.9   18.2   18.7  18.8 
SD  2.43  2.09   2.63   2.35   2.91  2.14 
Psilocybin    M    18.0  17.7   18.2   17.8   18.1  18.1 
Mushrooms 
      SD  2.19  1.77   2.53   2.30   2.28  2.04 
Prescription    M    17.2  17.0   17.4   17.3   16.9  17.4 
Drugs 
      SD  2.76  2.49   3.29   3.06   2.96  2.35
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Table 17 (continued) 
Age of First Use of Ecstasy, Marijuana, Amphetamines, LSD, Powder Cocaine, 
Psilocybin Mushrooms, Prescription Drugs in a Non-Prescribed Manner and Alcohol  in 
the Total Sample and Each Ecstasy Use Group  
 
                  Group 
             Total Sample  U    E    Q    I   C 
Drug    n (group)  322  56    55    64    46   101 
 
Alcohol     M     7.8  6.0   6.0   8.8   8.7  8.9
 
      SD   7.74  6.97   5.77   8.88   7.47  8.20
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Table 18 
Group Means (M) and Standard Errors (SE) for Age of First Use of Ecstasy 
 
    
 
Group         M   SE 
 
User   18.90  .41   
Experimenter  19.35  .42   
Quitter   17.58  .41   
Infrequent User  17.64  .43 
   
Note. Standard Errors were derived from the statistical model used to conduct the 
analyses. 
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Table 19 
Source Table for Age of First Use of Ecstasy  
 




  U v. E v. Q planned contrast   .170 2, 170 < .001* 
 Group main effect (U, E, Q, and I)   .115 3, 185  < .001* 
Control 
  Gender    .006  1, 184  .226 
  Ethnicity    .013  1, 184  .070 
  Education    .005 2, 184  .547 
  Sexual Orientation    .005 2, 184  .560 
  Treatment    .003  1, 184  .370 
  Referral Type    .010 3, 184  .468 
   
Note. U = User; E = Experimenter; Q = Quitter; and I = Infrequent User. The differences 
between the User, Experimenter, and Quitter groups were tested with a 2-df planned 
contrast. The main effect for Group was tested against Scheffé’s critical value for a post 
hoc test of a main effect following a planned comparison. See text for details regarding 
this analytic approach. 
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Notably, 97.8% of the entire sample had used marijuana with a mean age of first 
use of 15.6 (SD = 2.38). For amphetamines, LSD, cocaine, and psilocybin mushrooms, 
mean ages of first use were 17.32 (SD = 4.98), 17.44 (SD = 2.41) 17.44, (SD = 2.41) and 
18.48 (SD = 2.43), respectively. Approximately three-quarters (76.4%) of the sample had 
used a prescription medication in a non-prescribed manner with a mean age of first use of 
17.24 (SD = 2.76). As expected, the majority of the sample (98.1%) had used alcohol; 
however, the mean age of first use was 7.83 (SD = 7.74), which was much lower than 
expected.  TResults from the 2003 National Survey on Drug Use and Health: National 
findings of adults (ages 21 and older) indicated that only 4% of the sample had used 
alcohol prior to age 12 (TOffice of Applied Studies, Substance Abuse and Mental Health 
Services Administration, 2004).    
 Past 90-Day use. Participants were asked to provide a history of their use of eight 
substances (Ecstasy, marijuana, psilocybin mushrooms, cocaine powder, LSD, 
amphetamines, prescription medications in a non-prescribed manner, and alcohol) during 
the past 30 days, 90 days, year, and lifetime. Given the variability in frequency of Ecstasy 
use, 90-day data (see Table 20) was judged to most accurately reflect overall patterns of 
usage. For example, a participant in the User Group may have not used Ecstasy in the 
past month, but may have used Ecstasy 5 times in the past 3 months. Examining past 90-
data allows for this finding. In examining the data from the entire sample for the past 90 
days (see Table 20), almost one-quarter (23.3%) reported having used Ecstasy, and about 
60% reported having used three or more substances. Approximately three–quarters (72%) 
had used marijuana, one quarter had used powder cocaine (23.3%), one-fifth had used 
amphetamines (22%), and one-fifth (19.3%) had used psilocybin mushrooms. Notably, 
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almost half of the sample (44.7%) reported having used a prescription drug in a non-
prescribed manner. Finally, the majority (91.9%) of participants had used alcohol. 
Because Ecstasy is an amphetamine, participants may have included Ecstasy in their 
report of their history of use of amphetamines. In addition, because the drug history 
questions were in free–response format, numerous participants reported that they did not 
know their history of use for the past year or lifetime because the frequency of their use 
was extremely high. For example, for history of marijuana use in the past year, 57 
participants provided responses such as “a lot,” “countless,” “I have no idea” “hundreds,” 
“100+ … 1000+,” or entered a seemingly random number (e.g., 9999999). For lifetime 
history of marijuana use, 73 participants were unable to provide an estimate. Therefore, 
past year and lifetime use were not analyzed, given the resulting concerns regarding the 
reliability of such data. This concern will be reviewed further in the discussion section. 
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Table 20 




Drug         Total Sample  U E Q I C 
 
Ecstasy n (Group) 75  50  0 0 24  0 
  
    Group % 23.3  89.3  0 0 52.2  0 
 
Marijuana   n (Group) 232  46 35 31 35 85 
  
 Group % 72.0  82.1 63.6 48.4 76.1 84.2 
Amphetamines n (Group) 71  25 6 4 16 20 
  
 Group % 22.0  44.6 10.9 6.3 34.8 19.8 
LSD     n (Group) 40  20 3 2 7 8 
  
 Group % 12.4  35.7 5.5 3.1 15.2 7.9  
Powder Cocaine n (Group) 75  22 11 12 14 16 
  
 Group % 23.3  39.3 20.0 18.8 30.4 15.8 
Psilocybin  n (Group) 62  20  0 6 10 26 
Mushrooms  
 Group % 19.3  35.7  0 9.4 21.7 25.7 
Prescription  n (Group) 144  31 17 18 19 59 
Drugs  
 Group % 44.7  55.4 30.9 28.1 41.3 58.4 
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Table 20 (continued) 
 




Drug         Total Sample  U E Q I C 
 
Alcohol  n (Group) 296  52 52 57 45 90 
   
 Group % 91.9  92.9 94.5 89.1 97.8 89.1 
Total  n (Group) 322     56 55 64 46 101 
 
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control.   
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Substance Use History for Each Ecstasy Use Group 
 Past 90-Day Use. Data for past 90-day drug use were collected for each of the 
Ecstasy Use Groups (see Table 20). First, the percentages of the 56 participants in the 
User Group who had used each of the eight substances during the past 90 days were 
examined: Ecstasy (89.3%); marijuana (82.1%); amphetamines (44.6%); LSD (35.7); 
powder cocaine (39.3%); psilocybin mushrooms (35.7%); prescription drugs (55.4%); 
and alcohol (92.9%). Second, of the 55 participants in the Experimenter Group, the 
percentages of those who had used each of the eight substances during the past 90 days 
were found to be: Ecstasy (0%); marijuana (63.6%); amphetamines (10.9%); LSD (5.5); 
powder cocaine (20.0%); psilocybin mushrooms (0%); prescription drugs (30.9%); and 
alcohol (94.5%). Third, the percentages of the 64 participants in the Quitter Group who 
had used each of the eight substances during the past 90 days were reviewed: Ecstasy 
(0%); marijuana (48.4%); amphetamines (6.3%); LSD (3.1); powder cocaine (18.8%); 
psilocybin mushrooms (9.4%); prescription drugs (28.1%); and alcohol (89.1%). Fourth, 
the percentages of the 46 participants in the Infrequent User Group who had used each of 
the eight substances during the past 90 days were examined: Ecstasy (52.2%); marijuana 
(76.1%); amphetamines (34.8%); LSD (15.2); powder cocaine (30.4%); psilocybin 
mushrooms (21.7%); prescription drugs (41.3%); and alcohol (97.8%). Finally, of the 101 
participants in the Control Group, the percentages of those who had used each of the 
eight substances during the past 90 days were found to be: Ecstasy (0%); marijuana 
(84.2%); amphetamines (19.8%); LSD (7.9); powder cocaine (15.8%); psilocybin 
mushrooms (25.7%); prescription drugs (58.4%); and alcohol (89.1%).  
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Patterns of Ecstasy consumption. The four groups of participants who had used 
Ecstasy were asked to report the average number of Ecstasy pills taken on one occasion. 
The 2-df Ecstasy Use Group planned contrast revealed significant differences among the 
three groups (Users, Experimenters, and Quitters) (RP2 P = .101, p < .001) as well as a main 
effect for the four groups (RP2P = .086, p < .001). Pairwise comparisons indicated that the 
average number of Ecstasy pills taken on one occasion by Quitters was significantly 
greater than that of Experimenters (RP2 P = .092, p < .001). No significant effects were 
found for Age, Gender, Ethnicity, Education, Sexual Orientation, Treatment, or Referral 
Type (all ps > .018). 
Participants with a history of Ecstasy use were also asked to report the largest 
number of Ecstasy pills taken on one occasion. The 2-df Ecstasy Use Group planned 
contrast revealed significant differences among the three groups (User, Experimenter, and 
Quitter) (RP2 P = .092, p = .001) as well as a main effect for the four groups (RP2 P = .093, p = 
.002; Users, M = 6.12, SE = .1.02; Experimenters, M = 2.83, SE = .1.03; Quitters, M = 
6.13, SE = .1.01; and Infrequent Users, M = 5.53, SE = .1.07). Pairwise comparisons 
indicated that the largest number of Ecstasy pills taken on one occasion by Quitters was 
significantly greater than that of Experimenters (RP2 P = .075, p < .001). No significant 
effects were found for Age, Gender, Ethnicity, Education, Sexual Orientation, Treatment, 
or Referral Type (all ps > .008).     
Table 21 shows the means and standard deviations of the typical and largest 
number of Ecstasy pills taken on one occasion for each Ecstasy Use Group. The average 
number of Ecstasy pills taken on one occasion for Users, Experimenters, Quitters, and 
Infrequent Users were 2.30 (SD = 1.15), 1.40 (SD = .56), 2.65 (SD = 2.54) and 1.93     
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(SD = .97), respectively. The average of the largest number of Ecstasy pills taken in one 
occasion for Users, Experimenters, Quitters, and Infrequent Users were 5.74 (SD = 4.04), 
1.65 (SD = 1.07), 5.58 (SD = 6.76) and 5.07 (SD = 3.85), respectively. 
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Table 21 
Group Means (M) and Standard Deviations (SD) for Typical and Largest Number of 
 
Ecstasy Pills Taken on One Occasion 
    
 
Group         M   SD 
 
Typical Number of Pills 
User   2.30  1.15   
Experimenter  1.40   .56   
Quitter   2.65  2.54   
Infrequent User  1.93   .97 
 
Largest Number of Pills 
User   5.74  4.04   
Experimenter  1.65  1.07   
Quitter   5.58  6.76   
Infrequent User  5.07  3.85 
   
  
 
   
 
       
105 
 Reliability of Scales 
 Social Conformity Scale. Cronbach’s internal consistency " was calculated for each 
of the three subscales. For the subscale, Cronbach’s internal consistency "s for the Law 
Abidance and Liberalism subscales were .438 and .453, which are low and will be 
examined further in the Discussion section. However, Cronbach’s internal consistency " 
for the Liberalism subscale was .861, which is more than adequate (see Table 22). 
 Sensation Seeking Scale. Marginally-adequate to adequate reliabilities were 
obtained for each of the subscales of the Sensation Seeking Scale (see Table 23). 
Cronbach’s internal consistency "s for the Thrill and Adventure Seeking, Experience 
Seeking, Disinhibition, and Boredom Susceptibility subscales were .758, .520, .641, and 
.571, respectively. 
 General Risk Appraisal Scale (Own Risk Appraisal). Cronbach’s internal 
consistency " for the four subscales (Crime Risk, Financial Risk, Minor Violations Risk, 
and Sports Risk) of the General Risk Appraisal Scale (Own Risk Appraisal) was 
examined for Own Risk and Own Behavior and results were indicative of adequate 
reliability. Cronbach’s internal consistency "s for the Crime Risk,  
Financial Risk, Minor Violations Risk, and Sports Risk subscales were .783, .611, .620, 
and .728, respectively (see Table 24).  
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Table 22  
Means (M), Standard Deviations (SD), and Intercorrelations of the Social Conformity 
Scale for the Sample of Ecstasy Use Groups with Cronbach’s Internal Consistency 
Reliability (α) on the Diagonal 
 
Pearson Correlation Coefficients for the Social Conformity Scale  
 
     Law Abidance    Liberalism     Religiosity  
 
Law Abidance                        (.438)a                    
Liberalism                     -.243          (.453)b              
Religiosity                   .191           -.128            (.861)c      
     N                     321         317         318     
      M                     37.16        37.34        31.87         
     SD                   9.585        8.85        13.89         
Note. For the calculation of Cronbach’s Internal Consistency Reliability, participants who 
were missing an item for any subscale were excluded from the analysis (an = 321; bn = 
317; and cn = 318).    
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Table 23  
Means (M), Standard Deviations (SD), and Intercorrelations of the Sensation Seeking 
Scale for the Sample of Ecstasy Use Groups with Cronbach’s Internal Consistency 
Reliability (α) on the Diagonal 
 
Pearson Correlation Coefficients for the Sensation Seeking Scale 
 
TAS          ES        DIS        BS 
 
TAS                    (.758)a                          
ES                     .277           (.520)b        
DIS                   .154           .134            (.641)c       
BS                 .145            .168             .339            (.571)d 
  M             6.91       7.15        6.27       3.89 
  SD            2.58       1.81        2.22       2.10  
Note. (N = 322). For the calculation of Cronbach’s Internal Consistency Reliability, 
participants who were missing an item for any subscale were excluded from the analysis 
(an = 310; bn = 311; cn = 314; and dn = 313). 
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Table 24  
Means (M), Standard Deviations (SD), and Intercorrelations of the General Risk 
Appraisal Scale (Own Risk Appraisal) for the Sample of Ecstasy Use Groups with 
Cronbach’s Internal Consistency Reliability (α) on the Diagonal 
 
Pearson Correlation Coefficients for the General Risk Appraisal Scale (Own Appraisal) 
 
   Crime      Financial    Minor Violations  Sports 
   Risk       Risk       Risk          Risk 
       Appraisal    Appraisal    Appraisal       Appraisal 
 
Crime                        (.783)a                  
Risk Appraisal 
                
Financial                 .457            (.611)b            
Risk Appraisal 
 
Minor Violations          .599            .360              (.620)c        
Risk Appraisal 
                 
Sports                 .328            .192              .404             (.728)d 
Risk Appraisal 
                N     321        321          308         309 
 
               M     17.73       19.15         14.10        8.84 
 
               SD    4.70       3.20         3.08        2.17 
Note. Correlations below the diagonal are the simple Pearson product moment 
correlations. For the calculation of Cronbach’s Internal Consistency Reliability, the 
number of participants varies per subscale as any participant who was missing an item for 
a subscale was excluded from that analysis (an = 304; bn = 308; cn = 302; and dn = 303). 
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varies per subscale as any participant who was missing an item for a subscale was 
excluded from that analysis (PaPN = 304; PbPN = 308; PcPN = 303; and Pd PN = 302). 
 
 General Risk Appraisal Scale (Own Risky Behavior). Cronbach’s internal 
consistency " for the four subscales of the General Risk Appraisal Scale (Crime Risk, 
Financial Risk, Minor Violations Risk, and Sports Risk) were examined for Own Risk 
and Own Behavior and results were indicative of marginally adequate reliability. 
Cronbach’s internal consistency "s for the Crime Risk, Financial Risk, Minor Violations 
Risk, and Sports Risk subscales were .554, .534, .635, and .512, respectively (see Table 
25).  
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Table 25  
Means (M), Standard Deviations (SD), and Intercorrelations of the General Risk 
Appraisal Scale (Own Risky Behavior) for the Sample of Ecstasy Use Groups with 
Cronbach’s Internal Consistency Reliability (α) on the Diagonal 
 
Pearson Correlation Coefficients for the General Risk Appraisal Scale (Own Behavior)  
 
   Crime      Financial    Minor Violations  Sports 
   Risky      Risky      Risky         Risky 
       Behavior    Behavior    Behavior       Behavior 
 
Crime                        (.554)a        
Risky Behavior 
                
Financial                 .186           (.534)b         
Risky Behavior 
                  
Minor Violations          .401            .270               (.635)c         
Risky Behavior  
                  
Sports                 .021            .072              .245            (.512)d 
Risky Behavior 
               N      321        321          308         309 
 
              M      11.64       9.20         12.30        6.05 
 
              SD     4.10       3.29         3.98        2.54 
Note. Correlations below the diagonal are the simple Pearson product moment 
correlations. For the calculation of Cronbach’s Internal Consistency Reliability, the 
number of participants varies per subscale as any participant who was missing an item for 
a subscale was excluded from that analysis (an = 304; bn = 308; cn = 303; and dn = 302). 
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 Reasons for Ecstasy Use Scale: AMPS. Analyses of the subscales of the Reasons 
for Ecstasy Use Scale: AMPS revealed adequate reliability coefficients, especially given 
the number of items for each scale: (1) Alter Perception (2 items): α = .3383; (2) Mood (5 
items): α = .6273; (3) Personal Growth (5 items): α = .7934; and (4) Social/Interpersonal 
(10 items): α = .7902. In addition, simple Pearson product-moment correlations among 
the four subscales were examined in order to evaluate the degree of overlap; each 
subscale was judged to uniquely contribute to the scale (see Table 26).    
 Furthermore, a factor analysis was conducted to explore alternative groupings of 
the 30 reasons for use of Ecstasy and 4 factors were found (see Table 27). Similar 
reliabilities were found in comparison to the experimenter’s derived scale: Alter 
Perception: α = .3383; (2) Mood: α = .6274; (3) Personal Growth: α = .7934; and (4) 
Social/Interpersonal: α = .7902. However, the analytically derived scale was not as 
powerful in detecting a significant difference among the three groups (Users, 
Experimenters, and Quitters) (see Table 28). Therefore, the experimenter’s Reasons for 
Use Scale: AMPS was selected for data analysis.
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Table 26 
Means (M), Standard Deviations (SD), and Intercorrelations of the Reasons for Ecstasy 
Use Scale: AMPS with Cronbach’s Internal Consistency Reliability α on the Diagonal 
                                
Mood   Alter Perception    Personal Growth  Social/Interpersonal
 
Mood                   (.627)       
Alter Perception            .466           (.338)        
Personal Growth           .303           .187            (.793)      
Social/Interpersonal     .658            .444             .636           (.790) 
M               11.74       6.41        10.84      24.09 
SD              3.74       2.13        4.54      8.34 
Note. N = 219. Correlations below the diagonal are the simple Pearson product moment 
correlations.  
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Table 27 
Reliability Coefficients for the 4 Subscales of the Reasons for Ecstasy Use Scale: AMPS  
and the 4 Subscales Derived from Iterated Principal Factor Analysis 
 
Subscale             α     Number of Items  
 
 
Reasons for Ecstasy Use Scale: AMPS 
 Alter Perception         .338    2   
Mood            .627     5     
Personal Growth         .793    5     
Social/Interpersonal        .790     10 
Factor Analytically Derived Subscales 
 Subscale 1           .754    9 
 Subscale 2           .877    11 
 Subscale 3           .489    3 
 Subscale 4              ─    1 
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Table 28 
Source Table for the 4 Subscales of the Reasons for Ecstasy Use Scale: AMPS  
and the 4 Subscales Derived from Iterated Principal Factor Analysis  
 
U v. E v. Q planned contrast    Roy’s θ   df   p 
 
 
Reasons for Ecstasy Use: AMPS Subscales .248   4, 204      < .001* 
Factor-Analytically Derived Subscales  .236   4, 203       < .001* 
Note. U = User; E = Experimenter; and Q = Quitter. The differences between the User, 
Experimenter, and Quitter groups were tested with a 2-df planned comparison. See text 
for details regarding this analytic approach. An asterisk denotes the detection of a 
significant difference among the three groups. 
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 Reasons for First Use of Ecstasy Scale: AMPS. Analyses of the Reasons for Use of 
Ecstasy Scale: AMPS revealed adequate reliability coefficients (see Table 29), 
particularly given the number of items for each scale: (1) Alter Perception (2 items): α = 
.344; (2) Mood (5 items): α = .595; (3) Personal Growth (5 items): α = .631; and (4) 
Social/Interpersonal (10 items): α = .746. Finally, Pearson Correlation Coefficients were 
examined, and values were similar to those found for the Reasons for Use of Ecstasy 
Scale: AMPS. There was some degree of overlap among the subscales (see Table 29), but 
each subscale was judged to uniquely contribute to the scale.  
 A factor analysis was conducted to explore alternative groupings of the 31 reasons 
for first use of Ecstasy and 4 factors were found (see Table 30). Consistent with findings 
for the Reasons for Ecstasy Use Scale: AMPS, the experimenter’s scale, was found to be 
superior to the factor analytically derived scale (see Table 31).     
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Table 29  
Means (M), Standard Deviations (SD), and Intercorrelations of the Reasons for First Use 
of Ecstasy Scale: AMPS with Cronbach’s internal consistency reliability (α) on the 
diagonal 
 
Pearson Correlation Coefficients for the Reasons for First Use of Ecstasy Scale: AMPS   
 
Mood   Alter Perception    Personal Growth  Social/Interpersonal
 
Mood                   (.595)      .436          .322       .552 
Alter Perception            .466           (.344)         .328       .390 
Personal Growth           .303           .187              (.631)      .554 
Social/Interpersonal     .658            .444               .636            (.746) 
M               1.05       .95           .91        2.06 
SD              1.11       .78           1.12       2.19 
Note. N = 219. Correlations below the diagonal are the simple Pearson product moment 
correlations, while correlations above the diagonal are the Pearson product moment 
correlations from which Age, Gender, Ethnicity, Education, Sexual Orientation, 
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Table 30 
Reliability Coefficients for the 4 Subscales of the Reasons for First Use of Ecstasy  
Scale: AMPS and the 4 Subscales Derived from Iterated Principal Factor Analysis 
 
Subscale             α     Number of Items  
 
 
Reasons for First Use of Ecstasy Use Scale: AMPS 
 Alter Perception         .343    2   
Mood            .595     5     
Personal Growth         .631     5     
Social/Interpersonal        .746     10 
Factor Analytically Derived Subscales 
 Subscale 1           .853    14 
 Subscale 2           .657    5 
 Subscale 3           .432    4 
 Subscale 4           .518    3 
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Table 31 
Source Table for the 4 Subscales of the Reasons for First Use of Ecstasy Scale: AMPS  
and the 4 Subscales Derived from Iterated Principal Factor Analysis  
 
Group main effect (U, E, Q, and I) Roy’s θ  df p 
 
 
Reasons for First Use: AMPS  Subscales .031 4, 203 .185 
Factor-Analytically Derived Subscales .021 4, 203  .376 
Note. U = User; E = Experimenter; Q = Quitter; and I = Infrequent User. The main effect 
for Group was tested against a critical value for Roy’s greatest characteristic root test. 
See text for details regarding this analytic approach. 
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Correlations of Variables 
 The primary dependent measures that were examined in this study included the 
following: Sensation Seeking subscales (Thrill and Adventure Seeking, Experience 
Seeking, Disinhibition, and Boredom Susceptibility); Normative Influence Scale; Social 
Conformity subscales (Law Abidance, Liberalism, and Religiosity); General Risk 
Appraisal Scale subscales for own risk appraisal and own risky behavior (Crime Risk, 
Financial Risk, Minor Risk Violations, and Sports Risk); the Mood subscale of the  
Reasons for Ecstasy Use: AMPS; and the total number of drugs used during the past 90 
days.  
Correlations of Subscales for Primary Dependent Measures 
 The simple Pearson product-moment intercorrelations among each of the subscales 
within the Sensation Seeking Scale, Social Conformity Scale, and General Risk Appraisal 
Scale (Own Risk Appraisal and Own Risky Behavior) were examined (see Tables 22, 23, 
24, and 25, respectively). First, for the Sensation Seeking Scale, negligible to weak 
positive correlations were found among all of the subscales (Thrill and Adventure 
Seeking, Experience Seeking, Disinhibition, and Boredom Susceptibility), except for a 
moderate positive association between the Disinhibition and Boredom Susceptibility 
subscales. These correlations were weaker than expected, given the sample population. 
Notably, Galizio et al. (1993) found a moderate association between the Experience 
Seeking and Disinhibition subscales in their study of polydrug users, but this association 
was not found in the current study. Second, the intercorrelations for the Social 
Conformity Scale subscales were examined, and were also weaker than expected. 
However, the directions of the associations were consistent with what was expected (a 
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positive association between law abidance and religiosity and a negative association 
between law abidance and liberalism) within the sample population. Third, the 
intercorrelations for the 4 subscales of the General Risk Appraisal Scale (Own Risk) were 
examined and strong positive correlations were found between Crime Risk and Financial 
Risk as well as between Crime Risk and Minor Violations Risk. Moderate positive 
associations were found between Crime Risk and Sports Risk as well as between 
Financial Risk and Minor Violations Risk. Finally, the association between Financial 
Risk and Sports Risk was negligible. All of these correlations are consistent with what 
was expected, given this sample population. Finally, the intercorrelations of the 4 
subscales of the General Risk Appraisal Scale (Own Risky Behavior) were examined and 
the following associations were found: (1) strong positive correlation between Crime 
Risky Behavior and Minor Violations Behavior; (2) weak positive correlations between 
Minor Violations Behavior and both Financial Risky Behavior and Sports Risky 
Behavior; (4) negligible correlations between Financial Risky Behavior and both Crime 
Risky Behavior and Sports Risky Behavior; and (5) negligible correlation between Crime 
Risk Behavior and Sports Risky Behavior.  Again, all of these latter correlations are 
consistent with what was expected, given the study sample. 
Correlations Between Primary Dependent Measures  
 The correlations between the primary dependent variables were generally weaker 
than expected (see Appendix N). However, the following moderate correlations were 
found and are consistent with what would be expected, given the study sample: (1) 
negative correlations between Law Abidance and both Disinhibition (r = -.32) and 
Boredom Susceptibility (r = -.31); (2) negative correlation between Law Abidance and 
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Crime Behavior (r = .36); (3) positive correlation between Thrill and Sensation Seeking 
and Sports Risky Behavior (.33). In addition, although weak, negative correlations were 
found between Crime Risk and Crime Behavior (r = -.26) as well as between Minor 
Violations Risk and Minor Violations Behavior (r = -.26), suggesting that the lower that 
participants evaluated their risk for engaging in some type of crime or minor violation, 
the more likely they were to engage in those types of behaviors. Finally, surprisingly, 
only week associations were found between the total number of drugs used in the past 90 
days and (a) Boredom Susceptibility, r = .25 ; (b) Normative Influence, r = .27; and (c) 
Law Abidance, r = -.26.   
Tests of Hypotheses 
Hypothesis 1: Polydrug Use (Number of Substances Used in Past 90 Days Excluding 
Ecstasy) 
Hypothesis 1 predicted that there would be significant group differences among 
Users, Experimenters, and Quitters for the number of substances used during the past 90 
days. Specifically, Hypothesis 1 (a and b) predicted that Users would, on average, have 
used a greater number of substances in the past 90 days than both Experimenters and 
Quitters. The source table representing the results of the analysis for polydrug use in the 
past 90 days can be found in Table 32. The 2-df Ecstasy Use Group planned contrasts 
revealed that these hypotheses were both supported (RP2P = .111, p < .001; RP2 P = .092, p < 
.001, respectively). Users (M = 3.72, SE = .23) were significantly more likely to report 
having used a greater number of substances during the past 90 days than both 
Experimenters (M = 2.51, SE = .24) and Quitters (M = 2.36, SE = .23) (see Tables 33 and 
34). In addition, post hoc testing of the significant Ecstasy Use Group effect revealed two 
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additional significant pairwise comparisons. Users were significantly more likely than 
Controls (M = 2.95, SE = .23) and Infrequent Users (M = 3.43, SE = .23) were 
significantly more likely than Quitters and Experimenters to report having used a greater 
number of substances during the past 90 days. Finally, a significant effect for Age was 
found for past 90-day drug use (b = -.208, SE = .038, p < 001), indicating that younger 
participants were more likely than older participants to have used a greater number of 
substances during the past 90 days.  
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Table 32 
Source Table for Polydrug Use Excluding Ecstasy (Past 90 Days) 
 




  U v. E v. Q planned contrast   .111 2, 306 < .001* 
 Group main effect (U, E, Q, I, & C)   .092 4, 306  < .001* 
Control 
  Age     .069  1, 306 < .001* 
  Gender    .010  1, 306 .041 
  Ethnicity    .007  1, 306 .083 
  Education    .008 2, 306 .178 
  Sexual Orientation   < .001 2, 306 .983 
  Treatment    .012  1, 306 .022 
  Referral Type    .006 3, 306 .468 
   
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control. 
The differences between the User, Experimenter, and Quitter groups was tested with a 2-
df planned contrast. The main effect for Group was tested against Scheffé’s critical value 
for a post hoc test of a main effect following a planned comparison. See text for details 
regarding this analytic approach. 
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Table 33 
Group Means (M) and Standard Errors (SE) for Polydrug Use (Past 90 Days)  
    
Group         M   SE 
 
User   3.72  .23   
Experimenter  2.51  .24   
Quitter   2.36  .23   
Infrequent  3.43  .23   
Control   2.95  .23   
Note. Standard Errors were derived from the statistical model used to conduct the 
analyses. 
       
125 
Table 34 
Pairwise Comparisons of Group Means for Polydrug Use (Past 90 Days) 
    
Group v. Group  Mean Difference  SE  p  
 
 
User  Experimenter 1.206  .258               <.001*
   Quitter  1.356  .247               <.001*
   Infrequent .289  .257  .261
   Control  .766  .766                 .001* 
Experimenter User  -1.206  .258               <.001*
   Quitter  .150  .236  .526
   Infrequent -.917  .263                 .001*
   Control  -.441  .135  .929 
Quitter      User  -1.356  .247               <.001*
  Experimenter  -.150  .236  .526
   Infrequent -1.067  .249               <.001*
    Control  - .590  .224  .009 
Infrequent    User  -.289  .257  .261
    Experimenter .917  .263                 .001*
      Quitter  1.067  .249               <.001*
    Control  .476  .245                 .053  
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Table 34 (continued) 
Pairwise Comparisons of Group Means for Polydrug Use (Past 90 Days) 
    
Group v. Group  Mean Difference  SE  p  
 
 
Control     User  -.766  .230                  .001*
   Experimenter .441  .218  .044  
  Quitter  .590  .224  .009 
  Infrequent -.476  .053                 .053 
 Note. Mean differences determined to be significant by post hoc testing using Roy’s 
greatest characteristic root test are marked with an asterisk. 
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Hypothesis 2: Normative Influence 
Hypothesis 2 predicted that there would be significant group differences in level 
of normative influence, which was supported for the 2-df Ecstasy Use Group planned 
contrast among Users, Experimenters, and Quitters (RP2 P = .271, p < .001). The main effect 
for the five groups (Users, M = 3.15, SE = .14; Experimenters, M = 1.88, SE = .15; 
Quitters, M = 1.90, SE = .14; Infrequent Users, M = 2.67, SE = .14; and Controls, M = 
1.89, SE = .14) was also significant (RP2 P = .195, p < .001). The source table representing 
the results of the analysis of the Normative Influence Scale can be found in Table 35. 
Specifically, Hypothesis 2 (a and b) predicted that Users would, on average, have higher 
scores on normative influence than both Experimenters and Quitters. Pairwise post hoc 
comparisons revealed that these hypotheses were both supported. Users were 
significantly more likely to report having a greater number of friends who were currently 
using Ecstasy, than both Experimenters and Quitters (see Tables 36 and 37). In addition, 
post hoc testing of the significant Ecstasy Use Group effect revealed two additional 
significant pairwise comparisons. Infrequent Users were significantly more likely than 
both Quitters and Controls to report having a greater number of friends who were 
currently using Ecstasy (see Table 40). No significant effects were found for Age, 
Gender, Ethnicity, Education, Sexual Orientation, Treatment or Referral Type (all ps > 
.001).           
       
128 
Table 35 
Source Table for Normative Influence Scale 
 




  U v. E v. Q planned contrast   .271 2, 306 < .001* 
 Group main effect (U, E, Q, I, & C)   .228 4, 306  < .001* 
Control 
  Age   < .001  1, 306 .702 
  Gender    .003  1, 306 .206 
  Ethnicity    .003  1, 306 .229 
  Education  < .001 2, 306 .927 
  Sexual Orientation    .006 2, 306 .230 
  Treatment  < .001  1, 306 .649 
  Referral Type    .004 3, 306 .556 
   
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control. 
The differences between the User, Experimenter, and Quitter groups was tested with a 2-
df planned contrast. The main effect for Group was tested against Scheffé’s critical value 
for a post hoc test of a main effect following a planned comparison. See text for details 
regarding this analytic approach. 
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Table 36 
Group Means (M) and Standard Errors (SE) for Normative Influence Scale  
    
Group         M   SE 
 
User   3.15  .14   
Experimenter  1.88  .15   
Quitter   1.90  .14   
Infrequent  2.67  .15   
Control   1.90  .14   
Note. Standard Errors were derived from the statistical model used to conduct the 
analyses. 
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Table 37 
Pairwise Comparisons of Group Means for Normative Influence Scale 
    
Group v. Group  Mean Difference  SE  p  
 
 
User  Experimenter 1.270  .160               <.001*
   Quitter  1.250  .153               <.001*
   Infrequent .480  .160  .003
   Control  1.257  .143               <.001* 
Experimenter User  -1.270  .160               <.001*
   Quitter  -.019  .146  .897
   Infrequent -.789  .163               <.001*
   Control  -.026  .135  .929 
Quitter      User  -1.250  .153               <.001*
  Experimenter   .019  .146  .897
   Infrequent -.770  .154               <.001*
    Control   .007  .139  .960 
Infrequent    User  -.480  .160  .003
    Experimenter .789  .163               <.001*
      Quitter  .770  .154               <.001*
    Control  .777  .152               <.001* 
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Table 37 (continued) 
Pairwise Comparisons of Group Means for Normative Influence Scale 
    
Group v. Group  Mean Difference  SE  p  
 
 
Control     User  -1.257  .143               <.001*
   Experimenter .012  .135  .929  
  Quitter  -.007  .139  .960 
  Infrequent -.777  .152               <.001*
 Note. Mean differences determined to be significant by post hoc testing using Roy’s 
greatest characteristic root test are marked with an asterisk. 
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Hypothesis 3: Social Conformity 
The source table representing the results of the analysis of three Social 
Conformity subscales can be found in Table 38.  Hypothesis 3 predicted that there would 
be significant group differences in level of social conformity. Specifically, Hypothesis 3 
(a) predicted that Users would, on average, have lower scores on social conformity than 
Experimenters. This hypothesis was not supported, as the 2-df Ecstasy User Group 
planned contrast among the three groups (Users, Experimenters, and Quitters) was not 
significant (Roy’s θ = .010, p = .401). Furthermore, no main effect was found for the 
Ecstasy Use Group (Users, Experimenters, Quitters, Infrequent Users, and Controls) 
effect (Roy’s θ = .026, p = .101). In contrast, Hypothesis 2 (b), which suggested that 
Users would, on average, have similar scores on social conformity to Quitters, was 
therefore weakly supported.  
Age was also significantly related to social conformity (Roy’s θ = .069, p < .001). 
Post hoc testing of each of the three subscales of the Social Conformity Scale revealed 
that age was positively related to law abidance (b = 1.191, SE = .285 p < .001), indicating 
that older participants were more likely than younger participants to adhere to laws. In 
addition, there was a significant effect for Gender (females scored higher than males) for 
the linear composite score (M = 5.00 for males and M = 5.54 for females; SDBerror B = 1; p = 
.001. Notably, the means were more than half a standard deviation apart and suggest that 
females were more likely to conform than males. However, no significant differences 
were found for any of the subscales (Law Abidance, Liberalism and Religiosity), all ps > 
.001). 
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Table 38 
Source Table for Social Conformity Scale 
 




  U v. E v. Q planned contrast .010 3, 305 .401 
  Group main effect (U, E, Q, I, & C) .026 4, 306  .101 
Control 
  Age   .069 3, 304 < .001* 
  Gender  .059 3, 304 < .001* 
  Ethnicity  .008 3, 304 .500 
  Education  .047 3, 305 .003 
  Sexual Orientation  .008 3, 305 .468 
  Treatment  .030 3, 304 .228 
  Referral Type  .014 3, 306 .227 
   
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control. 
The differences between the User, Experimenter, and Quitter groups were tested with a 2-
df planned contrast. The main effect for Group was tested against a critical value for 
Roy’s greatest characteristic root test for a post hoc test of a main effect following a 
planned comparison. See text for details regarding this analytic approach. 
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Hypothesis 4: Sensation Seeking 
Hypothesis 4 predicted that there would be significant group differences in level 
of sensation seeking (see Table 39 for the Ecstasy Group means and Table 40 for the 
Source Table). The 2-df Ecstasy Use Group planned contrast revealed significant 
differences among Users, Experimenters, and Quitters (Roy’s θ = .043, p = .012) on the 
linear composite of the four Sensation Seeking Scale subscales (Thrill and Adventure 
Seeking, Experience Seeking, Disinhibition and Boredom Susceptibility). However, post 
hoc testing in each case revealed no significant pairwise mean differences. In addition, 
the Ecstasy Use Group (Users, Experimenters, Quitters, Infrequent Users, and Controls) 
effect was nonsignificant. Consequently, Hypothesis 4 (a), which predicted that Users 
would, on average, have higher scores on sensation seeking than Experimenters, was not 
supported. In contrast, Hypothesis 4 (b), which suggested that Users would, on average, 
have similar scores on sensation seeking to Quitters, was weakly supported, given a non-
significant difference between Users and Quitters for the linear composite score of the 
four Sensation Seeking Scale subscales.   
However, a significant effect for Gender (males scored higher than females) was 
found (Roy’s θ = .197, p < .001).  Post hoc testing of each subscale revealed a significant 
effect for Gender for the Thrill and Adventure Seeking subscale (M = 7.19, SE = .38 for 
males, M = 5.63, SE = .37 for females; p < .001) and the Boredom Susceptibility subscale 
(M = 4.80, SE = .31 for males, M = 3.33, SE = .30 for females; p < .001). These findings 
indicate that females are less likely than males to (1) engage in sports or activities 
involving some degree of physical danger and (2) evidence an aversion for a repetitive 
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experience of any kind, routine work or dull/predictable people as well as to feel restless 
when things are unchanging.    
 
Table 39 
Group Means (M) and Standard Errors (SE) for Sensation Seeking Scale  
    
Group         M   SE 
 
User   3.28  .187   
Experimenter  3.50  .196   
Quitter   2.83  .186   
Infrequent  3.12  .190   
Control   3.28  .186   
Note. Standard Errors were derived from the statistical model used to conduct the 
analyses.  The error standard deviation in this model is determined to be 1. 
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Table 40 
Source Table for Sensation Seeking Scale 
 




  U v. E v. Q planned contrast .043 4, 304 .012* 
  Group main effect (U, E, Q, I, & C) .045 4, 306  .009* 
Control 
  Age   .057 4, 303 .002 
  Gender  .197 4, 303 <.001* 
  Ethnicity  .023 4, 303 .147 
  Education  .054 4, 304 .003 
  Sexual Orientation  .045 4, 304 .009 
  Treatment  .025 4, 303 .109 
  Referral Type  .045 4, 305 .009 
   
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control. 
The differences between the User, Experimenter, and Quitter groups were tested with a 2-
df planned contrast. The main effect for Group was tested against a critical value for 
Roy’s greatest characteristic root test for a post hoc test of a main effect following a 
planned comparison. See text for details regarding this analytic approach. 
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Hypothesis 5: Risk Appraisal 
The source table representing the results of the analysis of the GRAS for Risk 
Appraisal (Own Risk) can be found in Table 41. Hypothesis 5 predicted that there would 
be significant group differences in level of risk appraisal for self. Specifically, Hypothesis 
5 (a) predicted that Users would, on average, have lower scores on risk appraisal than 
Experimenters. This hypothesis was not supported as the 2-df Ecstasy Use Group planned 
contrast among the three groups (Users, Experimenters, and Quitters) was not significant 
(Roy’s θ = .018, p = .275). Furthermore, the Ecstasy Use Group (Users, Experimenters, 
Quitters, Infrequent Users and Controls) effect was not significant (Roy’s θ = .043, p = 
.015). However, Hypothesis 5 (b), which predicted that Users would, on average, have 
similar scores on risk appraisal for self to Quitters, was weakly supported.  
Finally, a significant effect for Gender was found (males scored lower than 
females) on the linear composite score for Risk Appraisal (M = 2.14 for males and M = 
2.82 for females; SD = 1.0; p < .001). However, no significant effects were found for any 
of the four subscales (Crime Risk, Financial Risk, Minor Violations Risk and Sports 
Risk). Given that the means for males and females were more than half a standard 
deviation apart, results suggest that females were more likely than males to appraise a 
higher personal risk of a negative outcome if they were to commit a crime or minor 
violation, take a financial risk, or engage in a risky sporting activity.  
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Table 41 
Source Table for General Risk Appraisal Scale: Risk Appraisal 
 




  U v. E v. Q planned contrast .018 4, 304 .275 
  Group main effect (U, E, Q, I & C) .043 4, 292  .015 
Control 
  Age   .017 4, 289 .288 
  Gender  .093 4, 289 <.001* 
  Ethnicity  .049 4, 289 .008 
  Education  .047 4, 290 .010 
  Sexual Orientation  .036 4, 290 .036 
  Treatment  .013 4, 289 .436 
  Referral Type  .030 4, 291 .073 
   
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control. 
The differences between the User, Experimenter, and Quitter groups were tested with a 2-
df planned contrast. The main effect for Group was tested against a critical value for 
Roy’s greatest characteristic root test for a post hoc test of a main effect following a 
planned comparison. See text for details regarding this analytic approach. 
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Hypothesis 6: Risky Behavior (Own Behavior) 
The source table representing the results of the analysis of GRAS for Risky 
Behavior can be found in Table 42. Hypothesis 6 predicted that there would be 
significant group differences in level of risk-taking behaviors. Specifically, Hypothesis 6 
(a) predicted that Users would, on average, have higher scores on risk taking behaviors 
than Experimenters. This hypothesis was not supported, as the 2-df Ecstasy Use Group 
planned contrast among the three groups (Users, Experimenters, and Quitters) was not 
significant (Roy’s θ = .010, p = .556). Furthermore, the Ecstasy Use Group (Users, 
Experimenters, Quitters, Infrequent Users, and Controls) was not significant (Roy’s θ = 
.038, p = .026).  In contrast, Hypothesis 6 (b), which predicted that Users would, on 
average, have similar scores on risk taking behaviors to Quitters, was weakly supported.  
Moreover, a significant effect for Gender was found (males scored higher than 
females) for risk-taking behavior. Post hoc testing of each of the four subscales revealed 
a significant effect for Gender (males scored higher) for the Crime subscale (M = 13.42, 
SE = .62 for males, M = 10.87, SE = .60 for females; p < .001) and the Minor Violations 
subscale (M = 13.18, SE = .60 for males, M = 10.64, SE = .58 for females; p < .001). 
These findings indicate that males are more likely than females to have engaged in crime 
and minor violations.      
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Table 42 
Source Table for General Risk Appraisal Scale: Risk-Taking Behaviors 
 




  U v. E v. Q planned contrast .010 4, 304 .556 
  Group main effect (U, E, Q, I, & C) .038 4, 292  .026 
Control 
  Age   .122 4, 289 .288 
  Gender  .188 4, 289 <.001* 
  Ethnicity  .027 4, 289 .008 
  Education  .031 4, 290 .010 
  Sexual Orientation  .023 4, 290 .036 
  Treatment  .109 4, 289 .436 
  Referral Type  .047 4, 291 .073 
   
Note. U = User; E = Experimenter; Q = Quitter; I = Infrequent User; and C = Control. 
The differences between the User, Experimenter, and Quitter groups were tested with a 2-
df planned contrast. The main effect for Group was tested against a critical value for 
Roy’s greatest characteristic root test for a post hoc test of a main effect following a 
planned comparison. See text for details regarding this analytic approach. 
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Hypothesis 7: Use of Ecstasy to Alter Mood  
Hypothesis 7 predicted that there would be significant group differences in the use 
of Ecstasy to alter mood, which was supported by the 2-df Ecstasy Use Group planned 
contrast among Users, Experimenters, and Quitters (RP2 P = .149, p < .001).  The main effect 
for the four Ecstasy Use groups (Users, Experimenters, Quitters, and Infrequent Users) 
was also significant (RP2P = .125, p < .001). The source table representing the results of the 
analysis of the Mood Subscale of the Reasons for Use Scale: AMPS can be found in 
Table 43. Hypothesis 7 (a) predicted that Users would, on average, have higher scores on 
the mood subscale than Experimenters, was supported (see Tables 44 and 45). In thinking 
of the times in which they used Ecstasy, Users were significantly more likely than 
Experimenters to endorse having used Ecstasy to alter their mood. In addition, post hoc 
testing revealed another significant pairwise comparison. Quitters were also significantly 
more likely than Experimenters to endorse having used Ecstasy to alter their mood (see 
Tables 44 and 45). Hypothesis 7 (b), which predicted that Users would, on average, have 
similar scores on the mood subscale to those of Quitters, was weakly supported. No 
significant effects were found for Age, Gender, Ethnicity, Education, Sexual Orientation, 
Treatment, or Referral Type (all ps > .038).     
       
142 
Table 43 
Source Table for Reasons for Use: Mood Subscale 
 




  U v. E v. Q planned contrast   .149 2, 206 < .001* 
 Group main effect (U, E, Q, & I)   .125 3, 206  < .001* 
Control 
  Age   < .001  1, 206 .754 
  Gender    .018  1, 206 .035 
  Ethnicity    .003  1, 206 .380 
  Education    .008 2, 206 .386 
  Sexual Orientation    .009 2, 206 .309 
  Treatment  < .001  1, 206 .931 
  Referral Type    .014 3, 206 .313 
 
Note. U = User; E = Experimenter; Q = Quitter; and I = Infrequent User. The differences 
between the User, Experimenter, and Quitter groups were tested with a 2-df planned 
contrast. The main effect for Group was tested against Scheffé’s critical value for a post 
hoc test of a main effect following a planned comparison. See text for details regarding 
this analytic approach. 
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Table 44 
Group Means (M) and Standard Errors (SE) for Mood Subscale of AMPS  
    
Group         M   SE 
 
User   13.537  .70   
Experimenter  10.345  .73   
Quitter   13.793  .69   
Infrequent  12.341  .69   
Note. Standard Errors were derived from the statistical model used to conduct the 
analyses. 
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Table 45 
Pairwise Comparisons of Group Means for Mood Subscale of AMPS 
    
Group v. Group  Mean Difference  SE p  
 
 
User  Experimenter  3.192 .742 < .001*  
  Quitter   -.256 .717 .721  
  Infrequent  1.196 .736 .106   
Experimenter User   -3.192 .742 < .001*  
  Quitter   -3.449 .669 < .001*  
  Infrequent  1.452 .710 .042    
Quitter      User   .256 .717 .721 
  Experimenter  3.449 .669 < .001*  
  Infrequent  1.452 .710 .042   
Infrequent    User   -1.196 .736 .106   
  Experimenter  1.997 .748 .008     
  Quitter   -1.452 .710 .042   
Note. *Mean differences determined to be significant by post hoc testing using Roy’s 
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 Exploratory Analyses 
Reasons for First Use of Ecstasy Scale: AMPS 
Analyses were conducted to determine if there was an interaction between 
Ecstasy Use Group effect (Users, Experimenters, Quitters, and Infrequent Users) and the 
Scale effect for the Reasons for First Use Scale: AMPS.  Results indicated that there were 
no significant group differences on the profiles of four subscales for the reasons 
participants reported for their first use of Ecstasy.  However, Age was significantly 
related to the Mood and Alter Perception subscales (b = -.028, SE = .008, p = .001 and -
.047, SE = .014, p = .001, respectively).  Findings indicate that younger participants were 
more likely than older participants to report that the primary reason they first used 
Ecstasy was to alter their mood as well as to alter their perception. 
Primary Reason for First Use of Ecstasy 
Participants (Users, Experimenters, Quitters, and Infrequent Users) were asked in 
a free-response format what the primary reason was for why they first used Ecstasy (see 
Table 46). As noted in Methods, participants’ responses were reviewed and similar 
responses were grouped together. Based upon the frequencies of responses pertaining to 
using ecstasy because others had recommended it (“heard it was ‘good’”) and “for fun,” 
these reasons were also examined, creating a total of 33 reasons for first use of ecstasy. 
The four most commonly reported reasons for first using Ecstasy were (1) curiosity of 
what it would be like to use Ecstasy (52.5%), (2) use was recommended by others (heard 
it was “good”) (11.7%), (3) to have a new experience that would help to see the world 
differently (7.5%), and (4) to fit in with peers (others were using) (7.9%). 
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Table 46 
Primary Reason for First Use of Ecstasy in the Total Sample and Each Group 
      
Group 
Primary Reason        Total Sample U  E  Q  I        
 
Have a New Experience       n (Group)    18  4  6  4  4 
That Would Help You to 
See the World Differently    Group %a    7.5  6.5  10.2 5.6  8.5 
 
Fit in With Peers    n (Group) 19    4  5  8  2 
(Others Were Using)  
Group %a 7.9   6.5  8.5  11.1 4.3 
 
Curious What It Would Be n (Group) 126  29  31  41  25 
Like to Use Ecstasy 
       Group %a 52.5 46.8 52.5 56.9 53.2 
  
Use Recommended by Others n (Group) 28  5  5  11  7  
(Heard It Was Good) 
       Group %a 11.7  8.1  8.5  15.3 14.9 
 
Other       n (Group) 49   20  12  8  9 
  
Group %a 20.4  32.3 20.3 11.1 19.1 
No Reason Reported   n (Group) 15   4  5  2  4 
 
       Group %b 6.8   7.1  9.1  3.1  8.7 
 
Total Sample    n (Group) 221  56  55  64  46 
 
Total Responses    n (Group) 236  62  59  72  47 
 
Note. U = User; E = Experimenter; Q = Quitter; and I = Infrequent User.  Participants 
responded to a free-response question and responses were grouped together by category.  
Twenty-six participants endorsed two or more reasons. aPercentages were calculated 
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based on total number of responses in each group. Pb P ercentages were calculated based on 
total number of participants in each group.   
 
Reasons for Ecstasy Use Scale: AMPS 
In addition, Ecstasy use profiles (i.e., the pattern of means among the four 
subscales of the Reasons for Ecstasy Use Scale: AMPS) were also examined and 
compared among Users, Experimenters, and Quitters. Although a significant group 
difference was found (RP2 P = .054, p = .013), post hoc testing revealed no significant 
pairwise mean differences. Notably, in examining the means (see Table 47) for each of 
the four subscales for the User, Experimenter, and Quitter Groups, the highest mean for 
each group was for the Alter Perception subscale, and the lowest mean for each group 
was for the Personal Growth subscale. No significant effects were found for Age, Gender, 
Ethnicity, Education, Sexual Orientation, Treatment or Referral Type (all ps > .03).  
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Table 47 
Group Means (M) and Standard Errors (SE) for AMPS Ecstasy Use Profiles  
 
       Reasons for Ecstasy Use Subscale     
 
       
    Mood       Alter    Personal   Social/  




User   M  2.5  3.29  2.40  2.71 
   SE .08  .10  .11  .09  
 Experimenter M 1.97   2.79   1.72   1.82  
   SE .12  .171   .12  .11 
 Quitter  M 2.58  3.54  2.28   2.65 
   SE .094   .12   .10   .094  
 Infrequent  M 2.28  3.14   2.26  2.41 
 User 
   SE .084  .16   .15   .12 
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Primary Reason for Use of Ecstasy 
 Participants were asked in a free-response format what the primary reason was for 
why they used Ecstasy. Participants’ responses were reviewed and similar responses were 
grouped together. Based upon the frequency of responses pertaining to using ecstasy “for 
fun,” this reason was also examined, creating a total of 31 reasons for use of ecstasy. The 
three most commonly reported reasons for using Ecstasy were (1) for fun (17.2%), (2) to 
help to feel elated or euphoric (14.4%), and (3) to enhance an activity (12.4%).  
Psychological Addiction to Ecstasy 
 Participants in the four Ecstasy Use groups (Users, Experimenters, Quitters, and 
Infrequent Users) were asked, “Do you feel that you are or were at one time 
psychologically addicted to Ecstasy?” The frequency distributions of participants who 
answered “Yes” for the total sample and each group can be found in Table 48.  
Approximately 26% of the participants in the four groups responded affirmatively. Post 
hoc analyses (see Table 49) indicated that there was a significant difference among the 
four groups (χP2 P = 24.719, p < .001). Pairwise comparisons revealed that Users were 
significantly more likely than both Experimenters and Infrequent users to report 
psychological addiction to Ecstasy. However, Quitters were significantly more likely than 
Users to report a history of psychological addition to Ecstasy. Moreover, a significant 
effect for Treatment was found; Ecstasy users with a history of attending substance 
related psychological counseling or a support group were 4.1 times more likely to 
endorse psychological addiction to Ecstasy than those without a history of treatment (p < 
.001).      
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Table 48 
Frequency Distributions in the Total Sample and Each Ecstasy Use Group:  
Do you feel that you are or were at one time psychologically addicted to ecstasy?
 
Group 
Response        Total Sample U E Q I
 
Yes   n (Group)  57 20 2 28 7
  
 Group %  25.9 35.7 3.7 43.8 15.2
Total  n (Group)  220    56 54 64 46
 
Note. U = User; E = Experimenter; Q = Quitter; and I = Infrequent User. One participant 
in the User Group failed to answer the question. 
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Table 49 
Source Table for Psychological Addiction to Ecstasy:  
“Do you feel that you are or were at one time psychologically addicted to ecstasy?”   
 
Predictor Variable                 Wald                         Odds            Confidence    




 Group main effect (U, E, Q & I)    24.719       3     < .001* 
  I v. U contrast            .285            .098, .824 
  Q v. U contrast           1.507  .626, 3.627 
  E v. U contrast           .055            .011, .268 
Control 
 Age .084      1 .772    
 Gender  .017   1 .898    
 Ethnicity 12.025 6 .061 
 Sexual Orientation 1.578 2 .454 
 Treatment 9.893 1 .002 
 Referral Type 3.394 3 .335 
 
Note. U = User; E = Experimenter; Q = Quitter and I = Infrequent User. Controls were 
not included in this analysis as they did not respond to this question. The main effect for 
Group was tested at α = .01, while the remaining effects were tested at α = .0014. Only 
those contrasts that were significant following detection of a significant main effect are 
included in the table.  Confidence Intervals for the Group effect contrasts are 99% 
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intervals, consistent with the choice of α.  See text for details regarding the analytic 
approach. 
 
Testing of Ecstasy Pills 
Participants in the four groups (Users, Experimenters, Quitters, and Infrequent 
Users) were asked, “Do you or did you usually test your Ecstasy pills for their contents?” 
The frequency distributions of participants who answered “Yes” for the total sample and 
each group can be found in Table 50. Approximately 18% of the participants in the four 
groups responded affirmatively. Post hoc analyses failed to find a significant difference 
among the four groups (χ P2P = 9.979, p = .019). Furthermore, no significant effects were 
found for Age, Gender, Ethnicity, Education, Sexual Orientation, Treatment or Referral 
Type (all ps > .019).      
 
Table 50 
Ecstasy Use Question: “Do or did you usually test your ecstasy pills for their contents?”
      
Group 
Response        Total Sample U E Q I
  
Yes   n (Group)  40 18 2 9 11
  
 Group %  18.4 32.1 3.8 14.3 24.4
Total  n (Group)  217    56 53 63 45
 
Note. U = User; E = Experimenter; Q = Quitter and I = Infrequent User. Two participants 
in the Quitter Group and 1 participant in the User group failed to answer the question.   
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Taken to Prevent Side Effects Following the Use of Ecstasy 
Participants in the four groups (Users, Experimenters, Quitters and Infrequent 
Users) were asked, “Did or do you take any drugs or substances to try to prevent 
unwanted Ecstasy side-effects?” In examining the responses, 5-HTP and vitamins were 
the two responses that were most frequently reported. The frequency distributions of 
participants who reported taking 5-HTP and vitamins for the total sample and each group 
can be found in Table 51. Of the total sample, nineteen percent reported taking 5-HTP 
and nine percent reported taking vitamins.  
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Table 51 
Frequencies for Reported Use of 5-HTP and Vitamins to Prevent Side Effects Following 
Use of Ecstasy in the Total Sample and Each Ecstasy Use Group. 
      
Group 
Taken to Prevent Side        Total Sample U  E  Q  I 
Effects from Ecstasy Use            
 
5-HTP   n (Group)      42  16  2  10  14 
  
       Group %       19.0 28.6 3.6  15.6 30.4
 
Vitamins    n (Group)    20  9  1  4  6 
  
Group %    9.0  16.1 1.8  6.3  13.0
 
Total      n (Group)    62  25  3  14  20 
 
Group %    28.1 44.6 5.5  21.9 43.5
  
Total Sample   n (Group)   221  56  55  64  46 
 
 
Note. U = User; E = Experimenter; Q = Quitter and I = Infrequent User. Participants who 
had used ecstasy were asked in a free response format to list any substances they had 
taken in an attempt to prevent side effects from ecstasy use. Vitamins and 5-HTP were 
the two substances that were endorsed with the greatest frequency.      
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Reasons for Having Never Used Ecstasy 
Participants in the Control group were asked to respond “Yes” or “No” to a list of 
possible reasons (see Table 52) why they had never used Ecstasy? The five most 
commonly endorsed reasons were are provided in Table 53: (1) “I am concerned about 
the possible side effects” (61%); (2) “I have never been in an environment where others 
were using Ecstasy (e.g., bar, club, friend’s house)” (47.5%); (3) “I have not been able to 
obtain it” (42.6%); (4) I know of someone who had a bad experience related to Ecstasy 
use” (30.7%) and (5) “Other drugs/substances that I take give me similar experiences to 
what I believe using Ecstasy would give me” (26.0%). Due to the sample size, logistic 
regressions could not be conducted, even with the control variables, because the 
statistical model was too complex for the data in such a small sample.   
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Table 52 
Frequencies of “Yes” Responses by Controls for Reasons  
for Having Never Used Ecstasy: “I have NEVER used ecstasy because …”  
 
Reason              n (Group)        Group % 
 
Of the cost.          11 10.9 
  
I know of someone who had a bad experience    31 30.7 
related to ecstasy use. 
 
I am concerned about the possible side effects.    61 61.0 
I have not been able to obtain it (lack of availability).   43 42.6 
It is illegal.       7 6.9 
I am concerned about the legal consequences if I am caught.  18 17.8 
I am concerned about becoming addicted.    21 20.8 
I am concerned about the reaction of my parent(s).   16 15.8 
Ecstasy use goes against my religious/spiritual/beliefs/values.  8 7.9 
I am concerned about testing positive on a drug test    12 11.9 
(e.g., work, athletic team, testing by parent).   
My friends do not support the use of ecstasy.     22 22.0 
I have never been in an environment where others    48 47.5 
were using ecstasy (e.g., bar, club, friend’s house).   
 
Ecstasy does not produce the effects that I desire.      18 18.0 
Other drugs/substances that I take give me similar    26 26.0 
experiences to what I believe using ecstasy would give me.   
Note. n (Controls) = 101.   
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Table 53 
Primary Reason Reported by Controls for Having Never Used Ecstasy  
      
Control Group (n = 101) 
Primary Reason                       n    Group % 
 
Lack of availability/opportunity      26   23.85a 
 
Concern about the possible side effects/     25   22.94a 
Health concerns/ 
Consider ecstasy to be dangerous       
 
Lack of interest in using ecstasy      9   8.26a 
 
Concern about the purity of ecstasy pills    8   7.34a 
 
Other Reason          25   22.94a 
  
No Reason Reported          9   8.91b 
 
Note. U = User; E = Experimenter; Q = Quitter; and I = Infrequent User. Total responses 
(n = 109). Participants responded to a free-response question and responses were grouped 
together by category. Eight participants endorsed two reasons. aPercentages were 
calculated based on total number of responses in each group. bPercentages were 
calculated based on total number of participants in each group.   
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Knowledge and Beliefs about Ecstasy 
Participants in all of the groups (Users, Experimenters, Quitters, Infrequent Users, 
and Controls) were asked questions pertaining to their knowledge and beliefs about 
Ecstasy. Table 54 provides the frequency distributions of participants who answered 
affirmatively in the total sample and each Ecstasy use group. In examining the 
frequencies of responses for each question among the entire sample, the following results 
were found: (1) Almost all of the sample reported having read about Ecstasy on the 
Internet (92.8%); (2) A little more than one-third (35.5%) endorsed having read books 
about Ecstasy; (3) Three-quarters of the sample (75.5%) reported that they had read 
scientific research articles about Ecstasy; (4) Approximately one-third (34.2%) endorsed 
that they considered Ecstasy to be a safe drug; (5) A little less than half (43.8%) reported 
believing that Ecstasy is an addictive drug; (6) Approximately one-quarter (25.9%) 
endorsed that they felt they needed or would need to take more Ecstasy each time they 
used in order to get the same desired effects; (7) Almost half (48.1%) of the sample 
endorsed feeling that the benefits of using Ecstasy outweigh the risks; (8) Approximately 
62% responded that they would stop using Ecstasy if they learned that it caused 
permanent brain damage and (9) Almost 40% of the sample endorsed believing that they 
are more likely to engage in certain risky behaviors (unsafe sexual activity, driving, etc.) 
while using Ecstasy than when not under the influence of Ecstasy. Again, due to the 
sample size, logistic regressions could not be conducted because the statistical model was 
too complex for the data in such a small sample. 
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Table 54 
Frequency Distributions of Affirmative Responses to Questions Pertaining to Knowledge 
and Beliefs About Ecstasy in the Total Sample and Each Ecstasy Use Group 
      
Group   
Statement                                  Total Sample    U    E   Q      I       C
 
 
I have read about ecstasy          n (Group)     297 55  45    61    45    91
on the Internet. 
n (Missing) = 2 for Q Group % 92.8 98.2 81.8  95.3  100  91.0
 
I have read books about ecstasy.     n (Group)  114    28    12    28   26    20
n (Missing) = 1 for U 
                         Group %  35.5   50.0  22.2  43.8 56.5 19.8
 
I have read scientific research     n (Group)  243    50    34    55   40    64 
articles about ecstasy.   
                         Group %  75.5   89.3  61.8  85.9 87.0 63.4
 
Ecstasy is a safe drug.           n (Group)  110    33    10    14   24    29
 
                         Group %  34.2   58.9  18.2  21.9 52.2 28.7
 
Ecstasy is an addictive drug.       n (Group)  141    21    32    28   14    46
 
                         Group %  43.8   37.5  58.2  43.8 30.4 45.5 
 
I feel that I must (or would         n (Group)  82     6     19    31   4     22
need to) take more ecstasy  
each time using  in order to  Group %  25.9 10.9     34.5   49.2 8.7  22.7 
get the same desired effects. 
n (Missing) = 2 for U; 1 for Q; 
and 2 for C 
 
I feel the benefits of using        n (Group)  154    51    9     20   36    38
ecstasy outweigh the risks  
of using ecstasy.                Group %   48.1   91.1 16.4   31.3 78.3 38.4
n (Missing) = 2 for U 
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Table 54 (continued) 
Frequency Distributions of Affirmative Responses to Questions Pertaining to Knowledge 
and Beliefs About Ecstasy in the Total Sample and Each Ecstasy Use Group 
      
Group   
Statement                                  Total Sample    U    E   Q      I       C
 
 
If I learned that using           n (Group)     198 22  41   35    21    79
ecstasy caused permanent   Group % 61.9 39.3 74.5  55.6  45.7 79.0
brain damage, I would 
stop using ecstasy.   
n (Missing) = 2 for U 
 
I am more likely to engage        n (Group)  125    14    20   35     9    47
in certain risky behaviors  
(unsafe sexual activity, driving     Group %  39.3   25.0  36.4 54.7  19.6 48.5 
n (Missing) = 2 for U; 1 for Q; 




Intensity of Ecstasy Use for Users 
The intensity of Ecstasy use for the User group for the past 90 days was 
calculated by taking mean of the number of times Ecstasy was used in the past 90 days 
multiplied by the average number of Ecstasy pills taken per occasion. The average 
consumption intensity for Ecstasy Users during the past 90 days was 8.53 (SD = 6.78). 
Notably, a weak but negative correlation was found between age of first use of Ecstasy 
and current intensity of Ecstasy use (r = -.288), indicating that the younger Users were 
when they first experimented with Ecstasy, the greater their current consumption 
intensity of Ecstasy. 
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Discussion  
The current study examined substance use among young adults in the United 
States, with a focus on Ecstasy. The primary goal of this study was to increase our 
understanding of what factors differentiate between different ‘types’ of Ecstasy users. 
Specifically, what factors distinguish individuals who simply experiment with Ecstasy 
and cease use from individuals who initially experiment with Ecstasy and become regular 
users? Secondly, what factors distinguish individuals who become regular users of 
Ecstasy and eventually quit from individuals who continue to use? The following sections 
highlight the interesting and potentially important findings of this study, and are 
organized according to topic areas in a manner similar to the Results. In addition, 
limitations of the current study as well as directions for future research are discussed. 
Substance Use History 
Age of First Use 
 Of the 221 study participants who had used Ecstasy (68.6%), the average age of 
first use was 18, which is a year and a half younger than the mean age of first use 
reported in the 2004 National Survey on Drug Use and Health. This finding suggests that, 
in comparison to 2004, young adults are now experimenting with Ecstasy at a younger 
age. Furthermore, age of first use of Ecstasy was examined among Users, Experimenters, 
and Quitters; pairwise comparisons revealed that Experimenters were significantly more 
likely to be older than both Quitters and Infrequent Users when they first experimented 
with Ecstasy. Given that by definition, Quitters and Infrequent Users have an established 
history of Ecstasy use (≥ 12 occasions), this finding is consistent with prior research 
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findings that individuals who experiment with illicit drugs at an early age are at greater 
risk for later drug abuse (Hawkins et al., 1992).  
 In addition, the correlation between age of first use of Ecstasy and current intensity 
of Ecstasy use was examined for Users, and a negative correlation was found. Consistent 
with Boys and Madsen (2003), results suggest that individuals who begin using Ecstasy 
at a young age are at greater risk for more intense use in the future.  
Polydrug Use 
 Notably, all of the participants in this study were polydrug users. An examination 
of past 90-day drug use revealed that almost one-quarter of the sample reported they had 
used Ecstasy and approximately 60% had used three or more substances (Ecstasy, 
marijuana, psilocybin mushrooms, cocaine powder, LSD, amphetamines, and/or 
prescription drugs in a non-prescribed manner). Moreover, the most commonly abused 
illicit substance was marijuana (72%). Consistent with the trend of increased use of 
prescription pain relievers among young adults ages 18 to 25 (2004 National Survey on 
Drug Use and Health), 44.7% of participants reported having used a prescription drug in 
a non-prescribed manner during the past 90 days.  
 In comparing polydrug use among the five groups of participants (Users, 
Experimenters, Quitters, Infrequent Users, and Controls), significant group differences 
were found. Specifically, Users were significantly more likely to report having used a 
greater number of substances during the past 90 days than Experimenters, Quitters, and 
Controls. This finding is also consistent with the literature; current users of Ecstasy tend 
to be polydrug users (Boys et al., 2001; Boys & Marsden, 2003; Levy et al., 2005). In 
addition, results revealed that younger participants were more likely than older 
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participants to have used a greater number of substances during the past 90 days. Finally, 
as expected, the percentages of the 56 participants in the User Group who had used each 
of the eight substances during the past 90 days were quite large: Ecstasy (89.3%); 
marijuana (82.1%); amphetamines (44.6%); LSD (35.7); powder cocaine (39.3%); 
psilocybin mushrooms (35.7%); prescription drugs (55.4%); and alcohol (92.9%). Not 
surprisingly, the majority of Ecstasy users had a history of recent marijuana use which 
was expected, based upon the studies reviewed above.    
Patterns of Ecstasy Consumption   
 Results indicated that on average, during their period of use, Quitters tended to take 
significantly more Ecstasy pills per occasion than Experimenters. In addition, the largest 
number of Ecstasy pills taken on one occasion by Quitters was significantly larger than 
that of Experimenters. Given that Quitters had a more extensive use of Ecstasy than 
Experimenters, these results are consistent with prior findings that consumption patterns 
of Ecstasy tend to increase with use of Ecstasy (Boys et al., 2001).  
Potential Risk Factors for Ecstasy Use 
Substance Use by Peers 
 Prior research has consistently found that involvement in a substance-using peer 
group tends to be associated with various forms of both licit and illicit substance use 
(Chassin, Presson, Sherman, Montello, & McGrew, 1986; Hawkins, Catalano, & Miller, 
1992). Accordingly, current findings revealed that Users were significantly more likely to 
report having a greater number of friends who were currently using Ecstasy, than 
Experimenters, Quitters, and Controls. In addition, Infrequent Users were significantly 
more likely than Experimenters, Quitters, and Controls to report having a greater number 
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of friends who were currently using Ecstasy. Although young adults may deny 
acquiescing to peer pressure (Ter Bogt & Engels, 2005), peer pressure clearly plays an 
important role in young adult substance use. Notably, of the 221 participants with a 
history of Ecstasy use, 6.4% reported that the primary reason they used Ecstasy for the 
first time was “to fit in with peers (others were using).” These findings highlight the 
importance of examining the social network of young adults when developing prevention 
or intervention programs pertaining to Ecstasy use.  
Social Conformity 
 Consistent with the above findings, prior research has found a negative correlation 
between social conformity (degree of law abidance, conservatism, and religiosity) and 
proscribed activities such as drug use (Newcomb & Bentler, 1989). In the current study, 
participants completed a measure of social conformity and group differences were 
examined. Contrary to expectations, no significant Ecstasy Use Group differences were 
found. However, consistent with Stein et al. (1987), both age and gender were found to 
be significantly related to social conformity. Specifically, older participants were more 
likely than younger participants to adhere to laws. Furthermore, although no significant 
differences were found for the 3 subscales of the Social Conformity Scale, results 
indicated that females were more likely to conform than males.  The lack of significant 
group differences may be accounted for by the general tendency of polydrug users to 
score in the low range on measures of social conformity (Huba & Bentler, 1982).  
Sensation Seeking 
Prior research has found profiles of Ecstasy users to be characterized by high 
levels of sensation seeking (e.g., Bobes et al., 2002). In addition, prior studies suggest an 
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association between degree of sensation seeking and intensity of use of Ecstasy (Bobes et 
al, 2002; Daumann, 2001). In the current study, levels of sensation seeking were 
examined, and although significant differences were found among Users, Experimenters, 
and Quitters on the linear composite of the four Sensation Seeking Scale subscales (Thrill 
and Adventure Seeking, Experience Seeking, Disinhibition and Boredom Susceptibility) 
post hoc testing in each case revealed no significant pairwise mean differences. These 
findings are consistent with prior studies in that polydrug users (including Ecstasy users) 
tend to be high sensation-seekers (Gerra et al., 2004). Notably though, upon further 
examination, in comparing the mean of the Total Scale Scores for all Ecstasy Use Groups 
(Users, Experimenters, Quitters, Infrequent Users, and Controls) with that obtained by 
Gerra et al. (2004), the mean for the current sample (M = 24.22, SE = .308) was higher 
than the mean (M = 21.80, SE = .89) reported by Gerra et al. (2005) and the standard 
error is smaller, suggesting that participants in the current study tended to exhibit even 
higher levels of, and less variability in, sensation seeking than another sample of 
polydrug users; this result may have contributed to the inability to detect significant 
group differences in the current sample, and may be the cause of the lower correlations 
among the SSS subscales.   
In addition, also consistent with previous findings (Zuckerman, 1999), significant 
gender differences were found for the Thrill and Adventure Seeking and the Boredom 
Susceptibility subscales, suggesting that females are less likely than males to (1) engage 
in sports or activities involving some degree of physical danger and (2) evidence an 
aversion for a repetitive experience of any kind, routine work or dull/predictable people 
as well as to feel restless when things are unchanging.    
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Risk Appraisal (Own Risk) 
 In the current study, Horvath and Zuckerman’s (1993) concept of risk appraisal, "a 
cognitive trait specific to particular areas of risky behavior (p. 27)," was examined for 
group differences in how participants perceived the likelihood of negative consequences 
for various behaviors that they may or may not choose to engage in (crime risk, minor 
violations risk, financial risk, and sports risk). No significant differences were found. As 
suggested by Zuckerman and Kuhlman (2000), as a whole, polydrug drug users may 
evaluate the possibility of their drug use leading to negative outcomes such as addiction, 
overdose, and financial or legal problems as lower than low sensation-seekers (non-drug 
users), thus increasing the likelihood that they will engage in behaviors that low 
sensation-seekers would view as too risky, i.e., polydrug use).  
 Similar to the sensation seeking trait, significant gender differences were found for 
risk appraisal. Specifically, the means for males and females on the linear composite 
score of the General Risk Appraisal Scale (Own Risk) were more than half a standard 
deviation apart, suggesting that females were more likely than males to appraise a higher 
personal risk of a negative outcome if they were to commit a crime or minor violation, 
take a financial risk, or engage in a risky sporting activity.  
Risky Behavior (Own Behavior) 
Horvath and Zuckerman (1993) also examined the correlations between risk 
appraisal and risky behaviors (crime, minor violations, financial, and sports) and found 
that individuals who had evaluated risk for themselves as low in the above areas were 
more likely to self-report having engaged in those risky behaviors. Participants were 
asked to self-report their history of engaging in the above activities, and again, no 
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significant group differences were found. However, although weak, negative correlations 
were found between Crime Risk and Crime Behavior as well as between Minor 
Violations Risk and Minor Violations Behavior, suggesting that the lower that 
participants evaluated their risk for engaging in some type of crime or minor violation, 
the more likely they were to engage in those types of behaviors. Furthermore, findings 
indicated that males were more likely than females to have committed a crime or minor 
violation.      
 Overall, the above findings suggest that polydrug users in the current study tended 
to evaluate their risk for engaging in polydrug use as low; however, only 58.9% of 
participants in the User Group responded affirmatively to the following statement: 
“Ecstasy is a safe drug.” Therefore, 41.1% of Users self-reported use of Ecstasy, even 
though they did not consider it to be a ‘safe’ drug. These findings are consistent with 
those reported in a recent study conducted by Gamma, Jerome, Liechti, and Sumnall 
(2005), which examined the perceived harmfulness of Ecstasy use among 900 drug users, 
883 of whom self-reported at least a single lifetime use of Ecstasy. Results indicated that 
73.2% of respondents viewed Ecstasy to be associated with at least some risk (49.3% 
‘some risk,’ 18.0% dangerous,’ and 5.9% ‘very dangerous’). Only 26.1% reported 
believing that Ecstasy was either ‘safe’ or ‘very safe.’ However, respondents were also 
asked to estimate relative drug risks, and results indicated that respondents tended to view 
Ecstasy to be less dangerous than many other misused substances. Specifically, alcohol, 
amphetamines, cigarettes, cocaine, DXM, GHB, and heroin were ranked as possessing 
greater risk than Ecstasy. 
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 The above findings highlight the discrepancy between drug users’ perception of 
risk related to their drug use and their choice to use drugs, particularly Ecstasy. In 
thinking back to the findings of Horvath and Zuckerman (1993) regarding sensation 
seeking, they suggest that possibly it is the greater willingness of sensation-seekers to 
accept risks that puts them at greater risk through their behavior. In the current study, 
given that Ecstasy users tended to be high sensation-seekers, although some Ecstasy users 
may not perceive the risk of Ecstasy use to be low, they may simply be more willing to 
accept the risks associated with engaging in this type of behavior, particularly when they 
perceive the risks of Ecstasy use to be less dangerous in comparison to other substances.   
Motivations for First Use of Ecstasy 
 Participants (Users, Experimenters, Quitters, and Infrequent Users) were asked in a 
free-response format what the primary reason was for why they first used Ecstasy. 
Participants’ responses were reviewed and similar responses were grouped together. The 
four most commonly reported reasons for first using Ecstasy were: (1) curiosity of what it 
would be like to use Ecstasy (53.4%); (2) use was recommended by others (heard it was 
“good”) (11.9%); (3) to have a new experience that would help to see the world 
differently (7.6%); and (4) to fit in with peers (others were using) (6.4%). The current 
finding that curiosity was the primary reason self-reported for first use of Ecstasy is 
consistent with results reported by Van de Wijngaart et al. (1997) that Ecstasy was 
typically taken for the first time because of curiosity and a desire to “try out” the drug. It 
appears that the primary motivation self-reported for first use of Ecstasy has not changed 
over time. Furthermore, these findings suggest that first use of Ecstasy tends to result 
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from simple curiosity and that continued use of Ecstasy is motivated by additional 
factors, such as a positive experience with the drug itself (Levy et al., 2005).  
Motivations for Continued Use of Ecstasy  
 Prior research (Ter Bogt & Engels, 2005) has found that the reasons young adults 
use Ecstasy can be categorized in a similar manner to the motivations for the use of 
alcohol (Cox & Clinger, 1988): (1) drinking to get into a positive mood (enhancement); 
(2) drinking to obtain social rewards (need for sociability); (3) drinking to deal with 
negative emotions (coping); and (4) drinking to avoid social rejection (conformism). In 
the current study, the Reasons for Ecstasy Use Scale: AMPS (Alter Perception; Enhance 
Mood; Enhance Personal Growth; and Enhance Social/Interpersonal Relationships) was 
developed based upon a measure of functions for Ecstasy use developed by Boys et al. 
(2001) as well as data obtained during the pilot period of the study. Significant group 
differences were found among Users, Experimenters, Quitters and Infrequent Users for 
how often they had used Ecstasy for each of four subscales (AMPS); pairwise 
comparisons revealed the following significant differences: (1) Both Users and Quitters 
were significantly more likely than Experimenters to endorse having used Ecstasy to 
enhance their mood; (2) Quitters were significantly more likely than Experimenters to 
self-report using Ecstasy in order to alter their perception of the world; (3) Users and 
Quitters were significantly more likely than Experimenters to self-report the use of 
Ecstasy for personal growth; and (4) Users, Quitters, and Infrequent Users were all 
significantly more likely than Experimenters to endorse having used Ecstasy for 
social/interpersonal reasons.  
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 In addition, ‘Ecstasy use profiles’ (i.e., the pattern of means among the four 
subscales of the Reasons for Ecstasy Use Scale: AMPS) were examined and compared 
among Users, Experimenters, and Quitters. Although a significant group difference was 
found, post hoc testing revealed no significant pairwise mean differences. Notably, in 
examining the means for each of the four subscales for the User, Experimenter, and 
Quitter Groups, the highest mean for each group was for the Alter Perception subscale, 
and the lowest mean for each group was for the Personal Growth subscale. These 
findings suggest that individuals who use Ecstasy are most likely to self-report using 
Ecstasy to alter their perception of the world (“Just get really stoned or intoxicated;” 
“Enhance sensations.”)  
 Furthermore, all participants with a history of Ecstasy use were also asked in a free-
response format what the primary reason was for why they used Ecstasy. As for 
exploration of reasons self-reported for first use of Ecstasy, participants’ responses were 
reviewed and similar responses were grouped together. The three most commonly 
reported reasons for using Ecstasy were: (1) for fun (18.2%); (2) to help to feel elated or 
euphoric (14.2%); and (3) to enhance an activity (12.5%). The finding that the most 
frequently self-reported reason for using Ecstasy was “for fun” is consistent with the 
above finding that, on average, Ecstasy users self-reported that they most frequently used 
Ecstasy to alter their perception of the world, a subscale which encompasses using 
Ecstasy to “Just get really stoned or intoxicated” which young adults tend to associate 
with having fun. 
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Psychological Addiction to Ecstasy 
 Participants in the four Ecstasy Use groups (Users, Experimenters, Quitters, and 
Infrequent Users) were asked, “Do you feel that you are or were at one time 
psychologically addicted to Ecstasy?” Approximately 26% of the participants in the four 
groups responded affirmatively. These findings are consistent with prior studies in which 
Ecstasy users self-reported a history of psychological addiction to Ecstasy (e.g., Levy et 
al., 2005; Parrot et al., 2002). Post hoc analyses indicated that there was a significant 
difference among the four groups; pairwise comparisons revealed that Users were 
significantly more likely than both Experimenters and Infrequent users to report 
psychological addiction to Ecstasy. However, Quitters were significantly more likely than 
Users to report a history of psychological addition to Ecstasy. Given that by definition, 
Experimenters have used Ecstasy no more than 3 times and Infrequent Users have not 
used Ecstasy more than 4 times in the past year, it is not surprising that current active 
Users of Ecstasy were more likely to report currently being or having been 
psychologically addicted to Ecstasy. Furthermore, it is possible that one of the reasons 
Quitters were self-reportedly no longer using Ecstasy relates to a history of psychological 
addition. Unfortunately, this relationship was not examined in the current study.  
Notably, no significant effect was found for history of attending substance related 
psychological counseling or a support group. 
Testing of Ecstasy Pills 
 Participants in the four Ecstasy Use Groups (Users, Experimenters, Quitters, and 
Infrequent Users) were asked, “Do you or did you usually test your Ecstasy pills for their 
contents?” Approximately 18% of the participants in the four groups responded 
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affirmatively. Post hoc analyses failed to find a significant difference among the four 
groups, possibly due to the low rate of endorsement of testing Ecstasy pills in the overall 
sample.  
Use of 5-HTP and Vitamins 
Participants in the four groups (Users, Experimenters, Quitters and Infrequent 
Users) were asked, “Did or do you take any drugs or substances to try to prevent 
unwanted Ecstasy side-effects?” In examining the responses, 5-HTP and vitamins were 
the two responses that were most frequently reported. Of the total sample, 19% self-
reported taking 5-HTP and 9% self-reported taking vitamins. These findings are 
consistent with prior reports of Ecstasy users taking steps to “minimize” negative side-
effects related to their Ecstasy use (Maxwell, 2005). 
Reasons for Having Never Used Ecstasy 
Participants who denied a history of Ecstasy use (Controls) were asked to respond 
“Yes” or “No” to a list of possible reasons why they had never used Ecstasy? The five 
most commonly endorsed reasons were: (1) “I am concerned about the possible side 
effects” (61%); (2) “I have never been in an environment where others were using 
Ecstasy (e.g., bar, club, friend’s house)” (47.5%); (3) “I have not been able to obtain it” 
(42.6%); (4) I know of someone who had a bad experience related to Ecstasy use” 
(30.7%) and (5) “Other drugs/substances that I take give me similar experiences to what I 
believe using Ecstasy would give me” (26.0%). These findings indicate that the primary 
self-reported reason why non-Ecstasy users had never used Ecstasy was related to health 
concerns, suggesting that current prevention strategies which emphasize the education of 
young adults about the risks of Ecstasy use have had some degree of success. However, 
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results also highlight a significant concern that a large proportion of Controls had never 
used Ecstasy simply due to lack of opportunity/availability, suggesting that, similar to 
other substances, ease of access to Ecstasy is a high risk factor for use (Levy et al., 2005).  
Knowledge and Beliefs about Ecstasy 
Participants in all of the Ecstasy Use Groups (Users, Experimenters, Quitters, 
Infrequent Users, and Controls) were asked questions pertaining to their knowledge and 
beliefs about Ecstasy. In examining the frequencies of responses for each question among 
the entire sample, the following results were found: (1) Almost all of the sample reported 
having read about Ecstasy on the Internet (92.8%); (2) A little more than one-third 
(35.5%) endorsed having read books about Ecstasy; (3) Three-quarters of the sample 
(75.5%) reported that they had read scientific research articles about Ecstasy; (4) 
Approximately one-third (34.2%) endorsed that they considered Ecstasy to be a safe 
drug; (5) A little less than half (43.8%) reported believing that Ecstasy is an addictive 
drug; (6) Approximately one-quarter (25.9%) endorsed that they felt they needed or 
would need to take more Ecstasy each time they used in order to get the same desired 
effects; (7) Almost half (48.1%) of the sample endorsed feeling that the benefits of using 
Ecstasy outweigh the risks; (8) Approximately 62% responded that they would stop using 
Ecstasy if they learned that it caused permanent brain damage; and (9) Almost 40% of the 
sample endorsed believing that they are more likely to engage in certain risky behaviors 
(unsafe sexual activity, driving, etc.) while using Ecstasy than when not under the 
influence of Ecstasy.  
Many pertinent conclusions can be drawn from the above findings. It is clear that 
young adults use the Internet as a source of information, particularly about drugs. Similar 
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to current study findings, Falck, Carlson, Wang and Siegal (2004) found that a large 
proportion (50%) of their sample of 304 young adult Ecstasy users (aged 18-30) had self-
reported use of the Internet to obtain information about Ecstasy. Furthermore, the 
majority of the current sample self-reported having read scientific research articles about 
Ecstasy. Given the current availability of scientific literature on the Internet, results 
suggest that young adults are taking advantage of these Internet resources and that the 
Internet may provide a means for the implementation of mass scale substance-related 
prevention/intervention efforts.   
Summary of 3 Key Variables Associated with Significant Differences among Users, 
Experimenters, and Quitters   
 In summary, three variables were found to be of importance in exploring potential 
factors that distinguish between young adults who experiment with the use of Ecstasy and 
then quit (Experimenters), become active users of Ecstasy and continue use (Users) and 
become active users of Ecstasy and then quit (Quitters). First, age of initial use of Ecstasy 
was found to be a significant factor. Findings suggest that the younger individuals are 
when they when first experiment with Ecstasy, the more at risk they are for future risk. 
The second significant factor was found to be the peer group. Specifically, results suggest 
that young adults who have peers who use Ecstasy are at great risk for either the initiation 
or continuation of current Ecstasy use. Likewise, given the finding that Quitters tended to 
have fewer friends who currently used Ecstasy than Users, results also suggest that the 
peer group plays an important role in a young adult’s decision and/or ability to either quit 
or maintain sobriety from Ecstasy use following prior Ecstasy use; notably peer pressure 
may facilitate the use of Ecstasy as well as inhibit the use of Ecstasy (Ter Bogt & Engels, 
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2005). Consequently, it is vital that intervention plans evaluate Ecstasy users in the 
context of their peer group. Finally, significant group differences were found for the 
reasons endorsed for the continued use of ecstasy. Notably, results suggest that 
individuals who use ecstasy beyond the period of experimentation are significantly more 
likely to use ecstasy to enhance social/interpersonal relationships. 
Study Limitations and Directions for Future Research 
Experimental Design 
 Although prior research (Petraitis et al., 1998) has examined risk factors for the 
initiation of illicit substance use [e.g., friendship patterns and peer behaviors, absence of 
supportive parents, psychological temperament; history of abuse; socioeconomic status; 
affective states], a theoretical model does not exist which would provide for examining 
different ‘types’ of ecstasy users. Therefore, this study was designed to examine risk 
factors thought to differentiate ‘types’ of ecstasy users. The design of the current study 
was retrospective; therefore, it did not provide for the evaluation of dynamic or causal 
relationships between potential risk factors and Ecstasy use. Results of the current study 
are clearly consistent with prior research findings of the significant role of the peer group 
in Ecstasy use. As reviewed earlier, researchers have found that friends can influence 
drug use and that drug use itself can influence the selection of friends (Dishion & Owen, 
2002). A prospective study would allow for the evaluation of the directionality of the 
influence of peer group and Ecstasy use among young adults.  
Categorical v. Dimensional Approach 
 A categorical approach was used to assign participants to each of the Ecstasy Use 
Groups. Given that criteria for such groups (Users, Experimenters, and Quitters) were not 
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available in the literature, the inclusion criteria for each group in this study were 
somewhat arbitrary and narrow. As a result of this categorical approach, many ecstasy 
users and non-ecstasy polydrug users were excluded. A future study could contribute to 
the literature by using a dimensional approach to examine the full continuum of 
individuals with a history of ecstasy use.  
Sample Size 
 Sample size appeared to be adequate for examining group differences for the 
primary dependent variables: Sensation Seeking subscales (Thrill and Adventure 
Seeking, Experience Seeking, Disinhibition, and Boredom Susceptibility); Normative 
Influence Scale; Social Conformity subscales (Law Abidance, Liberalism, and 
Religiosity); General Risk Appraisal Scale subscales for own risk appraisal and own risky 
behavior (Crime Risk, Financial Risk, Minor Risk Violations, and Sports Risk); the 
Mood subscale of the Reasons for Ecstasy Use: AMPS; and the total number of drugs 
used during the past 90 days. Analyses revealed that for each dependent variable, either 
significant differences were clearly evident among the groups (ps < .001) or they were 
not at all present. However, power may have been low for post hoc tests. In addition, 
sample size, or the base rate of responding to the items, was found to be inadequate for 
examining some of the binary outcome variables, particularly those related to 
participant’s knowledge and beliefs regarding Ecstasy.  Due to the sample size, logistic 
regressions could not be conducted because the statistical model was too complex for the 
data in such a relatively small sample. 
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Validity of Drug History Data 
Because the drug history questions were in free–response format, numerous 
participants reported that they did not know their history of use for the past year or 
lifetime because the frequency of their use was extremely high whereas other participants 
provided what were clearly random responses (e.g. 999,999). Consequently, given 
concerns regarding the validity of data, past year and lifetime use were not analyzed. This 
restriction in the analysis of data limited examination of Ecstasy use spanning an 
extended period of time; frequency of Ecstasy use may have been relatively infrequent 
during the past 90-days but rather high during the past year which could not be 
ascertained from the data. However, this response, or lack of response tendency, suggests 
that participants responded in such a manner when they could not accurately estimate 
their history of use, which lends credibility to the data estimates that were provided for 
past 90-day use. Overall, participants’ apparent difficulty in providing free-response 
estimates of their past year and lifetime history of drug use suggests that a fixed response 
format such as a Likert scale may have provided for increased validity of data. However, 
such an approach would require a clear understanding of how to scale each response 
point on the scale. 
Another limitation related to the collection of drug history data was that large 
variances for lifetime history of Ecstasy use may have been present within the Ecstasy 
Use Groups (Users, Experimenters, Quitters and Infrequent Users), but could not be 
detected. For example, one participant in the User group may have used Ecstasy 8 times 
in the past year and have a lifetime history of Ecstasy use equal to 8 times; however, 
another participant in the User group may have used Ecstasy 8 times in the past year, but 
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have a lifetime history of Ecstasy use equal to 800 times. Limitations in the collection of 
data prevented these types of differences from being analyzed.  
Sampling and Response Biases  
 Because this study used convenience sampling, the design of this study was quasi-
experimental; participants self-selected themselves for the study and could not be 
randomly assigned to an Ecstasy Use Group. In addition, the length of the survey may 
have resulted in some prospective participants choosing not to participate in the survey. 
Some individuals may have begun completing the survey and then stopped, thus creating 
another form of response bias. It is likely that those individuals who chose not to 
participate at all, or who failed to complete the survey, were in some way different from 
those who chose to participate and to complete the survey. Due to limitations in the 
collection of drug history data, it is possible that a cohort of ‘heavy’ ecstasy users was not 
represented in this study and limits the generalizabilty of results. Furthermore, 
differences in motivation for completing the survey (i.e., for the lottery, to contribute to 
the field of psychology) may have affected the amount of time, thought, and effort put 
into responding to questions.  
Accuracy of Responding 
 The order of the questionnaires within the survey was not varied among the 
participants, and thus, order effects may have been present. There may have been a 
differential shift in the means as well as lower reliability than what may have been 
obtained had the order of the measures been varied. The length of time taken to complete 
the survey varied among participants, and some measures were much longer than others. 
Possibly, the obtained reliabilities for the Social Conformity Scale and the Sensation 
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Seeking Scale would have been higher had these measures come earlier in the survey. It 
is possible that in some cases, failure to find significant group differences may have been 
due to low power resulting from low reliability. However, it is important to note that the 
General Risk Appraisal Scale, a 120-item measure, was the last measure to be completed 
by participants and for which adequate reliabilities were obtained. Therefore, the lack of 
significant differences (i.e., sensation seeking, social conformity, risky appraisal and 
risky behavior, etc.) may truly be due to similar characteristics among polydrug users 
rather than a result of insufficient power. 
Generalizability   
 It is important to note that the current study was limited to the use of Ecstasy 
among young adults in the US. Given the extent of the use of Ecstasy outside of the US, a 
cross cultural study would make a significant contribution to the literature. Moreover, it 
would be beneficial to examine different ‘types’ of ecstasy users and patterns of use 
among older adults (beyond 25 years of age) in comparison to younger adults (ages 18-
25).  
 In addition, study participants were only recruited via the Internet. Therefore, 
individuals who did not have access to the Internet did not have the opportunity to 
participate. As noted by Gamma et al. (2005), the Internet provides for rapid access to 
and sampling of a large population, and anonymity of response may facilitate greater 
honesty in responses to questions regarding illegal behaviors. However, a study using the 
Internet does not provide for verification of factors such as age, sex, education, and 
current intoxication, which could be controlled for in the laboratory. Although the 
generalizabilty of findings from the current study is limited because a non-random 
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sample was used, the demographic characteristics of participants are similar to those 
found in recent studies of young adults in the United States with a history of Ecstasy use.   
 Notably, the demographic characteristics of Ecstasy users from the 2003 NSDUH 
study and the current study (see Table 55) are similar to the demographic data reported 
by Yacoubian, Deutsch, and Schumacher (2004) in their study of adult club rave 
attendees along the Baltimore-Washington corridor in 2002. The majority of this sample 
(2004) was male (64%) and Caucasian (69%), with 72% self-reporting a history of 
Ecstasy use. The mean age of the sample was 21 years and 96% had completed at least 
the 12Pth P grade. As noted by Yacoubian et al. (2004) and consistent with prior research 
(Urbach, Reynolds, & Yacoubian, 2003; Yacoubian, 2002, 2003; Yacoubian, Arria, Fost, 
& Wish, 2002; Arria, Yacoubian, Fost & Wish, 2002), the findings suggest that the use of 
Ecstasy is most common among educated, Caucasian, young adults. 
 Furthermore, prior research has found that young adults use the Internet to obtain 
information about drugs and that such information can influence drug-taking behavior 
(Borzekowski and Rickert, 2002; Wax, 2002). In 2003, Falck, Carlson, Wang, and Siegal 
(2004) conducted a study which specifically examined the use of the Internet by young 
adult ecstasy users. Falck et al. (2004) used a respondent driven sampling plan to recruit a 
community sample of recent ecstasy users (n = 304), aged 18-30, from a Metropolitan 
area in central Ohio. The sample was largely male (66.1%) and predominately white 
(81.6%), with a mean age of 21.2 years (S.D. = 2.8) and some college or a college degree 
reported by 50.3% of participants. The mean age of first use of ecstasy was 18.7 years 
(S.D. = 2.9). The demographic characteristics of the sample of Ecstasy users in the Falck 
et al. study (2004) are similar to those found for the current study which only recruited 
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through the Internet. Notably, Falck et al. (2004) found that about half of their sample 
had used the Internet to obtain information about Ecstasy, with younger and more 
educated participants significantly more likely to do so. This finding is consistent with 
the findings of the current study in that Ecstasy users frequently use the Internet to obtain 
information about Ecstasy. Therefore, future studies which examine various modes of 
prevention and intervention relating to the use of Ecstasy among young adults, 





Comparison of Demographic Data from a Subset of Participants (Ages 18-25 with a 
History of Ecstasy Use) from the 2003 National Survey on Drug Use and Health 
(NSDUH) with Demographic Data of Participants with a History of Ecstasy Use from the 
Current Study (Users, Experimenters, Quitters, and Infrequent Users)   
 
Variable NSDUH 2003  Current Study  
 
 
Age of first use of Ecstasy (years) M = 18.5  M = 18.0 
 SD = 2.14  SD = 2.15 
 
Gender (male) 52.7 %  56.6% 
 
Education (at least some college) 88.8 %  82.9% 
 
Ethnicity (non-Hispanic white) 74.9 %  78.6% 
 
 
   





PARTICIPANTS NEEDED (AGES 18-25) FOR AN UANONYMOUS U INTERNET STUDY 
CONDUCTED BY RESEARCHERS FROM THE DEPARTMENT OF PSYCHOLOGY, 
UNIVERSITY OF MARYLAND, COLLEGE PARK. FOR FURTHER INFORMATION 
ABOUT THE STUDY INVESTIGATORS, VISIT THE PSYCHOLOGY 
DEPARTMENT'S H0H0H0H0HUCLINICAL PSYCHOLOGY PROGRAM WEBPAGE UH. 
 
UPURPOSE: U I am a graduate student at the University of Maryland, College Park and I am 
conducting this study for my dissertation. My goal is to increase researchers' understanding 
of young adults' use of various substances (Ecstasy, Amphetamines, LSD, Cocaine Powder, 
Psilocybin Mushrooms, Heroin, or Prescription Drugs in a non-prescribed manner) in the 
United States, with a particular focus on Ecstasy.  
 
UCOMPENSATION: UAfter completing the survey, you will have the option to enter a lottery 
for one of five $50 prizes. In order to participate in the lottery, you will need to provide an 
email address that will not be connected in any way to the information you provide in the 
survey. You can create a free email account by clicking H1H1H1H1HUhereUH. If you are a winner in the 
lottery, your email address will be submitted to PayPal, an internet payment service. 
Winners will receive an email from PayPal which will provide instructions for how to open 
a free PayPal account to which the $50 will be credited. You will then have the option to 
transfer the $50 to a checking account, request a check, or send the $50 to someone else. For 
more information on how PayPal can be used to make this anonymous payment, click H2H2H2H2HUhereUH. 
 
UCRITERIA: UYou live in the United States and have used ECSTASY UORU at least 2 of the 
following: Marijuana, Amphetamines, LSD, Cocaine powder, Psilocybin mushrooms, 
heroin, or a prescription drug in a non-prescribed manner 
 
If you have any questions, send an email to: klevy@psyc.umd.edu 
 
Click NEXT below to take a brief screening to determine if you meet the selection criteria 
for this study. The survey will take approximately 15 to 30 minutes. 
 
NOTE: SCROLL DOWN ON EACH PAGE TO ANSWER QUESTIONS, THEN CLICK 
NEXT.  
SOME PAGES HAVE ONLY ONE QUESTION.  
NEXT
  PAGE 1 OF 22




ENTERING THE LOTTERY 
You have the opportunity to enter a lottery for $50. In order to participate in the lottery, 
you will need to provide an email address that will be emailed to klevy@psyc.umd.edu. 
There is no way in which we would be able to connect this email address to the information 
you provided in the survey you just completed. However, if your name typically appears in 
parentheses when you send an email, and you use this email account, we will know that you 
participated in the study. If you do not currently have an email account or would like to 
create a new one that is anonymous, you can create a free email account by clicking H3H3H3H3HUhereUH. If 
you are a winner in the lottery, an email will be sent from an internet payment service, 
PayPal, to the email address you provide. This email will provide instructions for how to 
open a free PayPal account which will enable you to either transfer the $50 you won to a 
checking account, request a check, or send the $50 to someone else. For more information 
on PayPal, click H4H4H4H4HUhereUH.  
 
If you would like to participate in the lottery, please enter your email address in the box below.  








If you have any problems submitting your email address above, please send an email with the 
SUBJECT: LOTTERY to H5H5H5H5HUklevy@psyc.umd.edu UH and include the email address where you would 
like to be contacted if you are a winner in the lottery. 
 
 
Once again, thank you for participating in our research study. 




Please read the following 2 statements:  
 
(A) My age falls into the category of 18-25.  
(B) I live in the United States.  
 
Are BOTH of the 2 statements above (A and B) TRUE about you?  
 
If NO, please H6H6H6H6HUCLICK HERE UH  
 
If YES, please CONTINUE with Question #1 below.  
 
1. Please read the following 4 statements:  
 
(A) I have used ECSTASY.  
(B) I have NOT used ECSTASY MORE THAN U3 U times.  
(C) I have NOT used ECSTASY in the past 6 months.  
(D) I do NOT intend to use ecstasy in the future.  
 
Are ALL 4 of the statements above (A, B, C, and D) TRUE about you?  
 YES NO  
 
2. Please read the following 2 statements:  
 
(A) I have used ECSTASY 12 or more times in the past year (past 12 months).  
(B) I intend to continue using ECSTASY in the future.  
 
Are BOTH of the 2 statements above (A and B) TRUE about you?  
 YES NO  
 
3. Please read the following 3 statements:  
 
(A) I have used ECSTASY 12 or more times.  
(B) I have NOT used ECSTASY in the past 6 months.  
(C) I do NOT intend to use ECSTASY in the future.  
 
Are ALL 3 of the statements above (A, B, and C) TRUE about you?  
 YES NO  
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4. Please answer TRUE or FALSE:  
 
I have NEVER used ECSTASY.  
 TRUE  
 FALSE  
5. Please answer TRUE or FALSE:  
 
I am currently using AT LEAST 2 of the following substances and intend to use these 





Cocaine powder  
Psilocybin Mushrooms  
Heroin  
Prescription drug in a non-prescribed manner  
 TRUE  
 FALSE  
BACK NEXT
  PAGE 2 OF 22 
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Appendix D 
Demographics Questionnaire  
 
Please answer the following questions: 
6. How old are you (years)?  
a. 18  
b. 19  
c. 20  
d. 21  
e. 22  
f. 23  
g. 24  
h. 25  
7. What state are you currently living in the United States? 
Please type your state in the box.  
8. What is your sex?  
a. Male  
b. Female  
9. What is your sexual orientation?  
a. Heterosexual  
b. Homosexual  
c. Bisexual  
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10. Please select UALLU items that describe you:  
a. I am currently a high school student.  
b. I am currently a college student.  
c. I am currently employed.  
d. I am currently unemployed.  
11. What is the highest level of education you completed?  
a. Some High School  
b. High School Diploma or GED  
c. Some College  
d. Associates Degree  
e. B.A. or B.S.  
f. M.A. or M.S.  
g. Ph.D.  
h. M.D.  
12. What is or was your approximate high school GPA (grade point average) letter 
grade equivalent?  
a. Don't Know  
b. A  
c. B  
d. C  
e. D  
f. E  
g. F  
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13. What is or was your COLLEGE GPA (if applicable) letter grade equivalent?  
a. Not Applicable  
b. Don't Know  
c. A  
d. B  
e. C  
f. D  
g. E  
h. F  
 
14. What is your current marital status?  
a. Single  
b. Married  
c. Divorced  
d. Separated  
e. Widowed  
15. If you are financially DEPENDENT on your caregiver(s), please estimate the 
combined income of your caregivers' annual household income.  
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17. What is your Ethnicity? Please select ALL that apply.  
a. Caucasian  
b. African-American  
c. Hispanic  
d. Asian/Pacific Islander  
e. Native American  
f. Other  
18. Have you ever received counseling or attended a support group for your substance 
use?  
YES NO  
19. How did you hear about this study? Please be as specific as possible (e.g., website; 
flyer; friend who saw it on a particular website; AOL chat room; AOL Bulletin 
Board; YAHOO chat room, search engine such as Google, etc.). If from a website, 
please specify which site if possible. If from a flyer, where was it posted? 
 
BACK NEXT
  PAGE 4 OF 22
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Appendix E 
Drug History Questionnaire 
PLEASE TYPE A NUMBER IN THE BOX IN RESPONSE TO THE FOLLOWING 
QUESTIONS REGARDING YOUR USE OF UECSTASY U. PLEASE PROVIDE YOUR 
BEST UESTIMATE U RATHER THAN LEAVING A BOX BLANK. IF YOU NEED TO, USE 
A PLUS. FOR EXAMPLE, 100+ = MORE THAN 100 TIMES.  
 
IF YOU HAVE UNEVER USED ECSTASY U, PLEASE SKIP TO THE BOTTOM OF THIS 
PAGE AND CLICK UNEXT U.  
20. Age you first used ECSTASY  
21. Number of times you used ECSTASY in the past U30 U days  
22. Number of times you used ECSTASY in the past U90 U days  
23. Number of times you used ECSTASY in the past UyearU (past 12 months) 
  
24. Number of times you used ECSTASY in your UlifetimeU  
25. In thinking of your most recent period of ecstasy use, how many pills would you 
typically take in one occasion?  
26. What is the largest number of ecstasy pills you have ever taken in one occasion? 
  
27. Do you feel that you are or were at one time physically addicted to ecstasy?  
 YES NO  
28. Do you feel that you are or were at one time psychologically addicted to ecstasy?  
 YES NO  
29. Do or did you usually test your ecstasy pills for their contents?  
 YES NO  
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30. Please list any other drugs (including alcohol) that you did or do usually take with 
ecstasy. If none, please type NONE.  
 
31. Did or do you take any drugs or substances to try to prevent unwanted ecstasy side-
effects? If yes, please list any substances in the box. If no, please type NO. 
 
32. Have you quit using ECSTASY?  
YES NO  
BACK NEXT
  PAGE 5 OF 22 
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Please type a number in the box in response to the following questions. Please provide your 
best ESTIMATE rather than leaving a box blank. If you need to, estimate using +. For 
example, 100+ = more than 100 times. If you have NEVER used MARIJUANA, click 
NEXT, below.  
84. Age you first used MARIJUANA  
85. Number of times you used MARIJUANA in the past U30 U days  
86. Number of times you used MARIJUANA in the past U90 U days  
87. Number of times you used MARIJUANA in the past UyearU (past 12 months) 
 
88. Number of times you used MARIJUANA in your UlifetimeU  
BACK NEXT
  PAGE 9 OF 22 
Please type a number in the box in response to the following questions. If you have never 
used AMPHETAMINES, click NEXT, below.  
89. Age you first used AMPHETAMINES  
90. Number of times you used AMPHETAMINES in the past U30U days  
91. Number of times you used AMPHETAMINES in the past U90U days  
92. Number of times you used AMPHETAMINES in the past UyearU  
93. Number of times you used AMPHETAMINES in you UlifetimeU  
BACK NEXT
  PAGE 10 OF 22 
Please type a number in the box in response to the following questions. If you have never 
used LSD, click NEXT, below.  
94. Age you first used LSD  
95. Number of times you used LSD in the past U30U days  
96. Number of times you used LSD in the past U90U days  
97. Number of times you used LSD in the past UyearU  
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98. Number of times you used LSD in your UlifetimeU  
BACK NEXT
  PAGE 11 OF 22 
 
Please type a number in the box in response to the following questions. If you have never 
used COCAINE POWDER, click NEXT, below.  
99. Age you first used COCAINE POWDER  
100. Number of times you used COCAINE POWDER in the past U30U days  
101. Number of times you used COCAINE POWDER in the past U90U days  
102. Number of times you used COCAINE POWDER in the past UyearU  
103. Number of times you used COCAINE POWDER in your UlifetimeU  
BACK NEXT
  PAGE 12 OF 22 
Please type a number in the box in response to the following questions. If you have never 
used PSILOCYBIN MUSHROOMS, click NEXT, below.  
104. Age you first used PSILOCYBIN MUSHROOMS  
105. Number of times you used PSILOCYBIN MUSHROOMS in the past U30U days 
 
106. Number of times you used PSILOCYBIN MUSHROOMS in the past U90U days 
 
107. Number of times you used PSILOCYBIN MUSHROOMS in the past UyearU 
 
108. Number of times you used PSILOCYBIN MUSHROOMS in your UlifetimeU 
 
BACK NEXT
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Please type a number in the box in response to the following questions. If you have never 
used a PRESCRIPTION DRUG IN A NON-PRESCRIBED MANNER, click NEXT, below.  
109. Age you first used a PRESCRIPTION DRUG IN A NON-PRESCRIBED MANNER 
 
110. Number of times you used a PRESCRIPTION DRUG IN A NON-PRESCRIBED 
MANNER in the past U30U days  
111. Number of times you used a PRESCRIPTION DRUG IN A NON-PRESCRIBED 
MANNER in the past U90U days  
112. Number of times you used a PRESCRIPTION DRUG IN A NON-PRESCRIBED 
MANNER in the past UyearU  
113. Number of times you used a PRESCRIPTION DRUG IN A NON-PRESCRIBED 
MANNER in your UlifetimeU  
BACK NEXT
  PAGE 14 OF 22 
Please type a number in the box in response to the following questions. If you have never 
used POLYTHENZINE, click NEXT, below.  
114. Age you first used POLYTHENZINE  
115. Number of times you used POLYTHENZINE in the past U30U days  
116. Number of times you used POLYTHENZINE in the past U90U days  
117. Number of times you used POLYTHENZINE in the past UyearU  
118. Number of times you used POLYTHENZINE in your UlifetimeU  
BACK NEXT
  PAGE 15 OF 22 
Please type a number in the box in response to the following questions. Please provide your 
best ESTIMATE. If you need to, use a plus. For example, 100+ = more than 100 times. If 
you have never used ALCOHOL, click NEXT, below.  
119. Age you first used ALCOHOL  
120. Number of times you used ALCOHOL in the past U30U days  
121. Number of times you used ALCOHOL in the past U90U  
122. Number of times you used ALCOHOL in the past UyearU  
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123. Number of times you used ALCOHOL in your UlifetimeU  
BACK NEXT
  PAGE 16 OF 22 
 
124. Please list the names of any additional drugs (not asked about above) which you 
have used in the PAST 30 DAYS. 
 
BACK NEXT
  PAGE 17 OF 22 
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If you have UEVERU used ECSTASY, please click NEXT below.  
 
If you have UNEVERU used ECSTASY , please respond with TRUE or FALSE to the 
following questions regarding reasons why you have NEVER used ECSTASY.  
 
I HAVE UNEVERU USED ECSTASY BECAUSE ........  
68. Of the cost.  
TRUE  
FALSE  
69. I know of someone who had a bad experience related to ecstasy use.  
TRUE  
FALSE  
70. I am concerned about the possible side effects.  
TRUE  
FALSE  
71. I have not been able to obtain it (lack of availability).  
TRUE  
FALSE  
72. It is illegal.  
TRUE  
FALSE  
73. I am concerned about the legal consequences if I am caught.  
TRUE  
FALSE  
74. I am concerned about becoming addicted.  
TRUE  
FALSE  
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76. Ecstasy use goes against my religious/spiritual beliefs/values.  
TRUE  
FALSE  
77. I am concerned about testing positive on a drug test (e.g., work, athletic team, 
testing by parent).  
TRUE  
FALSE  
78. My friends do not support the use of ecstasy.  
TRUE  
FALSE  
79. I have never been in an environment where others were using ecstasy (e.g., bar, 
club, friend’s house).  
TRUE  
FALSE  
80. Ecstasy does not produce the effects that I desire.  
TRUE  
FALSE  
81. Other drugs/substances that I take give me similar experiences to what I believe 
using ecstasy would give me.  
TRUE  
FALSE  
82. Are there any other reasons why you have NEVER used ECSTASY. If YES, 
please explain. If NO, please type NO. 
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83. What is the MAIN reason why you have NEVER used ECSTASY? 
 
BACK NEXT
  PAGE 8 OF 22 
 
 




165. Please estimate how many of your friends currently use ecstasy. Please think 
of friends as people with whom you regularly spend time with (at least once a 
month).  
a. None  
b. A few  
c. Some  
d. Most  
e. All  
BACK NEXT
  PAGE 19 OF 22
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Appendix G 
Reasons for the Use of Ecstasy Scale: AMPS 
PLEASE ANSWER THE FOLLOWING QUESTIONS REGARDING THE 
REASONS YOU HAVE USED ECSTASY.  
HOW OFTEN HAVE YOU USED ECSTASY TO …….. 
33. Make yourself feel better when down or depressed?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
34. Help you to 'keep going' on a night out with friends?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
35. Help you to feel elated or euphoric?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
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36. Just get really stoned or intoxicated?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
37. Help you to lose weight?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
 
38. Help you to enjoy the company of your friends?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
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39. Help you to relax?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
40. Help you to feel more confident or better able to talk to people in a social situation?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
41. Improve the effects of other substances?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always 
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42. Help ease the after effects of other substances?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
43. Help you to stay awake?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
44. Help you to lose your inhibitions?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
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45. Enhance feelings when having sex?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
46. Help you to stop worrying about a problem?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
47. Help make something you were doing less boring?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
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48. Help you to concentrate, to work, or to study?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
49. Enhance an activity such as listening to music, playing a game or playing a sport?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
50. Enhance empathy?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
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51. Enhance sensations (touch, taste, sight and smell)?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
52. Enhance intimacy?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
53. Develop insight into yourself?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
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54. Develop insight into others?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
55. Increase your ability to express yourself openly and honestly?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
56. Have a new experience that would help you to see the world differently?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
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57. As part of religious/spiritual practices?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
58. Facilitate a psychotherapeutic process?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
59. Facilitate creative processes such as drawing, writing, playing music, singing or other 
artistic activities?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
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60. Relieve pain?  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
61. Fit in with peers (because others were using)  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
e. Always  
62. Because it was there (available where you were spending time)  
a. Never  
b. Rarely  
c. Sometimes  
d. Often  
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63. Are there any other reasons why you have used ecstasy? If yes, please list each reason 
and specify how often you used ecstasy for each reason. (Rarely, Sometimes, Often, or 
Always). If there are no other reasons, please type NO. 
 
64. People use ecstasy for many different reasons. Is there a main reason why you use or 
used ecstasy? If yes, please explain your reason. If no, please type NO. 
 
BACK NEXT
  PAGE 6 OF 22 
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Appendix H 
Frequency Distribution of Responses to the 30 Items of the Reasons for Use of Ecstasy 
Scale: AMPS 
Frequency of Participants Who Endorsed Having Ever Used Ecstasy for Each of the 30 
Items (Reasons for Ecstasy Use)      
 
 
Reason for Use of Ecstasy     Frequency 
 
 








Help you to feel elated or euphoric 
 
207 
Just get really stoned or intoxicated  168 
 
Help you to lose weight  
 
24 




Help you to relax  
 
128 
Help you to feel more confident or better  
able to talk to people in a social situation  
 
127 
Improve the effects of other substances  
 
97 




Help you to stay awake  
 
87 
Help you to lose your inhibitions 
 
128 
Enhance feelings when having sex  
 
115 

















Enhance an activity such as listening to 
music, playing a game or playing a sport  
 
159 
Enhance empathy  
 
127 




Enhance intimacy  
 
158 
Develop insight into yourself  
 
162 
Develop insight into others  
 
155 
Increase your ability to express yourself 
openly and honestly  
 
154 
Have a new experience that would help you 
to see the world differently  
 
178 
As part of religious/spiritual practices  
 
47 
Facilitate a psychotherapeutic process  64 
 
Facilitate creative processes such as 
drawing, writing, playing music, singing or 
other artistic activities  
 
98 
Relieve pain  
 
37 
Fit in with peers (others were using)  
 
87 
Because it was there 169 
 
Note. N = 221. 
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Appendix I 
Reasons for First Use of Ecstasy Scale: AMPS 
65. Please select UALLU of the reasons below for WHY YOU USED ECSTASY THE 
FIRST TIME (select as many as apply).  
a. Make yourself feel better when down or depressed  
b. Help you to 'keep going' on a night out with friends  
c. Help you to feel elated or euphoric  
d. Just get really stoned or intoxicated  
e. Help you to lose weight  
f. Help you to enjoy the company of your friends  
g. Help you to relax  
h. Help you to feel more confident or better able to talk to people in a social 
situation  
i. Improve the effects of other substances  
j. Help ease the after effects of other substances  
k. Help you to stay awake  
l. Help you to lose your inhibitions  
m. Enhance feelings when having sex  
n. Help you to stop worrying about a problem  
o. Help make something you were doing less boring  
p. Help you to concentrate, to work, or to study  
q. Enhance an activity such as listening to music, playing a game or playing a 
sport  
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r. Enhance empathy  
s. Enhance sensations (touch, taste, sight and smell)  
t. Enhance intimacy  
u. Develop insight into yourself  
v. Develop insight into others  
w. Increase your ability to express yourself openly and honestly  
x. Have a new experience that would help you to see the world differently  
y. As part of religious/spiritual practices  
z. Facilitate a psychotherapeutic process  
aa. Facilitate creative processes such as drawing, writing, playing music, singing or 
other artistic activities  
bb. Relieve pain  
cc. Fit in with peers (others were using)  
dd. Because it was there (available where you were spending time)  
ee. Curious what it would be like to use Ecstasy  
66. Are there any other reasons why you used ECSTASY the first time? 
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67. What is the MAIN reason why you FIRST USED ECSTASY? 
 
BACK NEXT
  PAGE 7 OF 22 
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Appendix J 
Measure of Knowledge and Beliefs about Ecstasy  
Please answer the following questions with either TRUE or FALSE. 
166. I have read about ecstasy on the Internet.  
TRUE  
FALSE  




168. I believe there are some jobs that I would not enjoy doing.  
TRUE  
FALSE  
169. Ecstasy is an addictive drug.  
TRUE  
FALSE  
170. I do some things better than others.  
TRUE  
FALSE  
171. I feel the benefits of using ecstasy outweigh the risks of using ecstasy.  
TRUE  
FALSE  
172. I have read books about ecstasy.  
TRUE  
FALSE  
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174. Some things don't turn out exactly as I plan them.  
TRUE  
FALSE  
175. I have read scientific research articles about ecstasy.  
TRUE  
FALSE  
176. I am more likely to engage in certain risky behaviors (unsafe sexual activity, 
driving, etc.) while using ecstasy than when I am not using ecstasy.  
TRUE  
FALSE  
177. I have sometimes hesitated before making a decision.  
TRUE  
FALSE  
178. I feel that I must (or would need to) take more ecstasy each time using in order to 
get the same desired effects.  
TRUE  
FALSE  
179. Of the people I know, I like some better than others.  
TRUE  
FALSE  
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Thank you for your interest in our Ecstasy study. Although you do not meet the 
selection criteria for this research project, please find below educational 
information about Ecstasy. If you have any questions, feel free to send an email to 
klevy@psyc.umd.edu. 
What is MDMA? 
 
MDMA (3-4 methylenedioxymethamphetamine) is more commonly known as Ecstasy and is 
a synthetic, psychoactive drug which is chemically similar to the stimulant, 
methamphetamine, and the hallucinogen, mescaline.  MDMA is known for its 
empathogenic, euphoric, and stimulant effects.  In its pure form, MDMA is a white 
crystalline powder that can be found in capsule form, in pressed pills, or as loose powder.  
One of the primary concerns for ecstasy users is purity. Ecstasy tablets may contain other 
substances in addition to MDMA which may have undesired effects.  In addition, other 
drugs which are chemically similar to MDMA are sometimes sold as ecstasy.  For example, 
PMA (paramethoxyamphetamine) is a synthetic hallucinogen that has stimulant effects that 
are similar to MDMA, but the effects take longer to occur.  Deaths by overdose of PMA 
have been reported in the U.S. and Australia.     
 
What are the biological effects of MDMA? 
 
MDMA affects the serotonin system in the brain which plays an important role in 
regulating mood, aggression, sexual activity, sleep and sensitivity to pain.  Animal research 
suggests that MDMA has long term effects on the serotonin system which appear to be 
toxic.  However, further research is needed to fully understand the effects of MDMA on the 
human brain.  A great controversy continues among researchers regarding the question of 
neurotoxicity.    
 
What are the psychological effects of MDMA? 
 
Reports of the psychological effects of MDMA vary.  Users of MDMA have frequently 
reported experiencing feelings of peace and happiness, emotional closeness with others, and 
an enhancement of the senses.  However, other reported effects that may occur during and 
sometimes days or weeks after the use of MDMA, include confusion, depression, anxiety, 
drug craving and paranoia.  
 
A recent study was conducted by Roiser, J.P., Cook, L.J., Cooper, J.D., Rubinsztein, D.C., 
and Sahakian, B.J. (2005) which examined the association between ecstasy use and 
subsequent depression.  Specifically, the focus of the research was to assess the contribution 
of a functional polymorphism in the gene encoding serotonin transporter to changes in 
emotional processing following chronic ecstasy use.  Based upon the results of their study, 
the authors hypothesize that chronic ecstasy use may cause long-term changes to the 
serotonin system, and that ecstasy users carrying the s allele may be at particular risk for 
emotional dysfunction.  Therefore, findings suggest that an individual’s risk of developing 
chronic depression as a result of taking ecstasy depends significantly on one’s genes. 
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Summary of reported effects of MDMA 
 
Below is a summary of data published by Erowid (H7H7H7H7HUwww.erowid.org UH) which was gathered 
from users, research, and other resources detailing reported effects of MDMA. It is 
important to consider individual differences in experiences.  The effects of MDMA may 
vary significantly based on a variety of factors (body chemistry, age, gender, physical 
health, etc.).  Please note that negative side effects tend to increase with higher doses and 
frequent use:  
 
• Extreme mood lift  
• Increased willingness to communicate  
• Increase in energy (stimulation)  
• Ego softening  
• Feelings of comfort, belonging, and closeness to others  
• Feelings of love and empathy  
• Forgiveness  
• Increased awareness & appreciation of music  
• Increased awareness of senses (eating, drinking, smell)  
• Profound life-changing spiritual experiences  
• Neurotically based fear dissolution  
• Bright and intense sensations  
• Urge to hug and kiss people  
• Appetite loss  
• Visual distortion  
• Rapid, involuntary eye jiggling (nystagmus)  
• Mild visual hallucinations (uncommon)  
• Moderately increased heart rate and blood pressure (increases with dose)  
• Restlessness, nervousness, shivering  
• Change in body temperature regulation  
• Upwellings of unexpected emotion, emotional lability  
• Strong desire to do or want more when coming down  
• Inappropriate and/or unintended emotional bonding  
• Tendency to say things you might feel uncomfortable about later  
• Mild to extreme jaw clenching (trisma), tongue and cheek chewing, and teeth 
grinding (bruxia)  
• Difficulty concentrating & problems with activities requiring linear focus  
• Short-term memory difficulty  
• Confusion  
• Muscle tension  
• Erectile dysfunction and difficulty achieving orgasm  
• Increase in body temperature, hyperthermia, dehydration  
• Hyponatremia  
• Nausea and vomiting  
• Headaches, dizziness, loss of balance, and vertigo  
• Sadness on coming down, sense of loss or immediate nostalgia  
• Unpleasantly harsh comedown from the peak effect  
       
220 
• Hangover the next day, lasting days to weeks  
• Mild depression and fatigue for up to a week  
• Severe depression and/or fatigue  
• Possible psychological addiction (strong urge to repeat the experience)  
• Possible psychological distress requiring hospitalization (psychotic episodes, sever 
panic attacks) (rare)  
• Possible Liver toxicity (rare)  
• Possible neurotoxicity (controversial)  
• Risk of death (approximately 2 per 100,000 users have extreme negative reactions 
resulting in death) (rare)  
 
Erowid. (2005, November 19). MDMA Effects. Erowid.org. 
H8H8H8H8HUhttp://www.erowid.org/chemicals/mdma/mdma_effects.shtml UH.  
 
Is MDMA legal? 
 
No.  Ecstasy is classified as a "Schedule 1" controlled substance in the United States.  It is 
illegal to buy, sell, or possess MDMA without a DEA license.  It is also listed as Schedule I in 





http:// H9H9H9H9Hwww.maps.org H 
http:// H10H10H10H10Hwww.whitehousedrugpolicy.gov H 
http:// H11H11H11H11Hwww.nida.nih.govH 
H12H12H12H12Hhttp://www.dea.govH 
http:// H13H13H13H13Hwww.erowid.org H 
H14H14H14H14Hhttp://ajp.psychiatryonline.org H 
Association of a Functional Polymorphism in the Serotonin Transporter Gene With 
Abnormal Emotional Processing in Ecstasy Users. Roiser, Jonathan P.; Cook, 
Lynnette J.; Cooper, Jason D.; American Journal of Psychiatry, Vol 162(3), Mar 
2005. pp. 609-612. 




INFORMED CONSENT FORM 
 
 
Project Title: Substance Use Among Young Adults  
 
Why is this research being done?  
This is a research project being conducted by Kevin O'Grady, Ph.D. and Kira Levy, 
M.A. at the University of Maryland, College Park, Department of Psychology. We 
are inviting you to participate in this research project because you live in the United 
States, are between the ages of 18 and 25 and have a history of substance use. The 
purpose of this study is to increase researchers' understanding of young adults’ use 
of various substances (Ecstasy, Amphetamines, LSD, Cocaine Powder, Psilocybin 
Mushrooms, Heroin, and a prescription drug in a non-prescribed manner) in the 
United States, with a particular focus on Ecstasy, a street drug often referred to as 
'X.' The data obtained from this study will be used to gain a clearer understanding 
of the reasons young adults use Ecstasy.  
 
What will I be asked to do?  
The procedure involves completing an ANONYMOUS internet survey which will 
take approximately 15 to 30 minutes. The survey will ask you questions about the 
following main topics: 1) your history of drug use; 2) use of ecstasy by your peers; 3) 
your motivation for using ecstasy; 4) your interests and preferences; 5) your 
opinions and experiences with a variety of situations and 6) your religious beliefs.  
 
Will I be compensated for participating in this research?  
After completing the survey, you will be asked if you would like to participate in a 
lottery for $50. This is completely optional. In order to participate in the lottery, you 
will need to provide an email address that will not be connected in any way to the 
information you provide in the survey. You will be provided instructions for how to 
create a free email account which will be used for the lottery. If you are a winner in 
the lottery, an email will be sent from an internet service, PayPal, to the email 
address you provide. This email will instruct you how to open a free PayPal account 
which will enable you to either transfer the $50 you won to a checking account, 
request a check, or send the $50 to someone else.  
 
 
What about confidentiality?  
This is an anonymous survey. Each survey will be assigned a participant number. 
You will not be asked to provide any identifying information. Thus, information 
that you provide will NOT contain your name or IP address and CANNOT be 
connected to you in any way. The data collected from this study will be stored as a 
file and only the website administrators of the Office of Information Technology at 
the University of Maryland, College, Park as well as Dr. O'Grady, an Associate 
Professor, and Kira Levy, M.A., a doctoral student, in the Department of 
Psychology at the University of Maryland, College Park will have access to the data. 
If you choose to participate in the lottery, the file containing your email address will 
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be deleted as soon as the lottery has been completed. The data from the surveys will 
be kept for ten years on the personal computer of Kira Levy in password-protected 
form (only Dr. O'Grady and Kira Levy will know the password). The results of this 
study may be written up in the form of a report or an article.  
 
What are the risks of this research?  
There are no known risks to my participation in this research. However, in filling 
out the survey, you might become upset in thinking about your personal experiences 
relating to drug use. The study investigators, Kevin O'Grady, Ph.D. and Kira Levy, 
M.A., will be available by email or phone if you experience any distress related to 
this study. Either Dr. O'Grady or Ms. Levy will answer any questions you have and 
provide a referral for mental health resources, if necessary. You will also be 
provided educational information and a list of educational web sites pertaining to 
substance use.  
 
What are the benefits of this research?  
This research is not designed to help you personally, though you may benefit by 
deepening your understanding of the drug, Ecstasy, through your participation, and 
by obtaining educational information. In addition, after all study analyses have been 
completed, the practical implications of the general findings of this study will be 
made available to you upon your request, by sending an email to 
ogrady@psyc.umd.edu.  
 
Do I have to be in this research? May I stop participating at any time?  
Your participation in this research is completely voluntary. You may choose to not 
take part at all. If you decide to participate in this research, you may stop 
participating at any time. If you decide not to participate in this study or if you stop 
participating at any time, you will not be penalized or lose any benefits to which you 
otherwise qualify.  
 
What if I have questions?  
This research is being conducted by Kevin O'Grady, Ph.D. and Kira Levy, M.A. at 
the University of Maryland, College Park, Department of Psychology. If you have 
any questions about the research study itself, please contact Kira Levy, M.A. at: The 
University of Maryland, 2123H Biology-Psychology Building; (e-mail) 
klevy@psyc.umd.edu OR Kevin O'Grady, Ph.D. at: The University of Maryland, 
2123H Biology-Psychology Building; (e-mail) ogrady@umd.edu; (telephone) (301) 
405-5902.  
 
If you have any questions about your rights as a research subject or wish to report a 
research-related injury, please contact: Institutional Review Board Office, 
University of Maryland, College Park, Maryland, 20742; (e-mail) 
irb@deans.umd.edu; (telephone) 301-405-0678. 
This research has been reviewed according to the University of Maryland, College 
Park IRB procedures for research involving human subjects.  
 
By clicking on the NEXT button below, you are electronically signing this informed 
consent form and certifying that:  
o You are between the ages of 18 and 25.  
o You have read and understand the contents of this informed consent form.  
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o Your questions have been answered.  
o You freely and voluntarily choose to participate in this research project.  
 
YOU MAY PRINT A COPY OF THIS PAGE BY HOLDING DOWN THE 
‘Ctrl’ KEY AND PRESSING THE ‘P’ KEY  
BACK NEXT
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Thank you for your participation in our research study. We greatly appreciate your 
willingness to share your experiences which will further our knowledge regarding 
the use of Ecstasy among young adults. Please find below educational 
information about Ecstasy. If you have any questions, or would like to be informed 
of the research findings once the study is complete, please send an email to 
H15H15H15H15HUklevy@psyc.umd.edu UH.   If you are interested in entering the lottery, please click on 
the button at the bottom of this page. 
 
What is MDMA? 
 
MDMA (3-4 methylenedioxymethamphetamine) is more commonly known as Ecstasy and is 
a synthetic, psychoactive drug which is chemically similar to the stimulant, 
methamphetamine, and the hallucinogen, mescaline.  MDMA is known for its 
empathogenic, euphoric, and stimulant effects.  In its pure form, MDMA is a white 
crystalline powder that can be found in capsule form, in pressed pills, or as loose powder.  
One of the primary concerns for ecstasy users is purity. Ecstasy tablets may contain other 
substances in addition to MDMA which may have undesired effects.  In addition, other 
drugs which are chemically similar to MDMA are sometimes sold as ecstasy.  For example, 
PMA (paramethoxyamphetamine) is a synthetic hallucinogen that has stimulant effects that 
are similar to MDMA, but the effects take longer to occur.  Deaths by overdose of PMA 
have been reported in the U.S. and Australia.     
 
What are the biological effects of MDMA? 
 
MDMA affects the serotonin system in the brain which plays an important role in 
regulating mood, aggression, sexual activity, sleep and sensitivity to pain.  Animal research 
suggests that MDMA has long term effects on the serotonin system which appear to be 
toxic.  However, further research is needed to fully understand the effects of MDMA on the 
human brain.  A great controversy continues among researchers regarding the question of 
neurotoxicity.    
 
What are the psychological effects of MDMA? 
 
Reports of the psychological effects of MDMA vary.  Users of MDMA have frequently 
reported experiencing feelings of peace and happiness, emotional closeness with others, and 
an enhancement of the senses.  However, other reported effects that may occur during and 
sometimes days or weeks after the use of MDMA, include confusion, depression, anxiety, 
drug craving and paranoia.  
 
A recent study was conducted by Roiser, J.P., Cook, L.J., Cooper, J.D., Rubinsztein, D.C., 
and Sahakian, B.J. (2005) which examined the association between ecstasy use and 
subsequent depression.  Specifically, the focus of the research was to assess the contribution 
of a functional polymorphism in the gene encoding serotonin transporter to changes in 
emotional processing following chronic ecstasy use.  Based upon the results of their study, 
the authors hypothesize that chronic ecstasy use may cause long-term changes to the 
serotonin system, and that ecstasy users carrying the s allele may be at particular risk for 
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emotional dysfunction.  Therefore, findings suggest that an individual’s risk of developing 
chronic depression as a result of taking ecstasy depends significantly on one’s genes. 
   
Summary of reported effects of MDMA 
 
Below is a summary of data published by Erowid (H16H16H16H16HUwww.erowid.org UH) which was gathered 
from users, research, and other resources detailing reported effects of MDMA. It is 
important to consider individual differences in experiences.  The effects of MDMA may 
vary significantly based on a variety of factors (body chemistry, age, gender, physical 
health, etc.).  Please note that negative side effects tend to increase with higher doses and 
frequent use:  
 
• Extreme mood lift  
• Increased willingness to communicate  
• Increase in energy (stimulation)  
• Ego softening  
• Feelings of comfort, belonging, and closeness to others  
• Feelings of love and empathy  
• Forgiveness  
• Increased awareness & appreciation of music  
• Increased awareness of senses (eating, drinking, smell)  
• Profound life-changing spiritual experiences  
• Neurotically based fear dissolution  
• Bright and intense sensations  
• Urge to hug and kiss people  
• Appetite loss  
• Visual distortion  
• Rapid, involuntary eye jiggling (nystagmus)  
• Mild visual hallucinations (uncommon)  
• Moderately increased heart rate and blood pressure (increases with dose)  
• Restlessness, nervousness, shivering  
• Change in body temperature regulation  
• Upwellings of unexpected emotion, emotional lability  
• Strong desire to do or want more when coming down  
• Inappropriate and/or unintended emotional bonding  
• Tendency to say things you might feel uncomfortable about later  
• Mild to extreme jaw clenching (trisma), tongue and cheek chewing, and teeth 
grinding (bruxia)  
• Difficulty concentrating & problems with activities requiring linear focus  
• Short-term memory difficulty  
• Confusion  
• Muscle tension  
• Erectile dysfunction and difficulty achieving orgasm  
• Increase in body temperature, hyperthermia, dehydration  
• Hyponatremia  
• Nausea and vomiting  
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• Headaches, dizziness, loss of balance, and vertigo  
• Sadness on coming down, sense of loss or immediate nostalgia  
• Unpleasantly harsh comedown from the peak effect  
• Hangover the next day, lasting days to weeks  
• Mild depression and fatigue for up to a week  
• Severe depression and/or fatigue  
• Possible psychological addiction (strong urge to repeat the experience)  
• Possible psychological distress requiring hospitalization (psychotic episodes, severe 
panic attacks) (rare)  
• Possible Liver toxicity (rare)  
• Possible neurotoxicity (controversial)  
• Risk of death (approximately 2 per 100,000 users have extreme negative reactions 
resulting in death) (rare)  
 
Erowid. (2005, November 19). MDMA Effects. Erowid.org. 
H17H17H17H17HUhttp://www.erowid.org/chemicals/mdma/mdma_effects.shtml UH.  
 
Is MDMA legal? 
 
No.  Ecstasy is classified as a "Schedule 1" controlled substance in the United States.  It is 
illegal to buy, sell, or possess MDMA without a DEA license.  It is also listed as Schedule I in 





http:// H18H18H18H18Hwww.maps.org H 
http:// H19H19H19H19Hwww.whitehousedrugpolicy.gov H 
http:// H20H20H20H20Hwww.nida.nih.govH 
H21H21H21H21Hhttp://www.dea.govH 
http:// H22H22H22H22Hwww.erowid.org H 
H23H23H23H23Hhttp://ajp.psychiatryonline.org H 
Association of a Functional Polymorphism in the Serotonin Transporter Gene With 
Abnormal Emotional Processing in Ecstasy Users. Roiser, Jonathan P.; Cook, 
Lynnette J.; Cooper, Jason D.; American Journal of Psychiatry, Vol 162(3), Mar 
2005. pp. 609-612. 
 
 
Thanks again for your participation! 
 
CLICK H24H24H24H24HUhere UH IF YOU ARE INTERESTED IN ENTERING THE LOTTERY 
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Appendix N 
Intercorrelations of Primary Dependent Variables 
Intercorrelations of Primary Dependent Variables 
    
 
The CORR Procedure 
 
  18  Variables:    TAS      ES       DIS      BS       NORMATIV SCLAW    SCLIB 
                    SCRELIG  CRRISK   FRRISK   MVRRISK  SRRISK   CRBEH    FRBEH 
                    MVRBEH   SRBEH    MOOD     TOTAL90 
 
 
                                 Simple Statistics 
 
                    Variable   Label 
 
                    TAS        SSS Thrill and Adventure Seeking 
                    ES         SSS Experience Seeking 
                    DIS        SSS Disinhibition 
                    BS         SSS Boredom Susceptibility 
                    NORMATIV   Normative Influence 
                    SCLAW      SC Law Abidance 
                    SCLIB      SC Liberalism 
                    SCRELIG    SC Religiosity 
                    CRRISK    GRAS Crime Risk Appraisal 
                    FRRISK    GRAS Financial Risk Appraisal  
                    MVRRISK    GRAS Minor Violations Risk Appraisal   
                    SRRISK     GRAS Sports Risk Appraisal 
                    CRBEH    GRAS Crime Behavior 
                    FRBEH      GRAS Financial Risky Behavior 
                    MVRBEH     GRAS Minor Violations Behavior 
                    SRBEH    Sports Risky Behavior 
                    MOOD       Reasons for Use  
                    TOTAL90    Number of Drugs Used Past 90 Days 
 
 
The CORR Procedure 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                        TAS        ES       DIS        BS  NORMATIV 
 
 TAS                                1.00000   0.27694   0.15381   0.14477   0.04414 
 SSS thrill and adventure seeking              <.0001    0.0057    0.0093    0.4299 
                                        322       322       322       322       322 
 
 ES                                 0.27694   1.00000   0.13409   0.16841   0.07652 
 SSS experience seeking              <.0001              0.0161    0.0024    0.1708 
                                        322       322       322       322       322 
 
 DIS                                0.15381   0.13409   1.00000   0.33888   0.05229 
 SSS disinhibition                   0.0057    0.0161              <.0001    0.3496 
                                        322       322       322       322       322 
 
 BS                                 0.14477   0.16841   0.33888   1.00000   0.08936 
 SSS boredom susceptability          0.0093    0.0024    <.0001              0.1095 
                                        322       322       322       322       322 
 
 NORMATIV                           0.04414   0.07652   0.05229   0.08936   1.00000 
 normativ                            0.4299    0.1708    0.3496    0.1095 
                                        322       322       322       322       322 
       
228 
 
 SCLAW                             -0.09983  -0.03733  -0.31623  -0.30972  -0.09410 
 SC law abidance                     0.0736    0.5045    <.0001    <.0001    0.0918 
                                        322       322       322       322       322 
 
 SCLIB                             -0.05591   0.24250   0.05512   0.09278   0.02279 
 SC liberalism                       0.3173    <.0001    0.3241    0.0965    0.6838 
                                        322       322       322       322       322 
             
                                 The CORR Procedure 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                      SCLAW     SCLIB   SCRELIG    CRRISK    FRRISK 
 
 TAS                               -0.09983  -0.05591  -0.10870  -0.18465  -0.08130 
 SSS thrill and adventure seeking    0.0736    0.3173    0.0513    0.0009    0.1462 
                                        322       322       322       321       321 
 
 ES                                -0.03733   0.24250  -0.17104  -0.12129  -0.00770 
 SSS experience seeking              0.5045    <.0001    0.0021    0.0298    0.8908 
                                        322       322       322       321       321 
 
 DIS                               -0.31623   0.05512  -0.15685  -0.13582  -0.04023 
 SSS disinhibition                   <.0001    0.3241    0.0048    0.0149    0.4726 
                                        322       322       322       321       321 
 
 BS                                -0.30972   0.09278  -0.28460  -0.13548  -0.00320 
 SSS boredom susceptability          <.0001    0.0965    <.0001    0.0151    0.9545 
                                        322       322       322       321       321 
 
 NORMATIV                          -0.09410   0.02279  -0.06028  -0.10639  -0.09788 
 normativ                            0.0918    0.6838    0.2808    0.0569    0.0799 
                                        322       322       322       321       321 
 
 SCLAW                              1.00000  -0.15670   0.19130   0.23250   0.07275 
 SC law abidance                               0.0048    0.0006    <.0001    0.1936 
                                        322       322       322       321       321 
 
 SCLIB                             -0.15670   1.00000  -0.12831   0.00302   0.11507 
 SC liberalism                       0.0048              0.0213    0.9570    0.0394 
                                        322       322       322       321       321 
                                 The CORR Procedure 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                    MVRRISK    SRRISK     CRBEH     FRBEH    MVRBEH 
 
 TAS                               -0.13665  -0.27804   0.14469  -0.00077   0.12036 
 SSS thrill and adventure seeking    0.0164    <.0001    0.0094    0.9890    0.0347 
                                        308       309       321       321       308 
 
 ES                                -0.08309  -0.06975   0.20431   0.09617   0.08229 
 SSS experience seeking              0.1457    0.2215    0.0002    0.0854    0.1497 
                                        308       309       321       321       308 
 
 DIS                               -0.12463   0.01403   0.28099   0.12207   0.21401 
 SSS disinhibition                   0.0288    0.8060    <.0001    0.0288    0.0002 
                                        308       309       321       321       308 
 
 BS                                -0.14118  -0.05955   0.21631   0.06532   0.24004 
 SSS boredom susceptibility          0.0131    0.2967    <.0001    0.2432    <.0001 
                                        308       309       321       321       308 
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 NORMATIV                          -0.01366   0.02586   0.08832   0.09952   0.06261 
 normative                           0.8113    0.6506    0.1143    0.0750    0.2733 
                                        308       309       321       321       308 
 
 SCLAW                              0.12681  -0.00006  -0.35984   0.01390  -0.15279 
 SC law abidance                     0.0261    0.9992    <.0001    0.8041    0.0072 
                                        308       309       321       321       308 
 
 SCLIB                              0.06912   0.02644   0.16305  -0.16057  -0.00305 
 SC liberalism                       0.2264    0.6434    0.0034    0.0039    0.9574 
                                        308       309       321       321       308 
 
The CORR Procedure 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                            SRBEH          MOOD       TOTAL90 
 
       TAS                                0.32515      -0.13032       0.16778 
       SSS thrill and adventure seeking    <.0001        0.0530        0.0025 
                                              309           221           322 
 
       ES                                 0.08940      -0.06257       0.09556 
       SSS experience seeking              0.1168        0.3545        0.0869 
                                              309           221           322 
 
       DIS                                0.02421       0.08931       0.19265 
       SSS disinhibition                   0.6717        0.1859        0.0005 
                                              309           221           322 
 
       BS                                 0.05640       0.06328       0.24736 
       SSS boredom susceptibility          0.3231        0.3491        <.0001 
                                              309           221           322 
 
       NORMATIV                           0.01691       0.00605       0.27336 
       normative                           0.7672        0.9287        <.0001 
                                              309           221           322 
 
       SCLAW                              0.06505      -0.11197      -0.25881 
       SC law abidance                     0.2542        0.0968        <.0001 
                                              309           221           322 
 
       SCLIB                             -0.15066       0.01922       0.13659 
       SC liberalism                       0.0080        0.7763        0.0142 
                                              309           221           322 
The CORR Procedure 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                        TAS        ES       DIS        BS  NORMATIV 
 
 SCRELIG                           -0.10870  -0.17104  -0.15685  -0.28460  -0.06028 
 SC religiosity                      0.0513    0.0021    0.0048    <.0001    0.2808 
                                        322       322       322       322       322 
 
 CRRISK                            -0.18465  -0.12129  -0.13582  -0.13548  -0.10639 
                                     0.0009    0.0298    0.0149    0.0151    0.0569 
                                        321       321       321       321       321 
 
 FRRISK                            -0.08130  -0.00770  -0.04023  -0.00320  -0.09788 
                                     0.1462    0.8908    0.4726    0.9545    0.0799 
                                        321       321       321       321       321 
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 MVRRISK                           -0.13665  -0.08309  -0.12463  -0.14118  -0.01366 
                                     0.0164    0.1457    0.0288    0.0131    0.8113 
                                        308       308       308       308       308 
 
 SRRISK                            -0.27804  -0.06975   0.01403  -0.05955   0.02586 
                                     <.0001    0.2215    0.8060    0.2967    0.6506 
                                        309       309       309       309       309 
 
 CRBEH                              0.14469   0.20431   0.28099   0.21631   0.08832 
                                     0.0094    0.0002    <.0001    <.0001    0.1143 
                                        321       321       321       321       321 
 
 FRBEH                             -0.00077   0.09617   0.12207   0.06532   0.09952 
                                     0.9890    0.0854    0.0288    0.2432    0.0750 
                                        321       321       321       321       321 
             
                                 The CORR Procedure 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                      SCLAW     SCLIB   SCRELIG    CRRISK    FRRISK 
 
 SCRELIG                            0.19130  -0.12831   1.00000   0.10215  -0.02621 
 SC religiosity                      0.0006    0.0213              0.0676    0.6399 
                                        322       322       322       321       321 
 
 CRRISK                             0.23250   0.00302   0.10215   1.00000   0.45680 
                                     <.0001    0.9570    0.0676              <.0001 
                                        321       321       321       321       321 
  
FRRISK                             0.07275   0.11507  -0.02621   0.45680   1.00000 
                                     0.1936    0.0394    0.6399    <.0001 
                                        321       321       321       321       321 
 
 MVRRISK                            0.12681   0.06912   0.08200   0.59940   0.36040 
                                     0.0261    0.2264    0.1511    <.0001    <.0001 
                                        308       308       308       308       308 
 
 SRRISK                            -0.00006   0.02644   0.11109   0.32806   0.19198 
                                     0.9992    0.6434    0.0511    <.0001    0.0007 
                                        309       309       309       309       309 
 
 CRBEH                             -0.35984   0.16305  -0.06342  -0.26071  -0.02651 
                                     <.0001    0.0034    0.2572    <.0001    0.6361 
                                        321       321       321       321       321 
 
 FRBEH                              0.01390  -0.16057   0.08079  -0.05548  -0.02933 
                                     0.8041    0.0039    0.1487    0.3217    0.6006 
                                        321       321       321       321       321 
                                 The CORR Procedure 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                    MVRRISK    SRRISK     CRBEH     FRBEH    MVRBEH 
 
 SCRELIG                            0.08200   0.11109  -0.06342   0.08079  -0.06715 
 SC religiosity                      0.1511    0.0511    0.2572    0.1487    0.2400 
                                        308       309       321       321       308 
 
 CRRISK                             0.59940   0.32806  -0.26071  -0.05548  -0.19344 
                                     <.0001    <.0001    <.0001    0.3217    0.0006 
                                        308       309       321       321       308 
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 FRRISK                             0.36040   0.19198  -0.02651  -0.02933   0.09367 
                                     <.0001    0.0007    0.6361    0.6006    0.1008 
                                        308       309       321       321       308 
 
 MVRRISK                            1.00000   0.40412  -0.11095  -0.04101  -0.23476 
                                               <.0001    0.0518    0.4733    <.0001 
                                        308       308       308       308       308 
 
 SRRISK                             0.40412   1.00000   0.02181   0.06355  -0.00070 
                                     <.0001              0.7026    0.2654    0.9902 
                                        308       309       309       309       308 
 
 CRBEH                             -0.11095   0.02181   1.00000   0.18634   0.40065 
                                     0.0518    0.7026              0.0008    <.0001 
                                        308       309       321       321       308 
 
 FRBEH                             -0.04101   0.06355   0.18634   1.00000   0.26984 
                                     0.4733    0.2654    0.0008              <.0001 
                                        308       309       321       321       308 
             
                                 The CORR Procedure 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
        
                                      SRBEH          MOOD       TOTAL90 
 
       SCRELIG                           -0.05136       0.06409      -0.17202 
       SC religiosity                      0.3682        0.3430        0.0019 
                                              309           221           322 
 
       CRRISK                            -0.07045      -0.05473      -0.12172 
                                           0.2169        0.4192        0.0292 
                                              309           220           321 
 
       FRRISK                             0.02718      -0.08283      -0.01632 
                                           0.6341        0.2211        0.7708 
                                              309           220           321 
 
       MVRRISK                           -0.02627      -0.05574      -0.08909 
                                           0.6461        0.4206        0.1187 
                                              308           211           308 
 
       SRRISK                            -0.10064      -0.07599      -0.03079 
                                           0.0773        0.2719        0.5897 
                                              309           211           309 
 
       CRBEH                              0.02141       0.02351       0.24694 
                                           0.7078        0.7287        <.0001 
                                              309           220           321 
 
       FRBEH                              0.07200      -0.04825      -0.09062 
                                           0.2069        0.4765        0.1051 
                                              309           220           321 
        
                                 The CORR Procedure 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                        TAS        ES       DIS        BS  NORMATIV 
 
 MVRBEH                             0.12036   0.08229   0.21401   0.24004   0.06261 
                                     0.0347    0.1497    0.0002    <.0001    0.2733 
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                                        308       308       308       308       308 
 
 SRBEH                              0.32515   0.08940   0.02421   0.05640   0.01691 
                                     <.0001    0.1168    0.6717    0.3231    0.7672 
                                        309       309       309       309       309 
 
 MOOD                              -0.13032  -0.06257   0.08931   0.06328   0.00605 
 mood                                0.0530    0.3545    0.1859    0.3491    0.9287 
                                        221       221       221       221       221 
 
 TOTAL90                            0.16778   0.09556   0.19265   0.24736   0.27336 
                                     0.0025    0.0869    0.0005    <.0001    <.0001 
                                        322       322       322       322       322 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                      SCLAW     SCLIB   SCRELIG    CRRISK    FRRISK 
 
 MVRBEH                            -0.15279  -0.00305  -0.06715  -0.19344   0.09367 
                                     0.0072    0.9574    0.2400    0.0006    0.1008 
                                        308       308       308       308       308          
                                  
SRBEH                              0.06505  -0.15066  -0.05136  -0.07045   0.02718 
                                     0.2542    0.0080    0.3682    0.2169    0.6341 
                                        309       309       309       309       309 
 
 MOOD                              -0.11197   0.01922   0.06409  -0.05473  -0.08283 
 mood                                0.0968    0.7763    0.3430    0.4192    0.2211 
                                        221       221       221       220       220 
 
 TOTAL90                           -0.25881   0.13659  -0.17202  -0.12172  -0.01632 
                                     <.0001    0.0142    0.0019    0.0292    0.7708 
                                        322       322       322       321       321 
 
                         Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                    MVRRISK    SRRISK     CRBEH     FRBEH    MVRBEH 
 
 MVRBEH                            -0.23476  -0.00070   0.40065   0.26984   1.00000 
                                     <.0001    0.9902    <.0001    <.0001 
                                        308       308       308       308       308 
 
 SRBEH                             -0.02627  -0.10064   0.02141   0.07200   0.24471 
                                     0.6461    0.0773    0.7078    0.2069    <.0001 
                                        308       309       309       309       308                
                                 
 MOOD                              -0.05574  -0.07599   0.02351  -0.04825   0.03481 
                                     0.4206    0.2719    0.7287    0.4765    0.6151 
                                        211       211       220       220       211 
 
 TOTAL90                           -0.08909  -0.03079   0.24694  -0.09062   0.24025 
                                     0.1187    0.5897    <.0001    0.1051    <.0001 
                                        308       309       321       321       308 
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Pearson Correlation Coefficients 
                            Prob > |r| under H0: Rho=0 
                               Number of Observations 
 
                                            SRBEH          MOOD       TOTAL90 
 
       MVRBEH                             0.24471       0.03481       0.24025 
                                           <.0001        0.6151        <.0001 
                                              308           211           308 
 
       SRBEH                              1.00000       0.00675       0.08360 
                                                         0.9223        0.1426 
                                              309           211           309 
 
       MOOD                               0.00675       1.00000      -0.03599 
       mood                                0.9223                      0.5946 
                                              211           221           221           
                                
       TOTAL90                            0.08360      -0.03599       1.00000 
                                           0.1426        0.5946 
                                              309           221           322 
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